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ABSTRACT 
Techniques for the isolation and genetic manipulation of embryonic stem cells 
(ES cells) in the mouse are well established. However, little is understood regarding 
the mechanisms which enable pluripotent cells from the early mouse embryo to be 
diverted experimentally from their normal fate of differentiation in vivo and maintained 
instead in culture, as stable ES cell lines. 	Such knowledge might aid the 
establishment of ES cells from other mammalian species; particularly from farm 
animals, with the potential applications of genetically manipulating the stem cells to 
modify production traits. The objective of this thesis was to investigate various 
factors which may influence the potential of murine and ovine embryos to yield ES 
cells. 
Mouse genotype influences the capacity of embryos to give rise to ES cells. A 
significantly greater proportion of day 3.5 p.c. mouse embryos from the inbred 
129/Sv-CP strain yielded ES cell lines compared to crossbred F2 (C57BL/6 X 
CBA/Ca) embryos. The effect of mouse genotype was first observed in the 
significantly greater proportion of 129/Sv-CP embryos that gave rise to ES-like 
colonies at the first passage, following the disaggregation of inner cell mass (1CM) 
outgrowths. The efficiency of ES cell isolation was significantly increased by 
culturing murine blastocyst-stage embryos which had been induced experimentally, to 
enter a period of implantational delay for five days. 
Typically, murine ES cells have been derived from the day 3.5 p.c. 1CM, 
although day 2.5 p.c. morulae have also been used. Here, a study describes the 
isolation ofl7Stripotent  ES cell lines from the primitive ectoderm of day 5.5 p.c. egg 
cylinder-stage mouse embryos. Although this study has shown that in the mouse, 
primitive ectodermal cells influenced by endoderm can be established as ES cells in 
culture, the frequency is significantly lower than from the 1CM. ES cells isolated 
from the three different embryonic stages, equivalent to three days of development, 
have the same morphological characteristics. 
The brief exposure of day 3.5 p.c. embryos from the 129/Sv-CP mouse strain to 
treatments expected to perturb gene expression, heat shock or puromycin-containing 
medium, significantly increased the frequency of ES cell isolation. These effects 
resulted from increases in the proportion of embryos giving rise to ES-like colonies at 
the first passage which, in the case of heat shocked embryos, were also less likely to 
differentiate in subsequent passages. ES cell lines derived from embryos exposed to 
heat shock or puromycin have retained the capacity for in vivo development, as the 
stem cells colonised the germline in some chimaeric mice. These results suggest that 
1 
the isolation of ES cells depends upon reversible, epigenetic changes in the pattern of 
gene expression and that the heat shock and puromycin treatments utilised here, may 
have helped to promote these changes in vitro. It is suggested that heat shock and 
implantational delay may act through a similar mechanism; whereby the treatments may 
have interfered with the transcriptional activation of genes responsible for 
differentiation of the 1CM. 
Carbohydrate antigens which are expressed in a stage- and/or tissue-specific 
manner, have been detected on the cell surface of pre-implantation sheep embryos. Of 
the 11 antibodies studied, however, none detected antigens specific for the 1CM or 
primitive ectoderm, which could have been utilised as possible lineage markers for 
pluripotent cells, e.g. ovine ES cells. Antibodies specific for trophectodermal and 
endodermal antigens may be useful in selectively lysing differentiated cells in sheep 
stem cell cultures. 
Studies directed towards the isolation of permanent stem cell lines from sheep 
embryos were not successful in maintaining cells possessing an ES-like morphology 
for more than three passages in culture, before the cells either died or differentiated. 
In a comparison of six to nine day old embryos, day nine micro-dissected embryonic 
discs gave rise to the highest proportion of ES-like outgrowths. In addition, these 
day nine outgrowths yielded more first passage colonies, which maintained a stable 
morphology (slightly) longer. Medium containing 4% Ultroser and 5% FCS or, 
supplemented with PDGF and insulin, may have some limited effects on stimulating 
proliferation and/or maintaining a more stable ES-like cell morphology. Sheep 
embryos treated with heat shock or puromycin did not yield stable cultures of ES-like 
cells. The difficulties experienced in the isolation of stem cells from the sheep 
compared to the mouse, are due possibly to fundamental species differences in specific 
culture requirements and/or embryology. 
The studies described in this thesis have shown a better understanding of some 
of the factors which influence the capacity of murine embryos to yield permanent ES 
cell lines. These factors may also have implications for the isolation of ES cells from 
the sheep (and other species). 
11 
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Within the early mammalian embryo there exists for a brief period, a population 
of undifferentiated, pluripotent cells from which all the tissues of the foetus, including 
the germline, will develop. Two procedures have been utilised to divert pluripotent 
cells, from early mouse embryos, from their normal fate of differentiation and to 
establish them instead into tissue-culture as permanent, undifferentiated cell lines. 
Historically, the first pluripotent cells to be isolated were the embryonal carcinoma 
(EC) cell lines derived from teratocarcinomas and then later, the embryo-derived 
embryonic stem (ES) cell lines. These two cell types have many characteristics in 
common to those of pluripotent cells within the embryo itself, the major difference 
being that, under suitable culture conditions, these cell lines have the capacity for 
continued proliferation. However, when re-introduced into an early embryo, these 
stem cells retain the capacity to participate in normal in vivo development. 
This literature review describes the presence of these pluripotent cells within the 
early mouse embryo, their isolation into culture as EC or ES cells and the relationships 
between the three cell types. A section briefly reviews some of the applications of 
stem cells in the study of early development, including the exciting experiments 
involved with introducing precise genetic modifications into ES cells in vitro; with the 
aim of creating new mouse mutants, enabling the study of gene expression and 
function during in vivo development. A final section is devoted to the recent attempts 
to isolate these stem cells in species other than the mouse. 
1.1 PLURIPOTENT CELLS IN THE EARLY MURINE EMBRYO 
The orderly pattern of cell division and differentiation during early mammalian 
embryo development results in embryonic cells becoming progressively more 
specialised and allocated to form the "body plan" of the foetus. Studies utilising 
chimaeras, produced from genetically dissimilar pre-implantation embryos, have 
identified cells within the early murine embryo which are progenitors of subsequent 
tissues of the conceptus and form cell lineages (Gardner, 1985; Gardner and 
Beddington, 1988). The developmental potential of these progenitor cells may be 
classified as either totipotent (capable of contributing to all embryonic and extra-
embryonic, placental tissues of the conceptus), pluripotent (capable of contributing to 
all foetal tissues), or multipotent (contributing to only a few cell types). 
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Because of the constant change in the developmental potential of embryonic cells, the 
mammalian embryo possesses a totipotent/pluripotent cell population for a period of 
only a few days, before these cells all progressively differentiate to form the tissues of 
the developing foetus. This cell population is often referred to as "stem" cells; 
however, in embryology, this does not mean that these cells are capable of indefinite 
self-renewal in vivo, but simply that they are the "progenitor" cells of the subsequent 
foetal tissues (Gardner and Beddington, 1988). 
Following fertilisation in the mouse, all of the blastomeres up to the 16-cell-stage 
are potentially totipotent (Kelly, 1977; Ziomek et al., 1982a). Single blastomeres 
from two-cell-stage embryos have given rise to adult mice (Tarkowski, 1959). 
However, individual blastomeres from four-cell mouse embryos are probably unable 
to form viable offspring, because of the low number of cells in the inner cell mass 
(1CM) of resultant blastocysts (Kelly, 1977). When combined with genetically 
marked cells, single blastomeres from four-, eight- (Kelly, 1977) and 16-cell embryos 
(Ziomek et al., 1982a) are able to contribute to all tissues of the conceptus; that is, 
they are totipotent. 
Although the potential of blastomeres appears not to be restricted during 
cleavage, events in the non-manipulated eight- to 16-cell embryo result in the first 
differentiation of cells into two divergent cell lineages: the trophectoderm and the 1CM. 
This differentiative process commences with compaction, where the blastomeres 
increase cellular contact and become a tight mass of cells. This is then followed by 
cell polarisation, generating a population of six to eight inner (apolar) cells, which will 
form the 1CM, and eight to 10 outer (polar) cells, which will form the trophectoderm 
of the so-called blastocyst- stage embryo (Ziomek et al., 1982b). Cell lability may 
persist beyond the time of normal lineage allocation in the embryo, as early ICMs have 
the capacity to form trophectoderm derivatives in chimaeric conceptuses (Rossant and 
Lis, 1979). 
The first differentiative event ends on day 3.5 post coitum (day 0.5 p.c. is the 
morning of detection of the copulation plug) with the formation of a fully expanded, 
fluid-filled blastocyst consisting of an outer spherical layer of trophectoderm (which is 
multipotent, forming some tissues of the placenta) and a small group of around 15-20 
1CM cells at one pole of the embryo. At this stage, the cells of the 1CM are only 
plunpotent as they have lost the potential to form trophectoderm (Gardner, 1985). 
The next differentiative event is completed by 4.5 days p.c. (just prior to 
implantation) and involves the delamination of a primitive endoderm (or hypoblast) 
layer from the blastocoelic surface of the 1CM. The remaining 1CM is termed the 
primitive ectoderm (or epiblast) and colonises the foetus, extra-embryonic mesoderm 
and amniotic ectoderm - but not the extra-embryonic endodermal lineages (Gardner 
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and Rossant, 1979; Gardner, 1982). The findings of Gardner and co-workers (1985) 
have suggested that the majority of cells from the day 4.5 p.c. primitive ectoderm may 
all be equally pluripotent. 
As the cells of the trophectodermal and primitive endodermal lineages establish 
the 	implantation site , the primitive ectoderm proliferates rapidly, forming a pseudo- 
stratified epithelium, with no morphological signs of differentiation in the day 6.5 p.c. 
egg cylinder-stage embryo (Gardner and Beddington, 1988). Indirect methods have 
been utilised to study the fate of cells from post-implantation embryos, as there are 
technical difficulties in performing in vivo chimaeric analyses on such advanced 
developmental stages. The production of offspring following the destruction of 85% 
of the day 6.5 to 7.0 p.c. primitive ectoderm, has suggested that the allocation of cells 
to different lineages within the epiblast is unlikely (Snow and Tam, 1979). The short-
term in vitro experiments conducted by Beddington (1982), where regions of the day 
7.5 p.c. primitive ectoderm were grafted into heterotopic positions in synchronous host 
embryos, revealed that the posterior and distal regions of the primitive ectoderm were 
developmentally labile and not restricted to their normal fate. This was compatible 
with the concept that cell position plays an important role in the fate of cells colonising 
a particular lineage (Tarkowski and Wroblewska, 1967). The anterior region of the 
primitive ectoderm, in contrast, was shown by day 7.5 p.c. to have a strong preference 
to form the definitive ectoderm of the foetus (Beddington, 1982). This marks the 
beginning of 	 the overt differentiation of the primitive ectoderm into the 
extra-embryonic mesoderm and the definitive layers of the foetus itself - the embryonic 
ectoderm, endoderm and mesoderm. Hence, the loss of pluripotent cells from the 
mouse embryo occurs after day 7.5 p.c.. 
The germ cells are another source of potentially totipotent cells. In the mouse, 
the germ cell progenitors are not apparent until day 7.5 p.c. and are derived from the 
primitive ectoderm (Gardner et al., 1985; Ginsburg, Snow and McLaren, 1990). The 
germ cells themselves have restricted potential forming very specialised gametes. 
However, following fertilisation totipotency is restored to the zygote. 
1.2 MURINE EMBRYONAL CARCINOMA CELL LINES 
Spontaneous teratocarcinomas are tumours that most commonly occur in humans 
and certain inbred strains of mice and may occur in the gonads of both males and 
females. Teratocarcinomas may be composed of a chaotic array of many kinds of 
cells and tissues in various stages of maturation (Stevens and Hummel, 1957). Their 
stem cells, embryonal carcinoma (EC) cells, maintain the malignancy of the tumour, 
self-renewing the stem cell population and are pluripotent, differentiating to form the 
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cellular derivatives of the three primary germ layers - embryonic ectoderm, endoderm 
and mesoderm (Kleinsmith and Pierce, 1964). When all of the EC cells differentiate, 
the tumours become benign and are instead called teratomas. Unless specifically 
qualified, both types of tumour have been included in the general term "teratoma" in 
this thesis. 
This section reviews some of the factors which may influence the development 
of spontaneous and experimentally induced murine teratocarcinomas (from either male 
primordial germ cells or from early embryos) and the in vitro isolation and 
developmental characteristics of EC cells, derived from these tumours. 
1.2.1 Testicular Teratomas 
In mice, congenital testicular teratomas were first observed in 
approximately 1% of the males from a line of mice of the inbred 129 strain, 
subsequently designated 129/Sv (Stevens and Little, 1954). A number of genetic loci 
have been found to influence the susceptibility of mice to testicular teratomas. The 
introduction of the mutant Steel gene (Sly) onto the 129/Sv genetic background, 
markedly increased the incidence of spontaneous teratomas (to around 7%: Stevens 
and Mackensen, 1961). The males of a subline of mice (129/terSv) congeneic with 
129/Sv have a high (30%) spontaneous incidence of congenital testicular teratomas, 
thought to have been due to a single gene mutation (Stevens, 1973). The presence of 
the AY allele at the agouti locus has been shown to decrease the incidence of testicular 
teratomas (Stevens, 1975). 
Spontaneous testicular teratomas originate from the foetal primordial 
germ cells within the seminiferous tubules (Stevens, 1962). Abnormal proliferation 
of the primordial germ cells leads to the formation of embryonic ectoderm-like 
structures, which subsequently become disorganised and form tumours (Stevens, 
1983). Indeed, Pierce and Beals (1964) have noted the similarities in the 
ultrastructural morphology between primordial germ cells and EC cells. 
Testicular teratomas may be induced experimentally in some strains of 
mice (particularly strains 129/Sv-Sl and AIHeJ; Stevens, 1970a) by grafting (male) 
germinal ridges from day 12.5 to 13.5 p.c. foetuses into the testes of histocompatible 
adults (Stevens, 1964). The sex of the germinal ridge from day 12.5 p.c. foetuses 
cannot be morphologically determined and so half of the grafts developed into ovaries 
which did not contain teratomas (Stevens, 1964), presumably because the female 
primordial germ cells had entered meiosis (Monk and McLaren, 1981). 
The site of the graft appears to be important When germinal ridges 
were transplanted to abdominal sites, although they developed into testes, few of them 
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contained teratomas (Stevens, 1970b). Subsequently, Stevens (1975) demonstrated 
that the lower temperature of the scrotum enhanced the induction of 
teratocarcinogenesis. Age of the germinal ridge was also of importance. When day 
14.5 p.c. germinal ridges were grafted, very few teratomas developed, possibly 
indicating that the diploid male primordial germ cells had matured to a point where they 
were less susceptible to tumour induction (Stevens, 1970a). 
1.2.2 Ovarian Teratomas 
division 
Ovarian teratomas originate from post-first-meioticoocytes within the 
ovary that have undergone spontaneous parthenogenetic activation in situ (Eppig et 
al., 1977). They may develop into apparently normal early egg cylinder-stage 
embryos before becoming disorganised (Stevens and Varnum, 1974). This 
disorganisation may disrupt the normal cellular relationships within the embryo and 
allow the undifferentiated cells to proliferate further, or terminally differentiate 
(Stevens, 1970c). Half of the females from the LT/Sv strain of mice may develop this 
spontaneous form of ovarian tumour (Stevens and Varnum, 1974). 
1.2.3 Embryo-Derived Teratomas 
Experimentally, benign teratomas have been readily produced in 
various inbred lines from some animal species, by transplanting embryos to extra-
uterine sites. Embryo-derived teratomas have been studied in mice (Stevens, 1970c), 
rats (Skreb, Svajger and Levak-Svajger, 1971) and hamster (Damjanov, 1978). 
Theoretically, it should be possible to generate similar tumours in other animal species 
if inbred lines are available. However, malignant teratocarcinomas have only been 
produced efficiently in inbred mouse strains. 
The factors influencing the proportion of embryos giving rise to 
teratocarcinomas may be divided into embryo- and host-related factors. 
1.2.3.1 Embryo-Related Factors 
Ectopic transplantation of mouse embryos between the two-cell-
stage and day 7.5 p.c. of development may give rise to a teratocarcinoma, whereas 
older embryos give rise only to teratomas (Stevens, 1968, 1970c; Solter, Skreb and 
Damjanov, 1970; Damjanov, Solter and Skreb, 1971). This upper limit presumably 
corresponds to the loss of pluripotent stem cell progenitors after day 7.5 p.c.. Pre-
implantation embryos develop within the ectopic site into structures resembling the egg 
cylinder-stage embryo, before becoming disorganised (Stevens, 1968). Diwan and 
Stevens (1976) have shown that only the primitive ectoderm tissue of the embryo was 
responsible for generating the teratoma. On average, less than 5% of pre-
implantation-stage embryos transferred ectopically yield teratocarcinomas (due to the 
poor embryonic development within the ectopic site), compared to around 50% 
achieved with post-implantation stages (Stevens, 1968; 1970c). 
Whilst embryo-derived teratocarcinomas can be produced in 
most, if not all, inbred mouse strains, the ratio of benign to malignant tumours may 
vary from one inbred strain to another. Utilising day 7.5 p.c. embryos transplanted 
beneath the kidney capsule, the range may be from 3:7 in BALB/c mice, 1:1 in C3H 
mice and to 9:1 in C57BL/6 mice (Damjanov, Bagasra and Solter, 1983). Mouse 
strains in which more than 50% of the embryos grafted to an ectopic site yield 
malignant tumours, are termed "teratocarcinoma-permissive" strains and include A/J, 
BALB/cJ, DBAJ2J, CBA/J and C3H/J mice (Softer, Dominis and Damjanov, 1979). 
Low yield strains such as C57BL/6J and AKR/J, are termed "teratocarcinoma-
nonpermissive". The nature of this permissiveness is not clearly understood, but may 
have genetic and epigenetic components which reside in both the embryo and the graft-
receiving adult recipient. 
Utilising reciprocal F1 embryos from various inbred mouse 
strains, Damjanov and Solter (1982) demonstrated that some crosses between 
teratocarcinoma-permissive and nonpermissive parents yielded significantly more 
malignant tumours than embryos from the nonpermissive strain; but only when the 
mother of the F1 hybrid embryo was of a permissive strain. This indicated the 
presence of some unknown maternal effect operating on the embryo. 
1.2.3.2 Host-Related Factors 
Embryo-derived teratocarcinogenesis depends upon the genetic 
background of the adult recipient and in some mouse strains, on the sex of the 
recipient also. Data from transplantation studies have clearly shown that embryos 
from some nonpermissive strains are not genetically determined to form benign 
teratomas, as they may develop into teratocarcinomas at a high frequency if 
transplanted into an appropriate histocompatible F1 host, as opposed to the syngeneic 
recipient (Solter, Dominis and Damjanov, 1981). However, this hybrid stimulation 
does not occur in all F1 combinations and there appears to be an epigenetic maternal 
factor involved, with a tendency for a higher response to teratocarcinogenesis if the 
mother of the F1 host is from a permissive strain (Softer et al., 1981). Interestingly, 
males of the 129/J strain were significantly more teratocarcinoma-permissive, 
compared to when syngeneic embryos were grafted to 129/J females (Solter et al., 
1979). 
Other approaches to increase the proportion of teratocarcinomas 
experimentally, including the use of allogeneic recipients, since early embryos do not 
express histocompatibility antigens (H-2) (Damjanov, Damjanov and Solter, 1987) 
and utilising immunocompromised mice as recipients (Damjanov et al., 1983), have 
not been successful in overcoming the nonpermissiveness of certain inbred strains of 
mice. Conversely, when mice immunised with EC cells or mice bearing re-
transplantable tumours (see section 1.2.4) were used as hosts, the incidence of 
teratocarcinomas significantly increased (Damjanov et al., 1987). Thus, it appears 
that a normal or specifically stimulated immune response may be beneficial for 
development of embryo-derived teratocarcinomas. 
1.2.4 Re-Transplantable Teratocarcinomas 
Many testicular, ovarian and embryo-derived teratomas are benign and 
as a consequence fail to proliferate further following subsequent transplantation into a 
new host. This is also the commonest fate of primary malignant teratomas upon 
transfer. Occasionally, teratocarcinomas may continue to grow in histocompatible 
hosts after subcutaneous, or intramuscular, transfer of minced primary tumours. Re-
transplantable teratocarcinomas have been established from spontaneous testicular and 
ovarian tumours and from embryo-derived tumours induced experimentally (reviewed 
by Stevens, 1983). Re-transplantable tumours can be further passaged by periodic re-
transplantation and maintained as in vivo cell lines for several years in some instances 
(Stevens, 1958). During early transplant generations, this re-transplanting procedure 
generally favours the growth of the more malignant EC cells at the expense of the 
differentiated somatic tissues. However, with extended tumour generations, the stem 
cells may eventually become restricted in their developmental potency and may 
terminally differentiate into one or more cell types (Stevens, 1958). 
Some re-transplantable teratocarcinomas may also be passaged by 
intraperitoneal injection of finely minced fragments. Occasionally, this leads to the 
formation of multiple tumours which grow wherever the cells implant within the body 
cavity. Frequently, however, the injected cells continue to grow as ascitic tumours 
(Stevens, 1959). Ascites forms grow either as single-cells or may form aggregates 
resembling six day old mouse embryos, which float freely in the ascites fluid. These 
so-called "embiyoid bodies" may be composed of a core of EC cells surrounded by a 
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layer of endoderm-like cells or they may become fluid-filled and cystic. The inner 
stem cells of these embryoid bodies may remain undetermined for years, yet when 
they are transplanted subcutaneously they may give rise to teratocarcinomas composed 
of many different cell types (Pierce and Dixon, 1959). 
1.2.5 Establishment of Embryonal Carcinoma Cell Lines 
EC cells can be propagated for a number of years within the tumour 
environment (either in solid or ascites form), however, it is generally a more difficult 
task to recover the stem cells into tissue-culture. 	Cells with the typical 
undifferentiated EC morphology (small rounded cells lacking any specialised 
structures and possessing a large nuclear to cytoplasmic ratio, with one or more 
prominent nucleoli; Martin, 1975) have been established in culture from both solid 
tumours (Evans, 1972) and ascitic embryoid bodies (Kahan and Ephrussi, 1970). 
Briefly, the technique demands the disaggregation of tumours into small cellular 
clumps which are explanted into complex bicarbonate-buffered tissue-culture medium, 
with subsequent clonal selection of cells possessing an undifferentiated morphology. 
The co-culture of the disaggregated tumour cells with mitotically inactivated feeder cell 
layers may facilitate the establishment and maintenance of EC cell lines (Martin and 
Evans, 1975). However, EC cells may remain feeder-dependent as a result (Martin, 
1975). 
Teratocarcinomas which have been passaged several times in vivo 
contain a higher proportion of actively growing malignant cells (see section 1.2.4). 
So, the isolation of EC cells has been more successful with such re-transplantable 
tumours. Few in vitro EC cell lines have been established from primary tumours 
(Mintz and Cronmiller, 1981; McBumey and Rogers, 1982). 
The majority of EC cell lines that have been isolated into culture have 
their origins in embryo-derived teratocarcinomas. However, all EC cell lines can be 
traced back to only some 16 independently derived tumours (a comprehensive listing 
of EC cell lines is to be found in Appendix I of Silver, Martin and Strickland, 1983; 
and reviewed by Robertson and Bradley, 1986). A smaller number of in vitro EC 
cell lines have been isolated from spontaneously occurring teratocarcinomas. 
The different EC cell lines, although superficially resembling one 
another in basic morphology and in expression of cell surface antigens, compose a 
very heterogeneous set of tissue-culture lines (Robertson and Bradley, 1986). There 
is particular variability in their in vitro growth characteristics and requirements, 
chromosome constitution and differentiation ability as reviewed in the following sub- 
sections. 
1.2.6 Differentiation of Embryonal Carcinoma Cells In Vitro 
There are great differences between EC cell lines in their capacity to 
differentiate in vitro (Martin, 1975). Cell lines that show the most extreme type of 
restriction, known as "nullipotency", appear incapable of spontaneous differentiation. 
Other EC cell lines may be multipotent or pluripotent, reflecting the range of cell 
lineages present in the differentiated cell population. Generally, feeder-dependent EC 
cell lines are capable of differentiating into a larger range of different cell types than 
feeder-independent cell lines (Heath, 1983). 
Spontaneous differentiation into a variety of cell types can be induced by 
either allowing cultures to become over-confluent, removing feeder cells in feeder-
dependent cell lines, seeding cells at low plating density following passage, or by 
lowering the serum concentration (Rudnicki and McBurney, 1987). All of these 
methods are of little application in studying mechanisms of differentiation. Methods 
including the suspension culture of cellular aggregates and the addition of various 
exogenous drug promoters, induce more predictable and synchronous differentiation. 
Some EC cell lines develop into embryoid bodies in suspension culture, 
where they consist of an inner core of EC cells surrounded by a layer of endodermal 
cells which secrete a mucopolysaccharide layer known as Reichert's membrane 
(Martin and Evans, 1975). This is analogous to the early events of differentiation in 
the mouse embryo and provides a model system for studying differentiation during the 
early post-implantation period. When these embryoid bodies attach to a tissue-culture 
surface, they differentiate extensively into cell types representative of the three primary 
germ layers; indicating such EC cell lines to be pluripotent (Martin, 1975). 
The study of the cellular mechanisms involved in differentiation has 
been aided by certain chemical inducers promoting EC cells to differentiate into a 
specific cell type. For example, the addition of low concentrations of retinoic acid to 
monolayer cultures of EC cells from the nullipotent F9 cell line, stimulated the 
formation of parietal extra-embryonic endoderm cells (Strickland and Mahdavi, 1978); 
while exposure of cellular aggregates of F9 EC cells to retinoic acid resulted in the 
induction of visceral endoderm instead (Hogan, Taylor and Adamson, 1981). There 
is heterogeneity between different EC cell lines in their response to the same drug. 
For instance, aggregates of EC cells from the P19 cell line differentiated into neuronal 
cells in response to retinoic acid (McBumey et al., 1982). Other compounds, such as 
dimethyl suiphoxide, induce some EC cell lines to form cardiac and skeletal muscle 
(McBurney et al., 1982). 
1.2.7 Chromosomal Characteristics of Embryonal Carcinoma Cells 
EC cell lines are also heterogeneous with respect to chromosome 
complement. The majority of cell lines are aneuploid (abnormal chromosome number 
or structure); frequently with the loss of one sex chromosome (X or Y) and/or 
possessing various trisomic abnormalities. These karyotypic abnormalities may be 
due to the time EC cells persist within the tumour and may be further accentuated by 
the long term maintenance of cell lines in vitro. 
Cytogenetic studies have shown the majority of primary embryo-derived 
tumours to have a normal modal chromosome number of 40 (Martin, 1975). With the 
increasing passage generation of transplantable teratocarcinomas, two well reported 
effects are observed: the restriction of differentiative capacity (Stevens, 1958) and the 
aquisition of karyotypic alterations (Iles and Evans, 1977). This can occur within the 
first few passages in vivo and is generally more severe in ascitic rather than solid 
tumours (Iles and Evans, 1977). 
Only five completely euploid EC cell lines have been established (as 
listed in Silver et al., 1983; and reviewed by Robertson and Bradley, 1986), namely 
OTT 6050 maintained transiently in vivo (Cronmiller and Mintz, 1978), C145b 
(Papaioannou et al., 1979), P10 (McBurney and Strutt, 1980), METT-1 (Mintz and 
Cronmiller, 1981) and P19 (McBumey and Rogers, 1982). It is important to note 
that of these cell culture lines, two, P19 and METT- 1, were isolated from primary 
teratocarcinomas without serial transplantation. The prerequisite of a normal euploid 
karyotype cannot be over-emphasised if EC cells are to result in gem-dine transmission 
of the tumour cell genotype in chimaeric animals. 
1.2.8 Differentiation of Embryonal Carcinoma Cells In Vivo 
EC cells express either a neoplastic or a normal embryonic phenotype 
depending upon their immediate environment. In an extra-embryonic environment, 
EC cells develop into malignant teratocarcinomas that contain a disorderly variety of 
differentiated tissues, including trophoblast, various epithelia, muscle (smooth and 
cardiac), cartilage, bone, etc. (Kleinsmith and Pierce, 1964). 	Furthermore, 
teratocarcinomas are capable of causing the death of the host animal. In contrast, 
when placed in an embryonic environment, these formerly neoplastic cells may behave 
as normal embryonic cells, responding to developmental signals and contributing to 
the formation of normal tissues in the resultant chimaeric mouse (lilmensee and Mintz, 
1976). 
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Using cells taken directly from a transplantable tumour, Brinster (1974) 
was the first to show that EC cells can participate in the formation of a chimaeric 
mouse. Technically, this was achieved utilising a blastocyst injection procedure 
(Gardner, 1968). In addition to somatic contributions, two in vivo EC cell lines, 
both of which had appreciable subpopulations of cells with a normal karyotype, have 
also colonised the germ cell lineage and produced functional gametes in a limited 
number of founder chimaeras (Mintz and lllmensee, 1975; lllmensee and Mintz, 1976; 
Cronmiller and Mintz, 1978). From a total of three mice with in vivo EC-derived 
germ cells, two were males from a chromosomally XY ascites line (OTF 6050; a day 
6.5 p.c. embryo-derived 129/Sv-Sl teratoma) and one was a female from a 
chromosomally XX solid tumour line (LT-72484-395; a spontaneous ovarian teratoma 
from the LT/Sv strain). 
Papaioannou and co-workers (1975; 1978) were the first to demonstrate 
the capacity of EC cells that had been cultured in vitro to differentiate into the somatic 
lineages of resultant chimaeras. The first demonstration of germline transmission 
from an in vitro EC cell line was achieved by Stewart and Mintz (1981; 1982) 
working with a karyotypically normal XX embryo-derived teratocarcinoma cell line 
designated METT- 1 (Mintz and Cronmiller, 1981). The chimaera-forming efficiency 
of METF-1 was low (13%), typical of that of most EC cell lines (reviewed by 
Robertson and Bradley, 1986).and with only 10% of the chimaeras having gonadal 
isoenzyme 
contributions, as assayed by GPIf\separation and germline transmission (Stewart and 
Mintz, 1981; 1982). Furthermore, only approximately 6% of the germ cells 
transmitted EC cell genotype in the two female germline chimaeras produced in these 
studies. 
With regard solely to somatic chimaerism, the chromosomal constitution 
of an EC cell line may not be a good indicator of the in vivo pluripotency of the cells 
(a better assessment would be obtained from the in vitro differentiative capacity of the 
EC cells). For instance, cells with gross alterations in chromosome number and 
structure have been reported still to participate in the formation of apparently normal 
somatic tissues (lllmensee and Croce, 1979). It would appear that the interaction with 
normal host embryonic cells rescues the aneuploid EC cells. In contrast, some 
apparently normal euploid EC cell lines, such as C145b, have failed to make 
contributions to foetal tissues in any of several hundred mice analysed (Papaioannou 
et al., 1979). 
Other EC cell lines (for example P19: Papaioannou and Rossant, 1983) 
result in chimaeras with tumours. In fact, very few of the EC cell lines that have been 
examined have not resulted in the production of at least some tumour-bearing 
chimaeras. As summarised by Robertson and Bradley (1986), 17% of all liveborn 
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EC cell-chimaeras contained tumours and in an analysis of midgestation foetuses, 57% 
were judged to be abnormal and would have presumably failed to survive to term. It 
has been suggested that some of these tumour-bearing chimaeras may have arisen from 
failure of some injected EC cells to integrate with the 1CM of the host blastocyst and 
which instead, proliferated independently as EC cell colonies (Papaioannou and 
Rossant, 1983). Thus, the number of EC cells introduced into the host embryo may 
have some bearing on the likelihood of tumour formation (Martin, 1980). 
With the majority of chimaeric mice that have been generated via 
blastocyst injection, there has typically been very sporadic chimaerism;with EC cells 
not being present in all internal organs or tissues, nor in equal proportions in each 
tissue (Dewey et al., 1977). The approach of aggregating small clumps of EC cells 
with one or two cleavage-stage host embryos was utilised to increase the intermingling 
of the two cell types in the chimaeric embryo (Fujii and Martin, 1980). However, 
Fujii and Martin (1983) have shown there to be a correlation between increasingly 
abnormal development of midgestation chimaeric foetuses, with more extensive 
participation of EC cells when aggregated with embryos. In the case of euploid EC 
cell lines, this situation may be attributable to genetic defects that are not detectable 
cytologically (Hardy et al., 1990) and may reflect limitations in the ability of EC cells 
to direct normal development without the presence of substantial numbers of host 
embryonic cells (Fujii and Martin, 1983). 
1.2.9 Summary 
Teratocarcinomas are malignant tumours that may either arise 
spontaneously (in the testes or ovaries of certain inbred mouse strains) or 
experimentally, by grafting early embryos to an extra-uterine site. 	Their 
undifferentiated stem cells, embryonal carcinoma (EC) cells, have been isolated into 
culture from all three of the above sources. This questions the lineage of EC cells, as 
apparently the same cell type can be isolated from both male primordial germ cells and 
from cells within the early embryo. However, EC cells do have morphological, 
biochemical and immunological properties in common with pluripotent embryonic cells 
(see section 1.4). In some cases, in vitro differentiation of EC cells closely parallels 
development of early embryogenesis and has been utilised as an in vitro model system 
(see section 1.5). The most compelling evidence for the similarity between tumour 
stem cells and normal embryonic cells has been the ability of cells from some EC cell 
lines to participate in normal development, giving rise to chimaeric mice with somatic 
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Figure 1.1: Relationship between normal murine embryos, embryonal carcinoma 
cells and embryonic stem cells. (Adapted from: Martin, 1981). 
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There is, however, large heterogeneity between the different EC cell 
lines with regard to karyotype, in vitro and in vivo differentiative capacities and in 
particular, germline transmission in chimaeras. This has limited their potential to 
create new mouse mutants via in vitro modification of the mouse genome (see section 
1.5). 
Many of the problems associated with EC cells may be attributed to the 
intermediate tumour phase in their isolation history. Thus, attempts were made in the 
late 1970's and early 1980's to isolate permanent cell cultures of undifferentiated 
morphology directly from the early embryo itself - as illustrated by the "thick" arrow in 
figure 1.1. The isolation of such "embryonic stem cell lines" forms the topic of 
section 1.3. 
1.3 MURINE EMBRYONIC STEM CELL LINES 
The isolation into tissue-culture of pluripotent cells directly from the embryo (by-
passing teratocarcinoma formation; see figure 1.1) was first achieved by two 
independent laboratories, utilising different methods, in 1981 (Evans and Kaufman, 
1981; Martin, 1981). These cell lines were initially termed EK cells by Evans and 
Kaufman, to distinguish them from the morphologically similar EC cells. 
Subsequently, however, they have been generally referred to as ES (embryonic stem) 
cells and this is the nomenclature used here. Under suitable culture conditions, ES 
cells are capable of continuous, undifferentiated growth in vitro (without cell 
transformation: Suda et al., 1987). When re-introduced into an early embryo, ES 
cells are capable of differentiating in an organised manner and participating in normal 
embryo development (Bradley etal., 1984). 
This section reviews the early attempts to isolate cells of the ES cell lineage, 
followed by the eventual successful methods that were employed. Factors that may 
influence ES cell isolation and the characteristics of these stem cells are also reviewed. 
1.3.1 Early Attempts on the Direct Isolation of Stem Cells into 
Culture 
Evans (1981) reasoned that successful isolation may depend upon the 
identification of the developmental stage at which pluripotent cells within the embryo 
are capable of growth in vitro and explanting sufficient numbers of these precursor 
cells into a culture environment conducive to proliferation, as opposed to 
differentiation. Initial attempts at direct isolation of pluripotent cells were made from 
both early embryos and primordial germ cells, since studies on teratocarcinomas had 
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shown that cells with a stem cell morphology can be isolated from both of these 
sources (see section 1.2). 
The explanted germinal ridge has not, however, been a viable route to 
the isolation of stem cells, as primordial germ cells from day 11.5 or 12.5 p.c. 
germinal ridges failed to divide in culture despite variations in media and feeder cells 
(Evans, 1981). Transient proliferation has been achieved by decreasing the culture 
temperature to below 30°C, however, the primordial germ cells senesced within seven 
days (De Felici and McLaren, 1983). In contrast, the early embryo has provided a 
more amenable source of cells for in vitro growth. 
Cell surface antigens and patterns of protein synthesis within the early 
embryo have revealed that neither the cells of the day 6.5 p.c. ectoderm nor those of 
the day 3.5 p.c. 1CM share homology with EC cells, but cells of the day 5.5 p.c. 
primitive ectoderm may do so (Martin, Smith and Epstein, 1978; Evans et al., 1979; 
Lovell-Badge and Evans, 1980). Thus, cells from the early post-implantation embryo 
seemed the best candidates for progenitors of pluripotent cells in culture. Certainly, 
explant cultures from more advanced day 6.5 and 7.5 p.c. embryos only exhibited 
extensive differentiation (Evans, 1981). However, because of technical difficulties in 
isolating the day 5.5 p.c. primitive ectoderm, early efforts concentrated instead on 
culturing day 3.5 p.c. intact blastocysts (also capable of forming teratocarcinomas; see 
section 1.2.3) or isolated ICMs, following immunosurgery (Solter and Knowles, 
1975). Initial attempts to culture embryos in a variety of different media, were 
unsuccessful in establishing progressively growing cultures of pluripotent cells 
(Sherman, 1975a;b). 	However, differentiated cell lines of fibroblastoid and 
endodermal-like morphology were established from mouse embryos (Sherman, 
1975b) although cells possessing an undifferentiated phenotype had been transiently 
observed in culture in some early studies (Solter and Knowles, 1975; Atienza-Samols 
and Sherman, 1978). 
1.3.2 Establishment of Pluripotent Cells from Early Mouse 
Embryos 
The direct isolation of stable cell lines with an undifferentiated 
morphology from mouse embryos was first achieved by Evans and Kaufman (1981) 
and followed shortly after by Martin (1981). They used quite different strategies, but 
ultimately achieved success by diverting the 1CM from its normal fate of differentiation 
and instead encouraging continued proliferation in vitro. 
Evans and Kaufman (1981) used treatments (ovariectomy and 
progesterone injection) to induce mouse blastocysts to undergo a short period of 
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implantational delay; whereby the embryos hatched from the zona pellucida but were 
allowed to remain free-floating within the uterine lumen for three to five days before 
embryo recovery. Such a treatment has been shown to produce a small increase in the 
cell number of the 1CM (Copp, 1982) and although primitive endoderm may 
differentiate, no further development of the 1CM occurs (Gardner, Davis and Carey, 
1988). And so, the embryo enters a state of diapause. 
These delayed blastocysts were group-cultured in microdrops of tissue- 
culture medium, under paraffin oil on tissue-culture plastic Petri dishes (Evans and 
Kaufman, 1981). The intact blastocysts attempt to mimic implantation via attachment 
of the trophectodermal cells to the culture surface. The cells then grow out as a 
monolayer and differentiate into giant trophoblast cells. This abnormal in Vitro 
development, results in exposure of the 1CM to the culture environment. The 1CM 
subsequently develops into an upwardly growing egg cylinder-like structure after 
about four days. Earlier studies had shown that such outgrowths only gave 
differentiated cell phenotypes if left unmanipulated (Sherman, 1975b). Thus, Evans 
and Kaufman (1981) disaggregated the 1CM outgrowths using enzymatic and 
mechanical procedures. The embryonic cells were then passaged onto gelatin-
pretreated culture dishes containing a feeder cell layer of mitotically inactivated mouse 
STO fibroblasts (Martin and Evans, 1975). Cell colonies of EC-like morphology 
were identified in these primary cultures and were subsequently picked out, passaged 
and mass cultures grown (Evans and Kaufman, 1981). In one experiment, 30% of 
the delayed blastocysts explanted into culture gave rise to permanent stem cell lines. 
Cultures were routinely passaged by trypsinisation every two to three days and co-
cultured on STO feeder cells to maintain the ES cells in an undifferentiated state. The 
capacity of the ES cells to differentiate in vitro (forming embryoid bodies) and in ViVO 
(forming teratocarcinomas) demonstrated that these cells were pluripotent (Evans and 
Kaufman, 1981). 
With a different experimental technique, Martin (198 1) described the 
isolation of ES cells which were of the same lineage as the cells isolated by Evans and 
Kaufman (1981). Martin established her ES cell lines from immunosurgically isolated 
ICMs from day 3.5 p.c. blastocysts which were cultured together on STO feeder cells 
in medium that had been conditioned by an undifferentiated EC cell line (PSA-1). A 
proportion of such ICMs (4/30) were reported to give rise directly to colonies of stem 
cells, apparently without the necessity of any further specific manipulation. The 
failure of control ICMs, cultured in the absence of conditioned medium, to give rise to 
ES cells suggested the production of a factor(s) by the PSA- 1 EC cell line that either 
stimulated the proliferation or inhibited the differentiation of stem cells, or both. After 
five culture passages, conditioned medium was not required for the continued, stable 
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growth of the stem cell phenotype. 	This suggested the production of an 
autostimulatory growth factor(s) by these ES cells. Martin (1981) also demonstrated 
that each ES cell was pluripotent, as subclonal lines produced teratocarcinomas 
following injection into athymic mice. 
In a comparative study, Axelrod and Lader (1983) showed that the 
efficiency of ES cell isolation from ICMs cultured in either conditioned medium or 
normal medium were similar (2/17 and 2/16, respectively). They also demonstrated 
that ES cell lines could be derived from the outgrowths of intact day 3.5 p.c. 
blastocysts (at an efficiency of 6%) without the need to induce implantational delay. 
Hence, they demonstrated the feasibility of simplified techniques for the establishment 
of ES cell lines without the need for the production of conditioned medium, 
immunosurgery or ovariectomy. 
1.3.3 Factors Influencing the Isolation of Murine Embryonic Stem 
Cells 
There are few comparative reports regarding factors that influence the 
efficiency of ES cell isolation from mouse embryos. Despite differences which exist 
between some laboratories, this section reviews a number of important variables. 
1.3.3.1 Disaggregation of 1CM Outgrowths 
In terms of manipulating the embryo to achieve optimal 
proliferation of subsequent primary stem cell colonies, the timing of the disaggregation 
of the 1CM outgrowth is of critical importance. In a detailed account of the technique, 
Robertson (1987) has found that day 3.5 p.c. blastocysts usually attain a suitable 
morphology after a five day culture period, although variability exists between 
embryos in the rate of growth in vitro. Allowances may have to made for embryos 
recovered following a period of implantational delay, which tend to show slower rates 
of in vitro growth initially (Robertson and Bradley, 1986). Based on her experience, 
Robertson (1987) has noted that there was no absolute correlation between the 
phenotype of the 1CM outgrowth and the successful isolation of an ES cell line. 
However, outgrowths with extensive endoderm formation or those developing into 
multi-layered egg cylinder-like structures, have a reduced capacity to retain pluripotent 
cells. 
Another important factor is the disaggregation procedure itself. 
Cell survival is poor if the 1CM outgrowth is trypsinised into single-cells (Robertson, 
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1987). The aim should be to break the 1CM up into several small pieces, each 
containing a few cells. 
1.3.3.2 Mouse Strain 
One of the restrictions of EC cells is that they may only be 
isolated from teratocarcinomas derived from inbred lines of mice (see section 1.2.3). 
In contrast, ES cell lines have been isolated from inbred strains (e.g. 129/Sv//Ev: 
Evans and Kaufman, 1981; C57BL/6: Suemori and Nakatsuji, 1987) outbred strains 
(e.g. CD-1: Suda et al., 1987; CFLP: Robertson et al., 1983b) and numerous 
different F1 crosses (e.g. ICR X SWRJJ: Martin, 1981; C57BL/6 X C3H: Martin and 
Lock, 1983). Furthermore, ES cell lines have been produced which specifically carry 
a variety of genetic markers. These include lines carrying isozymal variants (GPI-la: 
Bradley et al., 1984), lines with an isozymally marked X chromosome (Pgk1a: 
Martin and Lock, 1983), lines with prominent translocation markers (Rb[1617]: 
Axelrod and Lader, 1983) and lines carrying a range of coat-colour phenotypes 
(Robertson et al., 1983b). A valuable use of this technique has been to produce ES 
cell lines from homozygous recessive, developmentally lethal mutations (e.g. tw5/t%'5: 
Magnuson et al., 1982; 1983). 
In a laboratory experienced in ES cell isolation, Robertson and 
Bradley (1986) have not found any specific mouse strain to be "non-permissive" and 
routinely expect 10% of day 3.5 p.c. blastocysts to yield ES cell lines. Also, in a 
study primarily examining the effect of feeder cell layers, there were no significant 
differences between the embryos from the inbred C57BL/6 and 129 (/J and /SvJ) 
strains and the F1 (C57BL/6 X 129) hybrid embryos, in the efficiency of ES cell 
isolation (18%, 18% and 12%, respectively; Suemori and Nakatuji, 1987). In 
contrast, the embryos from some mouse strains have been observed to yield ES cell 
lines at a lower frequency (5-10%) compared to others (35-45%), although no specific 
mouse strains were mentioned (Martin, Jakobovits and Joyner, 1984). 
1.3.3.3 Stage of Embryonic Development 
ES cells have been isolated from the blastomeres of day 2.5 p.c. 
morulae and from the 1CM of blastocyst- stage pre-implantation mouse embryos. ES 
cell lines derived from the 1CM have been obtained from fertilised day 3.5 p.c. or 
implantationally delayed blastocysts and from parthenogenetically and androgenetically 
produced blastocyst embryos. 
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The majority of workers have isolated ES cell lines from the 
readily available day 3.5 p.c. blastocyst-stage embryo. In a small study comparing 
isolation from either intact blastocysts or isolated ICMs from day 3.5 p.c. embryos, 
Axelrod and Lader (1983) found there to be no difference in the frequency of ES cell 
isolation (2/23=9% vs 2/16=13%, respectively). From experience, Robertson and 
Bradley (1986) expect blastocysts that have undergone a period of implantational delay 
to generate, on average, a three-fold increase in the efficiency of ES cell isolation 
compared to non-delayed, day 3.5 p.c. embryos. 
Given that ES cell isolation from both non-delayed and delayed 
blastocysts relies on the proliferation of the 1CM, the only other normal developmental 
stage from which stem cells have been obtained is from disaggregated 16- to 20-cell 
embryos (Eistetter, 1989). Here, individual blastomeres from decompacted morulae 
were cultured and 37% (17/46) of the initial embryos produced permanent ES cell lines 
with, in some instances, as many as four blastomeres from a single embryo giving rise 
to stem cell colonies. This was a significantly greater efficiency of ES cell isolation 
than in control experiments, where blastocysts were cultured conventionally 
(9/108=8%; Eistetter, 1989). The blastomere-derived cell lines appear to be of the 
same lineage as 1CM-derived ES cells, although a chimaeric analysis has not been 
reported. 
Several ES cell lines have been isolated from blastocyst 
outgrowths derived from parthenogenetically activated oocytes (Kaufman et al., 
1983). Both haploid and diploid parthenogenetic blastocysts gave rise to diploid ES 
cell lines, which have been "rescued" in vivo, to contribute to adult somatic chimaeras 
(Evans, Bradley and Robertson, 1985). 
Diploid androgenetic ES cells have also been produced (Mann et 
al., 1990). The in vivo differentiation of these androgenetically-derived stem cells 
into teratomas composed predominantly of muscle, and the postnatal skeletal 
abnormalities in chimaeras, suggests stage- and tissue-specific expression of 
developmentally important imprinted genes (Mann et al., 1990). 
1.3.3.4 Feeder Cells 
Historically, ES cells have been isolated and maintained on layers 
of mitotically inactivated, embryonic fibroblast "feeder" cells. If cultured in the 
absence of feeders, the ES cells rapidly differentiate (Evans and Kaufman, 1981). 
The function of the feeder cells, in addition to providing a more suitable attachment 
surface for direct co-culture (Martin and Evans, 1975), is in the active suppression of 
stem cell differentiation. It has recently been shown that a factor known as DIA/L1F 
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(see section 1.3.3.5), which inhibits the differentiation of stem cells, is produced by 
these feeder cells as both a diffusible protein and in an immobilised form, associated 
with the extra-cellular matrix (Rathjen et al., 1990b). Furthermore, it has been 
shown that in the co-culture system, ES cells secrete a heparin-binding growth factor 
responsible for the stimulation of DIA/LIF expression in the feeder cells (Rathjen et 
al., 1990a). 
The most commonly utilised fibroblast feeder layers have been 
those prepared from the STO cell line (Martin and Evans, 1975); a thioguanine- and 
ouabain-resistant derivative of a continuous embryonic fibroblast cell line isolated from 
the SIM mouse strain (Ware and Axeirad, 1972). Other embryonic fibroblast cell 
lines also capable of maintaining stem cells include C3H 1OT1/2 cells (Rathjen et al., 
1990b) and BALB-3T3/A3 1 cells (Ogiso et al., 1982). Alternatively, primary 
embryonic fibroblasts may be isolated from foetuses in the third trimester of 
pregnancy. 	Although such feeders have been favoured by some workers 
(Doetschman et al., 1985) a major disadvantage in their use is the limited in vitro life-
span of these primary cells; they become senescent after 15-20 cell divisions 
(Robertson, 1987). In order to prepare feeder cell layers for co-culture, the fibroblast 
cells must be mitotically inactivated. Typically, this has been achieved by treatment 
with the drug mitomycin C (Martin and Evans, 1975) or by exposure to irradiation 
(Wobus et al., 1984). 
In a comparative study, there was no significant difference in the 
efficiency of ES cell isolation between STO and primary embryonic fibroblast feeder 
cell layers (62/361=17% and 24/175=14%, respectively; Suemori and Nakatsuji, 
1987). However, primary fibroblasts were superior in supporting other stem cell 
characteristics. ES cells grown on the STO feeders tended to be morphologically 
unstable, which was reflected in their capacity to form only differentiated teratomas in 
vivo. Furthermore, ES cell lines isolated on the STOs became tetraploid, whereas 
those maintained on the primary fibroblasts were karyotypically stable. The above 
results are in conflict with the findings of other laboratories which routinely use STO 
feeders, where the majority (77%) of ES cell lines have been reported to be euploid 
(Robertson and Bradley, 1986). This may emphasise differences in the culture 
conditions between different laboratories. Also, it would appear that ES cells adapt to 
the culture environment they are grown in, as an ES cell line originally isolated on 
primary embryonic fibroblasts could not be maintained subsequently on STO feeders 
(Wobus et al., 1984). 
The effect of the feeder cell layer can be fully substituted by the 
addition of an exogenous factor (DIA/LIF) into the medium, which maintains the ES 
cell morphology of established lines and is also sufficient for the isolation of new stem 
cell lines. The effects of cell-conditioned medium and DIA/LIF form the subject of 
the following section. 
1.3.3.5 Cell-Conditioned Medium and Differentiation Inhibiting 
Factors 
The tissue-culture medium utilised is based upon a complex 
bicarbonate-buffered formulation, typically Dulbecco's Modification of Eagle's 
Medium (DMEM; Robertson, 1987) or Glasgow's MEM (Handyside et al., 1989). 
To this is added 13-mercaptoethanol (which enhances stem cell attachment and growth; 
Oshima, 1978) and non-essential amino acids (supplemented to prevent cellular loss 
across concentration gradients; Hooper, 1987). For ES cell isolation, serum 
concentrations between 10% (Martin, 1981) and 20% (Evans and Kaufman, 1981) 
have been successfully employed. Typically, serum has been a 50:50 combination of 
(selected batches) of foetal and newborn calf serum. Once ES cell lines have been 
established, the serum content may be reduced for routine maintenance in vitro 
(Robertson, 1987). 
Martin (1981) first demonstrated the use of cell-conditioned 
medium to facilitate ES cell isolation. The PSA-1 EC cell line used to produce this 
conditioned medium, was subsequently shown to secrete a factor (SCGF-1) which 
stimulated the proliferation of the stem cells that produced it (Jakobovits, Banda and 
Martin, 1985). Another potent mitogen, ECDGF has also been isolated from medium 
conditioned on the PC13 EC cell line (Heath and Smith, 1988). 
As all ES cell lines are feeder-dependent, with feeder cell removal 
resulting in ES cell differentiation, this suggested the presence of a differentiation 
inhibitory factor produced by the feeder cells. Medium conditioned on STO feeder 
cells (Smith and Hooper, 1983) and on a variety of other cell types from different 
species (Koopman and Cotton, 1984) were shown to only partially inhibit stem cell 
differentiation when cultured without feeders. It has since been shown that the major 
effect of the feeder layer is in the synthesis of an immobilised anti-differentiation 
factor, associated with the extra-cellular matrix and not only from the production of a 
diffusible factor (Rathjen et al., 1990b). 
Smith and Hooper (1987) found that medium conditioned by 
Buffalo rat liver (BRL) cells (Coon, 1968) contained a factor which was a far more 
potent inhibitor of stem cell differentiation than medium conditioned by STO cells. 
This factor, termed stem cell differentiation inhibiting activity (DIA), has been purified 
from BRL-conditioned medium and is a glycoprotein of Mr 43 000 (Smith et al., 
1988). Structural and functional comparisons have shown that DIA is identical to the 
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murine myeloid leukemia inhibitory factor (LW) (Smith et al., 1988; Williams et al., 
1988). Furthermore, a third growth factor, human interleukin for DA cells (HILDA), 
has been shown to be essentially identical to the human LW protein (Moreau et al., 
1988; Gough et al., 1988). 
The supplementation of DIA/LIF to medium has provided a 
complete substitute for feeder cells and hence, has greatly simplified the routine culture 
of ES cell lines. In addition, DIA/LIF has aided the biochemical study and in vitro 
manipulation of ES cells. Established ES cells have retained their full developmental 
potential and capacity to colonise the germline in chimaeras when maintained in the 
"crude" BRL-conditioned medium (Hooper et al., 1987) and in the presence of 
purified recombinant DIA/LIF (Gough et al., 1989). 
The isolation of ES cells has been aided by the combined use of 
BRL-conditioned medium and STO fibroblasts (Handyside et al., 1989). However, 
Robertson and Bradley (1986) have observed that while conditioned medium may 
enhance the growth of primary colonies, the majority tend to be of a "pre-trophoblast" 
lineage and ultimately differentiate. It has recently been shown that recombinant 
DIA/LIF, added in the culture medium, can replace feeder cells in the isolation of ES 
cell lines, which may retain their capacity for germline transmission (Nichols, Evans 
and Smith, 1990; Pease et al., 1990). 
DIA/LIF now appears to be implicated as a component governing 
stem cell proliferation and differentiation during mammalian development; for it has 
bioregulatory roles not only in the early embryo (Conquet and Brulet, 1990; Rathjen et 
al., 1990a) but also in other systems, including haematopoietic (Leary et al., 1990), 
leukaemic (Hilton et al., 1988) and osteogenic lineages (Abe et al., 1986; Metcalf and 
Gearing, 1989). 
1.3.4 Differentiation of Embryonic Stem Cells In Vitro 
A universal feature of ES cell lines appears to be their capacity for 
spontaneous differentiation under suspension culture; forming three-dimensional 
structures known as embryoid bodies (Evans and Kaufman, 1981; Martin, 1981). 
With prolonged culture, 50% of these embryoid bodies, from a particular cell line, 
may expand into large cystic structures containing alphafoetoprotein and transferrin, 
thus being analogous to the visceral yolk sac of the post-implantation embryo 
(Doetschman et al., 1985). A proportion of the cystic embryoid bodies may develop 
beating myocardium, and when cultured in human cord serum, blood islands also 
form (Doetschman et al., 1985). More extensive haematopoietic differentiation has 
been induced by culturing embryoid bodies in semi-solid medium (Wiles and Keller, 
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1991). Attachment of embryoid bodies to a culture surface may result in the growth 
of an array of cell types, including: nerve, adipose, muscle, cartilage and sometimes 
trophectoderm (Martin, 1981; Axelrod and Lader, 1983). 
ES cells can also be induced to differentiate in monolayer culture. 
When grown in DIA/LIF, the addition of retinoic acid induces parietal endoderm 
formation, while removal of DIA/LIF from the medium results in a population of ill-
defined mesoderm-like cells (Mummery etal., 1990). 
1.3.5 Chromosomal Characteristics of Embryonic Stem Cells 
The majority of ES cell lines, at least initially, have a normal euploid 
chromosome complement (Robertson and Bradley, 1986). This may be a result of the 
rapid isolation process, especially compared to tumour-derived EC cells. However, 
within most ES cell lines small populations of aneuploid cells may exist. With 
increasing time in vitro, the proportion of these pseudodiploid cells may increase 
(Suda etal., 1987). To regenerate a karyotypically normal cell line, the ES cells may 
be single-cell cloned and diploid cultures identified and re-expanded (Suda et al., 
1987). 
Established ES cell lines cultured without feeders, but in the presence of 
BRL-conditioned medium or DIA/LIF-containing medium, presumably retain a normal 
karyotype, based on the capacity of the stem cells to enter the germline in chimaeric 
mice (Handyside et al., 1989; Hooper et al., 1987; Gough et al., 1989). In terms of 
isolating karyotypically normal cell lines, however, co-culture with feeder cells may be 
important, as 93% of the ES cell lines established solely in DIA/LIF-containing 
medium have been reported to possess significant proportions of cells with 
chromosomal abnormalities (cf. Nichols et al., 1990 and Robertson and Bradley, 
1986). 
A common karyotypic abnormality found in the autosomal chromosome 
complement of ES cells has been trisomy 11 (Robertson and Bradley, 1986; Crolla, 
Brown and Whittingham, 1990). Chromosome 11 has also been found to be unstable 
in EC cells (McBurney, 1976). 
It has been noted in one laboratory that the majority (25/35) of ES cell 
lines from fertilised embryos have been male (XY) (Robertson and Bradley, 1986). 
Only five lines were female (XX) with the remainder being XO. This might suggest 
that undifferentiated cells possessing two active X chromosomes were discriminated 
against during the isolation process and the loss of one X chromosome may confer 
some selective growth advantage (Evans and Kaufman, 1983). Interestingly, all of 
the female ES cell lines isolated in DIA/LIF and without feeder cells, were either 
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wholly or partially tetraploid (Nichols et al., 1990). Parthenogenetically-derived ES 
cell lines have two (maternally) active X chromosomes (Rastan and Robertson, 1985) 
and the occurrence of a partial deletion of one X chromosome in these cell lines has 
been suggested to represent a compensatory mechanism for X inactivation (Robertson, 
Evans and Kaufman, 1983a). The extent of this deletion was variable between 
individual parthenogenetically-derived ES cell lines, however, the break-point on the 
X chromosome appeared to be constant within a particular cell line (Robertson et al., 
1983a). The partial deletion of a single X chromosome has only been reported for 
one ES cell line derived from a fertilised embryo (Martin, 1981). 
1.3.6 Differentiation of Embryonic Stem Cells In Vivo 
ES cells have been demonstrated to be pluripotent from the capacity to 
form teratocarcinomas (Evans and Kaufman, 1981; Martin, 1981) and germline 
chimaeric mice (Bradley etal., 1984), dependent upon the environment into which the 
stem cells are introduced. 
A study within one laboratory has found that without exception, all 17 
independently derived ES cell lines tested were capable of producing normal chimaeric 
mice following blastocyst injection (Evans et al., 1985). This seems to be true for a 
number of different laboratories (reviewed by Baribault and Kemler, 1989) and is in 
contrast to EC cells (see section 1.2.8). Typically, ES-chimaeras have been produced 
at high efficiency (35%), with the stem cells often contributing to 50% of all somatic 
tissues within the foetus or adult (Evans et al., 1985). Occasionally, trophectoderm 
and primitive endoderm derivatives in the extra-embryonic tissues, may also be 
colonised by ES cells (Beddington and Robertson, 1989; Suemori et al., 1990). 
Evans and associates (1985) found no significant foetal losses, nor any evidence of 
tumour formation in any of the 420 chimaeras produced. In fact, there has been only 
one report of an extra-gonadal teratocarcinoma derived from ES cells in a chimaeric 
mouse; presumably resulting as a consequence of the "escape" of one or more stem 
cells from the regulative control of the 1CM, following injection into the host 
blastocyst (Hardy et al., 1990). 
Using an euploid XY ES cell line, Bradley and colleagues (1984) first 
demonstrated the capacity of ES cells to colonise the germline in 19% of chimaeric 
males set-up for test breeding. In the chimaeric population, they noted a marked sex-
distortion effect; with 70% of chimaeras being phenotypic males. Because the Y 
chromosome is principally responsible for sex determination in mammals, injection of 
XY stem cells into an XX blastocyst, results in sex-conversion in a proportion of 
formerly female embryos. This is a localised effect, dependent upon the relative 
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contribution of host XX and ES-derived XY somatic cells in the germinal ridge 
(reviewed by Robertson, 1986). A small XY contribution may only exert a 
masculinising influence and result in animals which, although phenotypically male, 
may be sterile hermaphrodites. This may occur in two-thirds of the sexually 
converted chimaeras produced from the XY stem cell - XX embryo combination 
(Robertson and Bradley, 1986). The remaining fertile male, sex-converted animals 
transmitted only the XY ES cell-derived genotype to their progeny (Bradley et al., 
1984). Although these animals were probably sexual mosaics, XX host germ cells 
appear incapable of forming functional spermatozoa (McLaren, 1976). 
In an alternative sex combination (XY ES cells injected into an XY 
embryo) the phenotypic male chimaeras produced may transmit the ES genotype in 
only 0.3 to 3% of their sperm (Robertson, 1986). 
In achieving germline chimaerism, male ES cell lines have a greater 
potential, because the XY constitution is more stable in vitro (see section 1.3.5), sex-
conversion produces some chimaeric males that transmit only the ES cell genotype and 
breeding from males is more rapid. There are no reports of germline chimaeras from 
XX ES cell lines; probably because this event has not been extensively assayed. 
However, in vitro XX EC cells have colonised the female germline (see section 1.2.8) 
and XO ES cells have given rise to germline 	female chimaeras (Kuehn et al., 
1987). Apart from perhaps the loss of one sex chromosome, a normal, stable 
autosomal chromosome complement is apparently vital for transmission through the 
gametes. This generally implies the use of ES cells with a short culture history. 
However, germline transmission from ES cells following 260 cell generations in vitro 
has been demonstrated; but not without periodic subcloning (Suda et al., 1987). 
It is worth noting that the vast majority of workers that have 
demonstrated germline transmission from ES-chimaeras, have utilised ES cells derived 
from embryos of the 129 mouse strain (including a number of sub-strains; for a review 
see Baribault and Kemler, 1989). The only other mouse strain reported in the 
literature, from which ES cells have been derived and have produced germline 
chimaeras, is the CD-1 strain (Suda et al., 1987). However, there is no biological 
reason to assume that euploid ES cells derived from the embryos of any mouse strain 
would not be capable of colonising the germline. 
Factors which may increase the contribution of ES cells into the 
germline of chimaeras include: 1.) increasing the number of stem cells injected (from 
three or five to 10-15 cells: Robertson and Bradley, 1986); 2.) the choice of mouse 
strain from which to obtain host blastocysts (e.g. stem cells have entered the germline 
at a greater frequency when injected into C57BL/6 host embryos compared to MF1 or 
CD-1 strain embryos: Schwartzberg, Goff and Robertson, 1989); 3.) utilising strains 
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of mice carrying specific fertility mutations to produce host blastocysts (e.g. the W 
mutation ("dominant white spotting"): Robertson and Bradley, 1986); 4.) and the 
developmental stage of the host embryo (Lallemand and Brulet, 1990). The injection 
of ES cells into morula-stage embryos has shown more extensive chimaerism in 
midgestation foetuses compared to those from blastocyst injection (Lallemand and 
Brulet, 1990). This may in turn increase the probability of obtaining germline 
chimaeras and appears more efficient than earlier attempts at ES cell-morula 
aggregation experiments (Stewart, Vanek and Wagner, 1985). 
Recent studies have shown murine ES cells to be capable of supporting 
complete foetal development (Nagy et al., 1990). Newborn pups were produced 
which were 100% ES cell-derived, following the aggregation of stem cells with 
tetraploid cleavage-stage embryos. Tetraploid embryos were used in order to 
establish the placental connection (Nagy et al., 1990), as ES cells are not capable of 
contributing extensively to these extra-embryonic tissues (Beddington and Robertson, 
1989). The reason why these ES-derived newborn pups failed to survive after birth is 
not yet clear (Nagy et al., 1990). 
1.3.7 Summary 
Murine embryonic stem cells (ES cells) are immortal, pluripotent cell 
lines derived directly from the pre-implantation embryo. Cultured in the presence of 
either feeder cells or in medium containing DIA/LIF, ES cells maintain their 
undifferentiated phenotype. However, following introduction into early host embryos 
and transfer to the uteri of pseudopregnant female recipients, ES cells respond to 
normal developmental signals and are capable of contributing to the full range of foetal 
tissues, resulting in the formation of chimaeric offspring. Mosaicism may extend into 
the germ cell lineage and ES cells may contribute fully functional gametes. 
Consequently, ES cells are being increasingly utilised as cellular vectors for genetic 
modifications of the mouse genome (see section 1.5). Because ES cells can 
theoretically be isolated from any mouse strain, cell lines can be designed to carry the 
desired genetic background. 
ES cells represent a relatively homogeneous set of cell lines with respect 
to in vitro and in vivo differentiation characteristics. 	Generally, ES cells are 
karyotypically stable, at least during early cell generations. This is attributable to the 
rapid and direct nature of their isolation from the embryo. The exact relationship 
between EC cells, ES cells and the pluripotent cells within the mouse embryo, is 
reviewed in section 1.4. 
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1.4 RELATIONSHIP BETWEEN CULTURED PLURIPOTENT STEM 
CELLS AND CELLS IN THE EARLY MURINE EMBRYO 
The basic difference between cultured stem cells and pluripotent cells within the 
early mouse embryo is the capacity of the cultured cells for apparently unlimited 
proliferation, whilst still retaining their pluripotency in vivo (Suda et al., 1987). In 
contrast, during normal embryonic development there is a continuous restriction, albeit 
gradual, in the potency of the cells as differentiation proceeds (Gardner and 
Beddington, 1988). This section reviews the embryonic lineage that EC and ES cells 
best represent in the normal embryo and considers the two hypotheses put forward to 
explain how early embryonic cells can be isolated in vitro and diverted from their 
normal fate of differentiation. That is, are pluripotent stem cells normal embryonic 
cells, or is an epigenetic modification necessary for the isolation of stem cells into 
culture? 
1.4.1 The Stem Cell Lineage 
Within the embryo a population of pluripotent cells exists up to day 7.5 
p.c. of development; with the primitive ectoderm subsequently undergoing 
gastrulation, forming the definitive embryonic ectoderm, endoderm and mesoderm 
layers of the foetus (see section 1.1). Other embryonic cells that may be considered 
pluripotent are the progenitors of the germ cell lineage. Both male primordial germ 
cells and early embryos (up to day 7.5 p.c.) are capable of forming teratocarcinomas 
from which EC cells may be isolated (see section 1.2). EC cells from both of these 
sources appear morphologically and functionally similar (Martin, 1980; Evans, 198 1) 
and there are great similarities in the route of tumour formation. Spontaneous 
activation of oocytes (Stevens and Varnum, 1974) and ectopic transfer of pre-
implantation embryos (Stevens, 1968) may result in development of normal egg 
cylinder-stage embryos before they become disorganised in the foreign environment 
and lead to a tumourous growth. Interestingly, in the initial phase of tumour 
induction, undifferentiated primordial germ cells also proliferate into cells resembling 
primitive embryonic ectoderm (Stevens, 1983) and it is this tissue within the egg 
cylinder-stage embryo which is responsible for teratocarcinoma formation (Diwan and 
Stevens, 1976). Thus, there appears to be a common stage after which there may be 
malignant conversion. For the optimal isolation of ES cells from embryonic 
outgrowths of intact blastocysts, the 1CM has also been been allowed to develop into 
structures resembling early egg cylinder-stage embryos, before disaggregation in vitro 
(Robertson, 1987). However, this is not essential in view of the direct establishment 
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of ES cells from isolated ICMs (Martin, 1981) and blastomeres, from disaggregated 
morulae (Eistetter, 1989). 
In addition to morphological similarities between primitive ectoderm, 
ES cells, EC cells (Evans and Kaufman, 1981; Martin, 1981) and primordial germ 
cells (Pierce and Beals, 1964), there are biochemical and immunocytochemical 
similarities also. The cell surface antigen expression of S SEA-i appears to be 
correlated with developmental pluripotency; first appearing on the blastomeres of 
eight-cell embryos (Solter and Knowles, 1978), then subsequently becoming restricted 
to the 1CM, primitive ectoderm, primordial germ cells, EC cells (Fox etal., 198 1) and 
ES cells (Martin and Lock, 1983). Pluripotent stem cells fail to express cytoskeletal 
markers indicative of differentiated cell types (Mummery et al., 1990). High alkaline 
phosphatase enzyme activities have been observed in primordial germ cells (Ginsburg 
et al., 1990), EC cells (Bemstine et al., 1973) and ES cells (Wobus et al., 1984). 
Patterns of protein synthesis from EC cells and ES cells have shown greatest 
homology with the day 5.5 p.c. primitive ectoderm (Martin, Smith and Epstein, 1978; 
Evans et al., 1979; Lovell-Badge and Evans, 1980; Evans and Kaufman, 1983). 
However, detailed in vivo studies utilising ES cells have shown that these stem cells 
do not share the restricted developmental potential of primitive ectoderm; which by day 
4.5 p.c. is incapable of contributing to primitive endoderm and trophectodermal 
lineages (Gardner and Rossant, 1979; Gardner, 1985). ES cells on the other hand, 
have been shown to colonise these tissues in chimaeras, albeit at low frequency 
(Beddington and Robertson, 1989; Suemori et al., 1990). In this respect, ES cells 
resemble early 1CM cells in their developmental potency (Rossant and Lis, 1979; 
Gardner, 1985). This was all the more noteworthy as the cell lines utilised by 
Beddington and Robertson (1989) were derived from implantationally delayed 
blastocysts, in which the ICMs would have already differentiated into primitive 
ectoderm and primitive endoderm (Gardner et al., 1988). Thus, there may be some 
"de-differentiation" within the ES cell lineage. It would be interesting to conduct a 
mid-gestational chimaeric analysis comparing the colonisation of ES cell lines derived 
from the blastomeres of morula-stage embryos (Eistetter, 1989) with those derived 
from blastocysts. 
It has been difficult to assess subtle differences between EC cell lines, 
derived from different stage embryos or primordial germ cells, in the colonisation of 
extra-embryonic membranes in chimaeras because of the great heterogeneity that exists 
between the cell lines in general. Although, as suggested earlier, teratocarcinomas 
may develop through a common cell type (the primitive ectoderm) some stage 
differences in developmental potency, similar to the normal embryo, have been 
reported. Re-transplantable teratomas containing trophoblast tissue have been 
produced following the injection of single EC cells derived from primary testicular 
teratocarcinomas (Kleinsmith and Pierce, 1964) and teratocarcinomas derived from 
day 3.5 p.c. embryos (Evans, 1972) and hence, are of a similar developmental 
potential to immunosurgically isolated, early ICMs (Rossant and Lis, 1979). 
However, trophoblast was apparently not amongst the tissues present in teratomas 
produced from EC cells derived from a day 6.5 p.c. embryo (Mintz and Cronmiller, 
1981). Primitive endoderm derivatives have been observed in differentiated cell 
cultures and in chimaeric mice, with EC cells derived from day 3.5 p.c. embryos 
(Martin and Evans, 1975; Stewart, 1982), but not with EC cells derived from some 
day 7.5 p.c. embryos (Rossant and Papaioannou, 1984). 
Differences with regard to X chromosome inactivation have also been 
reported with stem cells derived from different embryonic stages. Within the 
primitive ectoderm of female embryos, random inactivation of one X chromosome is 
completed by day 5.5 p.c. (Rastan, 1982). With ES cells derived from the 1CM of 
parthenogenetically activated embryos, both X chromosomes are active (Rastan and 
Robertson, 1985). Some XX EC cell lines derived from older day 7.5 p.c. embryos 
have undergone X-inactivation, as would be expected in vivo (McBurney and 
Adamson, 1976). However, other EC cell lines derived from day 7.5 p.c. embryos 
have two active X chromosomes, thought to arise as a result of reactivation of a 
previously inactive X chromosome during the process of teratocarcinogenesis 
(McBurney and Strutt, 1980). Differentiation of these EC cells in vitro was 
accompanied by the inactivation of one X chromosome (McBurney and Stnitt, 1980). 
Because of the ability to isolate EC cells from both primordial germ 
cells and early embryos, it was initially thought that EC cells derived from embryos 
may have originated from those cells of the primitive ectoderm that would form the 
germ cell lineage (Papaioannou, Rossant and Gardner, 1978). The earliest sighting of 
primordial germ cells has not been before day 7.5 p.c. (Ginsburg et al., 1990), 
however, it is theoretically possible that they are determined at an earlier stage. A 
number of findings suggest that it is unlikely that pluripotent stem cells are derived 
only from early embryonic germ cell progenitors. Firstly, the day 6.5 p.c. primitive 
ectoderm is capable of self-renewal following tissue destruction, suggesting that 
allocation of cells to different lineages has not occurred by this stage (Snow and Tam, 
1979). Teratocarcinomas have been formed from embryos homozygous at the W 
locus, which causes severe deficiency of germ cells in mice (Mintz, Cronmiller and 
Custer, 1978). And thirdly, up to four individual blastomeres from each 16- to 20-
cell embryo have produced colonies with an ES-like cell morphology (Eistetter, 1989); 
these four blastomeres could not all be progenitors of the subsequent germ cell lineage. 
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1.4.2 Cultured Pluripotent Stem Cells: Normal or Epigenetically 
Modified Cells? 
There are two differing views proposing as to how it may be possible 
to isolate permanent cell lines of undifferentiated morphology from early embryos 
(discussed by Martin, 1980; Robertson and Bradley, 1986). Either, stem cells 
represent cells that have undergone a (reversible) epigenetic modification, or they are 
normal embryonic cells that continue to proliferate until they receive the appropriate 
developmental signals to differentiate. There are arguments for and against both of 
these hypotheses. 
Cell transformation events have been responsible for the establishment 
of somatic cells into tissue-culture as permanent cell lines; whereby the cells undergo a 
"growth crisis" and initially lose proliferative potential, followed by the appearance of 
genetically altered (typically tetraploid) immortalised cells, of an apparently unchanged 
morphology (Todaro and Green, 1963; Loo et al., 1987). Pluripotent stem cell lines 
have in common with transformed cell lines an apparently unlimited potential to 
proliferate in vitro. However, in the process of establishment, the ES cells do not 
undergo a "growth crisis" event, typical of transformed somatic cell lines (Suda et al., 
1987). Although EC cells do possess relatively more karyotypic abnormalities 
compared to ES cells, these generally only include various trisomies, chromosomal 
losses, partial deletions or translocations and the cells generally remain pseudodiploid. 
Chromosomal abnormalities may arise due to high selection pressures imposed upon 
cells. The EC cells within serially transplanted teratocarcinomas may be selected over 
long periods for a more malignant cell type, which may be aneuploid (Iles and Evans, 
1977). In Vitro EC cells grown without feeders no longer require exogenous growth 
factors for proliferation and lose their capacity for extensive differentiation (Heath, 
1983). Isolation of ES cells without feeders may place immense pressure on the stem 
cells, particularly on cells derived from female embryos and account for the finding 
that such ES cells were transformed to a tetraploid state (Nichols et al., 1990). 
Because EC cells have gone through an intermediate tumour phase, 
they have been considered developmentally abnormal (Robertson, 1986). Indeed, 
many lines may be so (see section 1.2.8). Even apart from aneuploid cell lines, high 
contributions from EC cells have often been incompatible with normal embryonic 
development (Fujii and Martin, 1983) which is the critical test for normalcy. There 
are notable exceptions, however (e.g. METT-1), where EC cells have entered the 
germline of chimaeras (Mintz and Cronmiller, 1981; Stewart and Mintz, 1981). Such 
a reversion of formerly malignant EC cells might imply that any tumour 
"transformation" event to have been of a non-mutational, epigenetic nature (Mintz, 
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1978). That is, a (reversible) change in gene expression (rather than a change in 
chromosome structure) brought about from neoplastic conversion, triggered by an 
abnormal environment. 
Another factor arguing against a mutational change, is the ease with 
which teratocarcinomas can be induced in inbred strains of mice by transferring 
embryos to an extra-uterine site (Mintz, 1978). However, unknown genetic factors in 
the graft-receiving host are important in the permissiveness of teratocarcinogenesis 
(see section 1.2.3). Although the establishment of EC cells from solid tumours has 
been difficult, because of the low numbers of stem cells amongst the vast assortment 
of differentiated cells (Evans, 1972; 1981), the culture of ascitic embryoid bodies has 
often resulted in the immediate isolation of EC cell lines (Kahan and Ephrussi, 1970). 
The rapid isolation of ES cells directly from embryos (in the absence of any obvious 
signs of cellular transformation: Suda et al., 1987) from (perhaps) any mouse strain, 
has been suggested to indicate that these cells are true homologues of the early embryo 
cell phenotype (Robertson, 1986). Certainly, they participate in normal embryo-
genesis at a high frequency (Evans et al., 1985). 
If (embryonic) stem cells do not undergo "transformation" or any 
change in gene expression, how might such cells arise ? The second hypothesis 
(Martin, 1980; Robertson and Bradley, 1986) proposes that growth of the 
1CM/primitive ectoderm tissue may be normally suppressed by (embryonic or uterine) 
factors. This tissue is under fine regulatory control in vivo; with mechanisms 
compensating for changes in cell number arising from either embryo aggregation 
(Lewis and Rossant, 1982) or cellular damage (Snow and Tam, 1979). When the 
architecture of the embryo is disrupted, either in tissue-culture or ectopically, the 
undifferentiated cells may be able to "escape" normal developmental control and 
proliferate further. If this is true, then stem cells may be like normal embryonic cells 
that are naturally programmed to divide, until they receive appropriate signals to 
differentiate; for example, when re-introduced into an early embryo. This explanation 
ignores the fact that all ES cells and those EC cell lines with extensive differentiative 
capacities, are feeder-dependent; requiring a differentiation inhibitory factor to ensure 
proliferation of the pluripotent stem cells. And recent evidence suggests that extra-
embryonic tissues of peri-implantation mouse embryos synthesise DIA/LIF which 
presumably interacts with the 1CM and primitive ectoderm tissues in a paracrine 
manner, maintaining the undifferentiated phenotype (Conquet and Brulet, 1990; 
Rathjen et al., 1990a). 
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1.4.3 Summary 
The best assessment of the true relation of EC and ES cells to normal 
embryonic cells, is to test their developmental potential in chimaeras. Some 
embryonic stage differences have been detected in the limited chimaeric analyses of EC 
cells. Although ES cells derived from the ICMs of late blastocyst-stage embryos 
appear to resemble the day 5.5 p.c. primitive ectoderm biochemically, their potency is 
more similar to that of the cells of the early 1CM. It appears that stem cells may be 
isolated from any undifferentiated, pluripotent tissue within the embryo (blastomeres, 
1CM or primitive ectoderm) or the foetus (primordial germ cells). The origin (early 
embryo or germ cell) is not important; the important point is that both of these sources 
contain undifferentiated, pluripotent cells. 
It remains unresolved as to whether stem cells are able to be established 
into culture as a consequence of some epigenetic change in gene expression, or if they 
represent the normal proliferative potential of pluripotent embryonic cells. In general, 
it has been suggested that EC cells fall into the former category, while ES cells fall into 
the second. Experimental work presented in chapter five of this thesis may challenge 
this concept. 
1.5 PLURIPOTENT STEM CELLS IN THE STUDY OF EARLY 
MURINE DEVELOPMENT 
Cultured pluripotent embryonic cells have provided a unique system for studying 
fundamental aspects of mammalian developmental biology. This has been realised 
through both in vitro models of embryogenesis and in vivo, with analysis of gene 
function in the entire animal following genetic modifications performed in the 
laboratory. 
1.5.1 In Vitro Models of Embryogenesis 
The availability in tissue-culture of pluripotent embryonic cells, which 
under appropriate culture conditions can be induced to differentiate in a pattern 
resembling the normal embryo (see sections 1.2.6 and 1.3.4), has aided the study of 
early developmental events. The aggregation of stem cells in suspension culture has 
provided a model in which to study the processes involved in embryo compaction 
(Littlefield, 1989). The complex embryoid bodies formed from the differentiation of 
ES cells, may provide an in vitro model to analyse the events involved in the 
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development of the haematopoietic system (Risau et al., 1988; Wiles and Keller, 
1991). 
Certain EC cell lines may differentiate to specific cell types with the 
appropriate chemical inducers and culture conditions; for instance, into parietal or 
visceral endoderm, cardiac muscle, neuronal tissue, etc. (see section 1.2.6). 
Although the cells may have been subjected to an embryologically inappropriate signal, 
controlled differentiation may provide tissue-culture models for differential gene 
expression. Qualitative differences between undifferentiated stem cells and 
differentiated cell populations in the expression profiles of proteins (Lovell-Badge and 
Evans, 1980), homeobox genes (Eistetter, 1987) and oncogenes (Lockett and Sleigh, 
1987) may be potentially important in regulating these processes. cDNA clones have 
been isolated specific for undifferentiated stem cells (Stacey and Evans, 1984) and 
differentiated parietal endoderm cells (Kurkinen et al., 1983). 
X chromosome inactivation has been studied in tissue-culture. Some 
female EC cell lines normally possess two active X chromosomes, with one X 
chromosome becoming inactivated upon in vitro differentiation (McBurney and Strutt, 
1980). However, when EC cells were exposed to retinoic acid and induced to form 
parietal endoderm, there was no preferentialinactivationof the paternal X chromosome 
as would be expected during normal embryo development (McBurney and Strutt, 
1980). Cytogenetic studies with several parthenogenetically-derived female ES cell 
lines, each possessing a different-sized deletion of one X chromosome, have located a 
region on the X chromosome, which must be present on more than one X 
chromosome, in order for X inactivation to occur during the induction of in vitro 
differentiation (Rastan and Robertson, 1985). 
An octomer binding transcription factor (known either as Oct-4 or Oct-3 
by Scholer et al., 1989 and Okamoto et al., 1990; respectively) has been found to be 
present in undifferentiated stem cells and which disappears once the cells are induced 
to differentiate. The Oct-3 gene is developmentally regulated during murine 
embryogenesis, with Oct-3 expression in the pluripotent cells of the primitive ectoderm 
rapidly becoming down-regulated during gastrulation., The Oct-3 gene is also expressed 
in primordial germ cells and in the female germilne (Rosner et al., 1990). 
Many antibodies which have been used to study the pre-implantation 
mouse embryo have been raised using EC cells as the immunogen, because of the 
similarities in origin and differentiation capacities between EC cells and early embryos. 
Some useful monoclonal antibodies have been produced which react with embryos in a 
stage- and/or tissue-specific manner (see Kimber, 1990 for a review). 
Analysis of factors regulating the proliferation and differentiation of 
cultured stem cells (e.g. DIA/LIF) has increased the understanding of the regulatory 
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networks controlling normal murine development (Heath and Smith, 1988; Rathjen et 
al., 1990a). Undifferentiated stem cells express very low levels of DIA/LIF, 
however, the activity of the genes is dramatically increased shortly after the induction 
of in vitro differentiation (Rathjen et al., 1990a). A regulatory feedback mechanism 
has been proposed by the authors, with the differentiated cell progeny synthesising 
DIA/LIF to inhibit further differentiation of the stem cells. Similar paracrine 
interactions may occur during embryo development, between pluripotent cells and 
differentiated derivatives, as DIA/LIF transcripts have been detected in the extra-
embryonic tissues of pen-implantation-stage mouse embryos (Conquet and Brulet, 
1990; Rathjen et al., 1990a). 
1.5.2 In Vivo Analysis of Early Development 
ES cells have been more applicable in the study of in vivo development 
than EC cells because they represent a more normal embryonic lineage. The capacity 
of ES cells to be maintained in long term culture, has allowed for the genetic 
manipulation and subsequent clonal selection of cells carrying the desired genetic 
modification, before using the stem cells to re-constitute an animal (Gossler et al., 
1986; Robertson et al., 1986). 
A recent approach increasing our understanding of the developmental 
function of specific genes, has been to introduce small mutations into genes by "gene 
targeting" whilst the ES cells are in culture, followed by analysis of the resultant 
phenotype in the chimaera or the F1 (heterozygous) or F2 (homozygous) ES cell-
derived progeny. Introducing DNA into ES cells has also increased the potential of 
identifying novel developmentally regulated genes, by insertional mutagenesis. 
The study of developmental mutations in existing mouse stocks has 
been aided by the isolation of ES cell lines from embryos homozygous at the mutant 
locus. For example, the differentiation of stem cells derived from embryos 
homozygous for the embryonic lethal tw5  haplotype (at the t-Complex) into 
teratocarcinomas composed of a wider range of tissues than occurs naturally by the 
time the embryos die in vivo, suggests than the mutation does not result in generalised 
cell death, nor does it interfere with differentiation per se (Magnuson et al., 1982; 
1983). In combination with the finding that homozygous t5  embryos aggregated 
with +1+ embryos resulted in abnormal chimaenic foetuses, it has been suggested that 
the tw5  cells are unable to differentiate in an organised manner in response to the 
normal developmental signals from the host embryonic cells (Magnuson et al., 1983). 
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1.5.2.1 Insertional Mutagenesis 
The insertion of foreign DNA into the cellular genome may cause 
mutational changes by disrupting the function of an endogenous gene. In some cases, 
the DNA may insert into genes that play an important role in development and as a 
consequence, may perturb normal embryogenesis. Furthermore, the introduced DNA 
may serve as a "tag" for molecular cloning of the affected gene. Insertional mutations 
have been induced in mice by microinjection of cloned DNA into the pronucleus or by 
infection of embryos or ES cells with retroviruses (see reviews by Gridley, Soriano 
and Jaenisch, 1987; Jaenisch, 1988). 
Retroviral vectors have been used to mutagenise cultured ES cells 
to facilitate the isolation of hypoxanthine guanine phosphoribosyl transferase-deficient 
variant cells (Kuehn et al., 1987). A similar approach has lead to the detection of a 
recessive embryonic lethal mutation (413.d: Conlon, Barth and Robertson, 1991). It 
has been shown that the mutation does not operate in a cell autonomous manner, as ES 
cells derived from homozygous 413.d embryos have been "rescued" in all embryonic 
lineages in chimaeras and the homozygous stem cells have also entered the germline 
(Conlon et al., 1991). It is hoped that cloning of the locus containing the inserted 
retroviral sequences, will lead to the identification of a gene expressed at the 
gastrulation stage of embryogenesis (Robertson, 1991). 
A potentially more efficient approach in identifying (and 
mutating) novel developmentally regulated genes, may be the use of reporter gene 
constructs (termed "enhancer trap" and "gene trap" or "promoter trap") introduced 
into ES cells (reviewed by Rossant and Joyner, 1989). Enhancer trap vectors possess 
a bacterial 13-galactosidase (lac Z) gene linked with a minimal promoter. The lac Z 
gene may be transcribed if the construct integrates adjacent to an activating enhancer 
element within the host stem cell genome. Translation produces a lac Z protein which 
may be visualised by histochemical staining of chimaeric foetuses (Gossler et al., 
1989). Temporally and spatially restricted patterns of B-galactosidase staining may 
indicate that the enhancer modulates the expression of an endogenous gene of 
developmental significance. In gene trap constructs the lac Z gene, lacking its own 
promoter, may be activated as a fusion transcript during development in the chimaeric 
foetus if the vector integrates within an endogenous gene following electroporation into 
ES cells. Restricted patterns of staining detecting the resultant lac Z fusion protein in 
the chimaeric foetus may indicate that the endogenous gene is developmentally 
regulated. Molecular cloning of the marked endogenous gene will be aided by the lac 
Z DNA sequences that are physically linked to the integration site. In addition, 
insertion of gene trap constructs are likely to generate a mutation in the host gene, 
which may be further analysed by breeding from the chimaera (Gossler et al., 1989). 
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1.5.2.2 Gene Targeting 
Gene targeting involves the site-directed recombination between 
introduced, cloned DNA sequences and homologous chromosomal sequences. 
Mammalian cells do possess the enzymatic machinery to generate this homologous 
recombination event, however, it occurs at a very low frequency; with the majority of 
the foreign DNA integrating at random sites within the chromosome (reviewed by 
Capecchi, 1989; Frohman and Martin, 1989). ES cells have proved amenable to 
methods of introducing DNA into cells (commonly by electroporation) and to the 
selection strategies devised to identify and propagate these rare targeted cells. 
Initial efforts on homologous recombination in ES cells 
concentrated on the X chromosome-linked, hypoxanthine guanine phosphoribosyl 
transferase (HPRT) gene because of the hemizygous state in male cells and because of 
the directly selectable phenotype for, or against, the presence of the gene in tissue-
culture. The HPRT gene has been both inactivated (Thomas and Capecchi, 1987) and 
corrected from a mutant ES cell line, with the genetic correction having been 
transmitted through the germline in chimaeras (Thompson et al., 1989). 
Few genes, however, can be altered to provide a directly 
selectable phenotype in vitro. Because experiments using the HPRT gene have 
shown that the frequency of random integration of DNA exceeds that of homologous 
recombination by a factor of a 1000-fold or more (Thompson etal., 1989) efficient 
vector design and selection strategies have had to be devised to enrich for those cells 
containing these rare targeted events (for discussion of the various strategies used see 
reviews by Capecchi, 1989; Frohman and Martin, 1989; Robertson, 1991). 
Commonly, gene targeting vectors have contained the neomycin resistance (neoR) 
gene introduced into a homologous sequence of DNA. The neoR gene may have the 
dual function of providing a selectable marker in vitro (conferring resistance to the 
drug G418) in addition to disrupting the coding sequence of the targeted gene (Thomas 
and Capecchi, 1987). 
Some of the refined strategies that have been utilised to enrich for 
homologous recombination events include the use of promotorless vectors, positive-
negative selection and so-called "hit and run" strategies. Not all of the clones selected 
by these strategies will have been targeted and it has been necessary to verify 
homologous recombination with polymerase chain reaction and/or Southern blotting 
analyses. 
The use of promoterless selection vectors (Jasin and Berg, 1988; 
Schwartzberg etal., 1989; Riele et al., 1990) is a strategy which is only applicable to 
target genes which are transcriptionally active in ES cells. The vector design is such, 
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that with homologous recombination the selection marker (e.g. the neoR  gene) is 
activated by the endogenous cellular promoter and may enrich for homologous 
recombination by a factor of 100-fold (reviewed by Robertson, 1991). 
A very successful scheme has been the so-called "positive 
negative selection" devised by Mansour and associates (1988). This strategy has 
proved extremely useful for recovering mutations in genes that are not expressed in 
cultured ES cells (Johnson et al., 1989; Thomas and Capecchi, 1990; McMahon and 
Bradley, 1990). With positive-negative selection, the replacement vector comprises 
a positive selection marker (the neoR  gene) and distal to the region of homology, a 
negative selection marker (the herpes simplex virus thymidine kinase - HSV-tk - gene). 
As random integration has been observed to occur via the ends of the introduced DNA 
(Capecchi, 1989), this results in the inclusion of the HSV-tk gene into the 
chromosome. Such cells are resistant to G418 (G418R) (i.e. positive selection: 
indicating that the cells had integrated foreign DNA) but are susceptible to drugs such 
as ganciclovir (GANC) or deoxy-fluoro-arabinofuranosyl-iodouridine (FIAU), as the 
HSV-tk gene metabolises these precursors into toxic nucleotide analogs. And so, 
cells that have undergone a random integration event are negatively selected. With 
homologous recombination on the other hand, the HSV-tk sequences are cut out of the 
vector during the process of integration and thus, the targeted cells are G418R and 
GANCRIFIAUR. A variation upon the positive-negative scheme has been reported, 
whereby negative selection was conducted without the addition of an exogenous drug. 
The HSV-tk gene in the vector was replaced instead with a diphtheria toxin A-fragment 
gene which, if transcribed after random integration, killed the cell and thus, enriched 
for homologous recombination (Yagi et al., 1990). Typically, positive-negative 
selection has decreased the background of random integrants by 10- to 100-fold, with 
variation possibly reflecting differences in the capacity for homologous recombination 
at different genetic loci (reviewed by Robertson, 1991). 
Insertion of the neoR  gene into the coding region of the target 
gene will inactivate the gene. Such null mutations have proved valuable in studying 
development (see below), however, for the detailed in vivo analyses of protein 
structure and function, more subtle (insertion, deletion, and substitution) mutations are 
needed. Recently, a two-step recombination procedure, termed "hit and run", has 
been utilised to introduce small mutations into the HPRT and Hox-2.6 genes, without 
any selectable markers remaining in the successfully targeted event (Hasty et al., 
1991). Thus, no neo cassette will be present to potentially interfere with transcription 
of neighbouring genes and confuse interpretation of the altered allele's phenotype. An 
alternative approach to introduce small mutations without a selectable marker, has been 
to microinject DNA directly into ES cells followed by screening the cells using the 
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polymerase chain reaction. 	Although technically demanding, homologous 
recombination has been reported to occur at a relatively high frequency (1/150 cells 
microinjected: Zimmer and Gruss, 1989). 
Following the selection of genetically modified cells in vitro, 
phenotypic analysis of the altered allele may be achieved in vivo by the examination of 
the chimaera itself or through the germline, in the ES-derived F1 (heterozygous) or 
intercrossed F2 (homozygous) progeny. Alternatively, some applications may be 
better addressed by altering both alleles in vitro and studying the pattern of stem cell 
differentiation in culture (Riele et al., 1990). 
Gene targeting experiments have provided interesting data on the 
developmental function of specific genes (see review by Robertson, 1991). For 
example, inactivation of the IGF-II gene resulted in normally proportioned, but 
miniature mice in the heterozygous F1 generation (DeChiara, Efstratiadis and 
Robertson, 1990). Subsequent breeding studies have found the IGF-11 gene to be 
parentally imprinted (DeChiara, Robertson and Efstratiadis, 1991). Partial functional 
redundancy of certain genes may explain the results of Joyner and colleagues (1991) 
where homozygous en-2 null mutant mice exhibited defects in only a subset of the 
tissues known to express the gene. Similar observations have been made for the 
Hox-1 .5 gene (Chisaka and Capecchi, 1991). Although the genetics are different, the 
pathology of homozygous-deficient Hox-1.5 mice is very similar to the human 
congenital disorder DiGeorge's syndrome and thus, these mice might provide a useful 
disease model (Chisaka and Capecchi, 1991). 
1.5.3 Summary 
This section has reviewed some of the applications of stem cells in the 
study of development. Both EC and ES cells have been utilised in studies on in vitro 
differentiation; the restricted capacity of some EC cell lines to differentiate only into 
one other cell type upon exposure to certain drugs, has been beneficial in generating 
homogeneous cell populations for biochemical and molecular analysis. Only ES cells, 
however, have allowed for the in vitro manipulation of the mouse germline. Random 
insertional mutagenesis has identified new developmentally significant genes. Future 
use of reporter constructs introduced into ES cells, followed by screening of 
"interesting" staining patterns in the chimaeric foetus, undoubtedly will uncover many 
more novel genes. The precise disruption of several known endogenous genes by 
homologous recombination (or gene targeting) has already revealed the function of 
these genes within the mutant animal. This novel genetic approach to studying 
development is becoming more sophisticated, with subtle modifications being 
introduced into genes to alter protein structure, rather than just creating null mutations. 
Furthermore, it appears to be feasible to target any known gene within the genome. 
There is also the possibility of generating mouse models for human genetic disorders. 
Apart from generating mutant mice for the study of development or disease, there is 
the potential of using gene targeting in ES cells to introduce "transgenes" into the 
genome to produce novel proteins, in the milk, for example. The major advantage of 
utilising ES cells compared to conventional methods of introducing foreign DNA 
sequences into the germline (see Jaenisch, 1988), rests in the ability to select the stem 
cell clone carrying precisely the desired modification in vitro. Methods such as 
pronuclear injection, allow no control over the chromosomal site of DNA integration 
nor the number of copies introduced. Thus, expression of the transgene may be 
highly variable in these animals. Following manipulation, the ES cells retain the 
capacity to colonise the germline in chimaeras and with subsequent backcrossing by 
conventional breeding, F1 progeny, heterozygous for the modified gene, are 
produced. Even allowing for the extra generation, genetic manipulation of cultured 
ES cells is a more efficient means of producing mutant and transgenic animals than 
pronuclear injection. 
1.6 EMBRYONIC STEM CELLS FROM OTHER MAMMALIAN 
SPECIES 
The mouse has provided a model system for the application of the ES cell 
technology; demonstrating a powerful alternative for transgenesis and genetic 
manipulation of the germline to that of zygote pronuclear injection of foreign DNA (see 
section 1.5.2.2). The prospect of further extending this technology into modifying 
genetic traits of economic importance in commercial domestic species, has principally 
lead to the intense interest in isolating ES cells from animals such as pigs, sheep and 
cattle. In these species, there is the additional exciting possibility, as suggested by 
Smith and Wilmut (1989), of performing nuclear transfer with donor stem cell nuclei 
and producing an animal that is entirely ES cell-derived. This by-passes the chimaeric 
generation and the subsequent time-consuming backcrossing necessary to produce a 
homozygous individual. Such a technology would be of tremendous importance in 
future livestock breeding. 
The prime interest in obtaining ES cells from other laboratory species, is more 
concerned with providing new animal disease models and alternative systems for the 
study of developmental gene function, which for some applications may be better 
addressed in species other than the mouse. 
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This section reviews published attempts to isolate ES cells from other rodent and 
farm animal species. 
1.6.1 Rodents 
The only other small laboratory species from which embryo-derived 
pluripotent cells have been isolated is the Syrian golden hamster (Mesocricetus 
auratus; Doetschman, Williams and Maeda, 1988). Stable cell lines of an 
undifferentiated morphology were obtained from 1% (4/409) of intact blastocysts 
grown on mouse embryonic fibroblasts. These cells possessed a normal chromosome 
number and exhibited extensive differentiation in suspension culture, forming cystic 
embryoid bodies (Doetschman et al., 1988). On the basis of this in vitro 
differentiative capacity, these cells have been deemed pluripotent by the authors and 
hence, termed "hamster ES cells"; however, no published data is available on the 
capacity of these cells to participate in normal embryo development in vivo. 
1.6.2 Farm Animals 
The difficulties experienced in the attempts to isolate stem cells from 
farm species may be due to fundamental species differences in embryology, compared 
to the mouse and/or to species specific culture requirements. 
Whilst the embryology of the farm species follows a similar pattern, the 
events after blastulation and leading up to implantation are quite different when 
compared to the mouse. With particular regard to ES cell isolation, the ICWprimitive 
ectoderm of the mouse blastocyst is a more proliferative tissue (Gardner and 
Beddington, 1988) than the equivalent "embryonic disc" in farm animals (McWhir et 
al., 1991). Thus, the expectation that these undifferentiated cells would not be easily 
cultured in vitro has been evident for the sheep (Handyside et al., 1987), pig 
(Mcwhir, 1988) and cow (Schellander et al., 1989). ES-like cells (so-called since the 
pluripotency of this cell lineage has not been proven) from these species display much 
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slower rates of growth in vitro compared to the mouse and Jis probably a reflection of 
the quiescent nature of the embryonic disc in vivo. As a consequence, passage 
intervals in culture are typically extended to between five (Evans et al., 1990) and 10 
days (Piedrahita, Anderson and BonDurant, 1990a). 
There has been an effort to identify embryonic stages in farm animals 
comparable to the day 3.5 p.c. mouse embryo; particularly to identify blastocyst-stages 
before endodermal delamination from the blastocoelic surface of the 1CM has 
occurred. This may be important, as Robertson (1987) has observed in the mouse 
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that the presence of endodermal cells in vitro promotes further differentiation within 
the culture. In the pig, endoderm differentiation does not take place until day 10-12 
post oestrus (p.o.) (Notarianni et al., 1991). However, endoderm differentiation 
appears to commence at relatively earlier blastocyst-stages in the sheep (day seven: 
Handyside et al., 1987; McWhir et al., 1991) and cow (day eight: Beuendge and 
Flechon, 1988). Thus, there have been difficulties in obtaining a large population of 
1CM cells that have not been influenced by endoderm, especially in the sheep. 
Workers that have been successful in isolating ES-like cells (from the pig) have tended 
to isolate the 1CM either immunosurgically (Piedrahita etal., 1990a) or mechanically 
(Notarianni et al., 1990b) in order to remove any influences of differentiated cells 
from the cultures. 
Isolation into tissue-culture of ES cells from these species has been 
extremely difficult because of problems associated with their inherent slow growth in 
vitro, further complicated by the fact that these cells are morphologically unstable 
(Handyside etal., 1987; Piedrahita etal., 1990b; McWhir et al., 1991) with very few 
ES-like colonies surviving beyond the third passage. Typically, putative ES cell 
colonies have been observed to progressively differentiate into large, flat epithelial-like 
cells, or to simply die from the culture (McWhir et al., 1991). McWhir (1988) was 
only able to maintain his porcine ES-like cell line in a stable state following 
transformation with the polyoma virus middle T antigen. However, recent reports 
(see below) have described the isolation of stable cell lines of primary ectodermal 
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origin from farm species, which may be 	after ES cells. 
There might be species specific culture requirements for farm animal 
stem cells, but there are no reports of major innovations along these lines - methods 
have been similar to those utilised for the mouse. Medium supplemented with anti-
differentiation factors, such as mouse LIF (McWhir et al., 1991) or 60% BRL-
conditioned medium (Handyside et al., 1987) were not able to prevent the 
differentiation of ovine ES-like cells in these studies. A comprehensive study 
concerning the influence of the feeder cell layer has shown that mouse STO fibroblasts 
remained superior for the isolation of porcine ES-like cells (Piedrahita et al., 1990a). 
Ware and First (1988) reported a combination of mitotically inactivated BRL cells and 
mouse primary foetal fibroblasts enhanced the proliferation of embryonic cells derived 
from pigs, sheep and cattle, however, this effect has not been repeated (Piedrahita et 
al., 1990a). 
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1.6.2.1 Pig (Sus scrofa) 
Two independent groups have isolated stable ES-like cell lines 
from day seven to day nine p.o. pig blastocysts (Evans et al., 1990; Notarianni et al., 
1990a; 1990b; 1991; and Piedrahita et al., 1990a; 1990b). The cells from both 
groups appear similar, but somewhat different compared to mouse ES cells. They 
grow instead as flattened colonies on the STO feeder cells. Individual ES-like cells 
do, however, possess large translucent nuclei with prominent nucleoli. Interestingly, 
differences in cell size between independently isolated ES-like cell lines has been 
reported (Notarianni et al., 1990b). This may indicate that these cell lines are not all 
of the same embryonic lineage. In vitro differentiation into cellular derivatives 
representative of the three primary germ layers has been observed (Evans et al., 
1990). However, Piedrahita and colleagues (1990b) have not been able to induce 
their porcine ES-like cell lines to differentiate in vitro or in vivo; with the cells not 
having formed embryoid bodies, teratomas or chimaeras (0/21 piglets born). It has 
not been reported whether the porcine ES-like cell lines isolated in the Evans' 
laboratory are capable of participating in normal embryo development. 
1.6.2.2 Sheep (Ovis aries) 
The isolation of one stable ES-like cell line derived from a day 
eight p.o. intact blastocyst has been reported (Notarianni etal., 1990a; 1991). These 
cells display similar morphology and growth characteristics to the porcine ES-like cell 
lines and spontaneously differentiate on reaching confluence into a range of cell types 
(Notarianni et al., 1990a). However, it has not been reported if these ovine ES-like 
cells are pluripotent and capable of forming chimaeras. Although ICMs isolated from 
day seven to day nine p.o. blastocysts have been reported to give rise to more 
outgrowths and primary ES-like colonies compared to intact blastocysts, no colonies 
maintained a stable ES-like morphology for more than two or three passages 
(Notarianni eral., 1990a; 1991). Only epithelial-like cell lines have been established 
from ovine ICMs (Piedrahita et al., 1990b). 
1.6.2.3 Cattle (Bos rauris) 
Few reports have been published for the cow. Bovine cell lines 
with a stem cell-like morphology have been isolated, however, no information is 
available on their culture history, or on their in vitro and in vivo differentiative 
42 
capacities (Evans et al., 1990). Similar cells have apparently been cultured to the 
fourth passage (Streichenko, Saito and Niemann, 1991). 
1.6.3 Summary 
It has not been a trivial task to isolate ES cells from other species. 
Although ES-like cells have been obtained in the hamster, pig, sheep and cow, none 
have yet been shown to be pluripotent in vivo. Many difficulties encountered in the 
isolation of stem cells from farm animals may be due to inherent species differences in 
early embryology and in the behaviour of pluripotent cells in vivo. Optimal culture 
conditions have yet to be defined for these species. 
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CHAPTER 2 
GENERAL MATERIALS AND METHODS 
UTILISED FOR 
MURINE EMBRYONIC STEM CELLS 
This chapter outlines the general materials and methods common to the 
subsequent experimental chapters on murine ES cells. Sections detail the tissue-
culture facility and standard procedures, the production of embryos from mice and the 
techniques used for ES cell isolation and routine culture. The basic protocols 
employed in this thesis, were to a large extent based upon the methodologies described 
by Robertson (1987). A section describes the micro-manipulative technique used for 
the production of chimaeric mice, via blastocyst injection. A final section describes 
the statistical analyses performed on the data presented in this thesis. Each 
experimental chapter contains a more specific account of the procedures and treatments 
that were utilised, especially in chapters six and seven concerning the 
immunohistology of ovine embryos and the attempts to isolate stem cells in the sheep. 
2.1 GENERAL TISSUE-CULTURE 
This section describes the equipment within the tissue-culture facility, the media 
used in the isolation and maintenance of murine ES cells and the procedures for the 
preparation of the STO feeder cell layers, which were used for the co-culture of 
embryos and ES cells. 
2.1.1 The Tissue-Culture Facility 
All experimental studies on stem cell isolation reported in this thesis 
were conducted at IAPGR, Roslin, in a laboratory established solely for sterile ES cell 
culture. The basic equipment in this laboratory included: a vertical flow tissue-culture 
cabinet (Gelaire); two humidified, 5% CO2 (in air) incubators (Flow Laboratories) set 
at 37°C; a bench-top centrifuge; a waterbath; an inverted, phase contrast microscope 
(magnification: x40, xlOO, x200; Nikon Diaphot) with a Nikon F-301 automatic 
camera (photographs taken on Pan F, 25 ASA film; Kodak); a binocular, dissecting 
microscope with transmitted illumination (magnification: x12-xlOO; M8, Wild) within 
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a perspex still-air cabinet; and one propane gas Bunsen burner, with a pilot flame, 
within each culture cabinet. 
Medium was dispensed with plastic, disposable pipettes (Sterilin; 
Sterilin Ltd., or Costar; Northumbria Biologicals Ltd.; pipette sizes: imi, 5ml, lOmi 
and 25m1) utilising a rechargeable battery operated, hand-held pipette-aid 
(Drummond). A water-generated vacuum, with two waste traps, was utilised to 
aspirate spent medium through a tube connected to disposable, heat-sterilised, long-
form glass Pasteur pipettes. 
Glassware designated specifically for stem cell culture was washed 
without any detergents. Glassware was soaked for one to two days in a bucket of 
double-distilled water and rinsed several times in ultra-purified "milli-Q-water" 
(Millipore filtration system). After draining, general glassware was heat-sterilised (at 
180°C for two hours) while bottles with screw on tops were autoclaved (at 101kPal for 
20 minutes). 
Standard sterile tissue-culture procedures were employed throughout. 
Personnel entry was restricted and no mice were handled in the tissue-culture 
laboratory. The majority of work was performed within the vertical flow cabinet. 
However, in the course of ES cell isolation, it was necessary to operate on the 
dissecting microscope within the still-air cabinet. With care, microbial contamination 
was kept to a minimum. Testing for mycoplasma-infected cells was performed by the 
AFRC Moredun Research Institute, Edinburgh and none was detected in these studies. 
2.1.2 Tissue-Culture Media and Solutions 
All tissue-culture medium was based upon a 1X strength of Dulbecco's 
Modification of Eagle's Medium (DMEM; Life Technologies) - a formulation without 
sodium pyruvate, but high (4500mg/ml) in glucose. The two media formulations 
used for ES cell culture are given in Table 2.1. The main difference was in the serum 
concentration. For ES cell isolation, medium contained 20% (v/v) serum (ES20), 
while established ES cell lines were maintained in medium with only 10% (v/v) serum 
(ES io) and supplemented with recombinant DIA/LIF (see section 2.4.1 and chapter 
1.3.3.5). In both instances, serum comprised a 1:1 mixture of selected batches of 
foetal calf serum (FCS: Globepharm) and newborn calf serum (NCS: Sera-Lab). The 
same batch of each serum type was used throughout these studies. The most suitable 
serum, from several test samples provided by various suppliers, had been selected 
after testing their plating efficiency with an established ES cell line. This serum 
testing was conducted by Mary Jones whilst at the Department of Pathology, 
University of Edinburgh. Serum for mouse ES cell culture was not heat-inactivated. 
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Table 2.1: Media for murine embryonic stem cell culture 
Medium for murine embryonic stem cell isolation (ES20 medium) 
64 ml Dulbecco's Modification of Eagle's Medium (DMEM) 
10 ml Foetal calf serum (FCS) 
10 ml Newborn calf serum (NCS) 
1 ml 200mM L-glutamine 
1 ml 100X non-essential amino acids (NEAA) stock 
1 ml fi-mercaptoethanol stock (final concentration:0.1 mM) 
13 ml Analar water 
That is, 20% sera in 100 ml of medium (Osmolarity: c.a. 290 mOs) 
Medium for murine embryonic stem cell maintenance (ES10 medium) 
74 ml Dulbecco's Modification of Eagle's Medium (DMEM) 
5 ml Foetal calf serum (FCS) 
5 ml Newborn calf serum (NCS) 
1 ml 200 mM L-glutamine 
1 ml 100X non-essential amino acids (NEAA) stock 
1 ml fi-mercaptoethanol stock (final concentration: 0.1 mM) 
13 ml Analar water 
That is, 10% sera in 100 ml of medium (Osmolariy: c.a. 290 mOs) 
To ES10 medium, 0.1% (v/v) human recombinant DIA/LIF supernatant was added 
(see section 2.4.1) 
100X 8-mercaptoethanol stock 
7 p1 of B-mercaptoethanol was dissolved in 10 ml of PBS (Table 2.2) and made 
fresh before addition to ES cell medium. 
All media was filter sterilised (0.22p.m) and stored at 4°C, warming to 37°C 
before use. 
Table 2.2: Recipes for tissue-culture solutions 
Trypsin / EGTA solution (TEG) 
To 11 of Analar water, add: 
7.0 	g NaCl 
0.3 g Na2HPO4.12H20 
0.24 g KH2PO4 
0.37 g KCI 
1.0 	g D-glucose 
3.0 g Tris [2-amino-2-(hydroxymethyl) propane-1,3-diol] 
1.0 	ml Phenol red 
Dissolve ingredients and discard 100 ml of the salts solution, then add: 
100 ml 	2.5% (lOX) trypsin in modified Hank's balanced salts 
solution (Flow Laboratories) 
0.4 g 	EGTA (ethyleneglycol-tetraacetic acid) 
0.1 g PVA (polyvinyl alcohol) 
TEG was adjusted to pH 7.6, filter sterilised (0.22j.tm), aliquoted into 20 ml 
sterile, plastic universals (Sterilin) and stored at -20°C. 
Phosphate buffered saline (PBS) 
Ca2 and Mg2 free PBS was prepared by dissolving pre-formulated tablets 
(Flow Laboratories) in Analar water. PBS was aliquoted into 500 ml bottles, 
sterilised by autoclaving and stored at room temperature. 
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In addition to serum, ES media were supplemented with 1% (v/v) of 
200mM L-glutamine (Flow Laboratories) since this amino acid is unstable, 1% (v/v) 
of a 100X stock solution of non-essential amino acids (Flow Laboratories; the final 
concentrations of the NEAA added were: glycine, L-alanine, L-asparagine, L-aspartic 
acid, L-glutamic acid 0.1mM each; L-proline, L-serine 0.2mM each) and 0.1mM B-
mercaptoethanol (Sigma)(Table 2.1). 
It was found that the osmolarity of DMEM, as supplied by Life Technologies, 
was approximately 345m0s and was still considered very high after all of the above 
supplements and serum had been added (ES20: c.a. 335m0s and ES10: c.a. 340m0s). 
Although an initial study found no significant differences in the efficiency of ES cell 
isolation with media of varying osmolarities (D.N. Wells, results not presented), the 
plating efficiency of an established ES cell line was observed to have been optimal 
with medium of 290m0s (Dr J. McWhir, pers. comm.). Hence, in all of these 
studies, the osmolarity of both ES 10 and ES20 media was reduced to around 290m0s 
by the addition of 13% (v/v) Analar water (Table 2.1). 
Medium was filter-sterilised after preparation by utilising a 60m1 
syringe to push the medium through a glass-fibre pre-filter overlying a 0.22p.m 
nitrocellulose filter, housed within a 47mm filter-holder (Millipore). Media were 
stored at 4°C and warmed to 37°C immediately before use. Medium older than two 
weeks was supplemented with 1% (v/v) of 200mM L-glutamine. 
For both ES cell isolation and routine culture, no antibiotics were used. 
If a culture became infected (especially if by fungus or yeast) it was generally 
discarded from the laboratory (see section 2.6 for the analysis of the data in cases 
where individual cultures became infected during the course of ES cell isolation 
experiments). If, however, a particularly valuable culture was infected with bacteria, 
it was extensively washed in Ca2 and Mg2 free phosphate buffered saline (PBS; 
Table 2.2) before medium containing 50 lU/mi penicillin (Na salt) and 50.tg/ml 
streptomycin (Sigma) was added. 
A 0.25% (v/v) trypsin, 0.04% (w/v) EGTA (ethyleneglycol-tetraacetic 
acid) solution was utilised in the sub-culture of both fibroblast and ES cell lines and 
for the disaggregation of 1CM outgrowths and putative stem cell colonies, in the 
process of ES cell isolation. The powdered ingredients (Table 2.2) were of tissue-
culture purity (purchased from Sigma or BDH) and kept solely for ES cell culture. 
2.1.3 Preparation of STO Feeder Cell Layers 
The STO fibroblast line (Martin and Evans, 1975) was routinely 
cultured in DMEM + 1% (v/v) 200mM L-glutamine + 5% (v/v) of both FCS and NCS 
(DMEM10 medium) in tissue-culture flasks, commonly with a 25cm2 growth area 
surface (Costar; Northumbria Biologicals Ltd.). Once confluent, the fibroblasts were 
passaged, or sub-cultured, into fresh flasks. The old medium was aspirated from the 
flask and the cells washed once with lOml of PBS. After the PBS was aspirated, 2m1 
of TEG was added and the flask incubated at 37°C for three minutes. After swirling 
the flask, so as to obtain a single-cell suspension (checked in the inverted 
microscope) the trypsin solution was neutralised by adding 3m1 DMEM10. Typically, 
a 1/10th aliquot (i.e. 0.5m1) of this suspension was added to lOmi of fresh DMEM10 
in a new flask. Under such a sub-culture regime, flasks reached confluency after four 
to five days. The sub-culture ratio and the number and size of the flasks seeded, was 
varied to suit the demand for STOs. The flasks were transferred into the CO2 
incubator with either their caps loosened or, tightened after being gassed whilst in the 
flow cabinet via a sterile, plugged Pasteur pipette connected to a cylinder containing 
5% CO2,20% 02 and 75% N2. 
Mitotically inactivated STO feeder cell layers were prepared using the 
following protocol. The old medium was aspirated from a sub-confluent flask of 
STOs and for a 25cm2 flask, replaced with lOml of DMEM10 containing lOpg/ml of 
mitomycin C (Sigma). Appropriate precautions were taken when handling this 
potential carcinogen. The stock solution was prepared by dissolving a 2mg vial of 
mitomycin C in 5m1 of PBS (i.e. 400.tg/ml) which was stored at 4°C for no longer 
than one month. The STO flasks were then incubated for three hours. 
After treatment, the mitomycin C medium was aspirated and the STO 
cells were washed three times with lOmi of PBS, before being trypsinised with 2ml of 
TEG. After three minutes incubation, the STOs were dissociated into single-cells and 
the TEG was neutralised with 8ml of DMEM10. The total lOml suspension was 
transferred into a 20ml conical, plastic universal (Sterilin). A minute volume of the 
suspension was drawn into a Pasteur pipette and transferred to a haematocytometer, in 
order to count the number of cells. The STO cell suspension was centrifuged at 1000 
r.p.m. for five minutes and the supernatant aspirated. The cell pellet was then 
disrupted by carefully flicking the tube and the cells were resuspended in DMEM10 
medium, to one of three alternative densities (see below). 
Feeder cell layers were prepared in three sizes with differing surface-
areas: either in microdrops under toxicity-tested, lightweight paraffin oil (BDH), in 
1.75cm2 four-well plates (Nunc; Life Technologies) or in 25cm2 flasks (Costar; 
Northumbria Biologicals Ltd.). To enhance STO cell attachment, all culture surfaces 
were pre-treated with gelatin (porcine skin; Sigma). The gelatin was made as a0.1% 
(w/v) solution in Analar water and sterilised by autoclaving. Microdrops were 
prepared by placing two rows of five 10.tl drops of gelatin on 6cm diameter tissue- 
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culture dishes (Costar; Northumbria Biologicals Ltd.), overlayered with 5m1 of 
paraffin oil. For wells and flasks, just enough gelatin was added so as to cover the 
culture surface. The gelatin was stored for about one hour at room temperature, 
before aspiration and replacement with the freshly prepared, inactivated STO cell 
suspension. 
The STOs were plated at a density to ensure a confluent, uniform 
monolayer of cells. For microdrops, 20.i1 of a suspension containing 3 x 105 STO 
cells/ml was introduced; each (1.75cm2) well, of a four-well plate, received imi of a 
suspension containing 1.5 x 105 cells/ml; while 25cm2 flasks were seeded with 1 x 
106 STO cells in 5m1 of DMEM10 medium. Feeders were generally used within five 
days, after which time, fresh feeder layers were prepared. The old medium was 
aspirated and fresh ES medium introduced, before the feeder layers were used for co-
culture with embryos or ES cells. 
2.2 PRODUCTION OF BLASTOCYST-STAGE MOUSE EMBRYOS 
For ES cell isolation, blastocyst- stage embryos were recovered 3.5 days p.c. 
from two mouse genotypes - crossbred F1 (C57BL/6 X CBA/Ca) females mated to F1  
(C57BL/6 X CBA/Ca) males and inbred 129/Sv-CP strain mice. The C57BL/6 and 
CBA/Ca mice were from existing inbred strains at IAPGR, Roslin, while the 129/Sv-
CP strain was obtained from R. Quinney of the MRC Radiobiology Laboratory, 
Harwell, U.K.. This 129 sub-strain was derived from 129/Sv-Sl, C, P, however, 
over a number of generations the mutant Steel (Sly) locus had been bred out of the 129 
genetic background. For blastocyst injection experiments, mice from the outbred 
MF1 strain were used (see section 2.5). 
F1  and MF1 mouse stocks were housed in a separate facility (SAU) to that used 
for the 129/Sv-CP strain (Hut 5a). The SAU had a light cycle of 14 hours light 
(04:00hrs to 18:00hrs) and 10 hours dark, whereas Hut 5a employed a 12 hour light 
(06:00 to 18:00) and 12 hour dark cycle. Mice were fed and watered ad libitum. 
2.2.1 Superovulation 
The hormones used to superovulate mice were pregnant mare's serum 
gonadotrophin (PMS, Folligon; Intervet) to increase follicle production and human 
chorionic gonadotrophin (hCG, Chorulon, Intervet) to induce ovulation artificially. 
Both PMS and hCG were prepared by dissolving the lyophilised powders in sterile 
0.9% (v/v) NaCl, to give a final concentration of 50 IU/ml. The hormones were then 
aliquoted, stored at -20°C and replaced after two months. 
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Six to eight week old virgin females, from all three mouse genotypes 
(129/Sv-CP , F and MT 1), were injected intraperitoneally with five IU (i.e. 0.lMI) of 
PMS at approximately 13:00hrs. Forty-seven hours later, the same females were 
injected intraperitoneally with five JU (i.e. 0.1 ml) of hCG. Females were then paired 
with stud males (of the appropriate strain) and checked for copulation plugs the 
following morning (designated day 0.5 p.c.). It was assumed that ovulation had 
occurred 12 hours after the administration of hCG, that is, around the mid-point of the 
dark cycle. 
2.2.2 Uterine Recovery of Blastocysts 
Females were killed by cervical dislocation on day 3.5 p.c.. They were 
laid out on their backs on absorbant tissues and the abdominal surface was soaked 
with 70% ethanol. The skin was pinched up with forceps and a small cut made across 
the midline. Grasping both sides of the cut firmly with forceps, the skin was pulled 
in opposing directions to expose the abdominal body wall, which was in turn cut 
open. The alimentary tract was displaced to one side to reveal the reproductive organs 
near the dorsal surface of the female. 
The uterus, containing the blastocysts, was removed by cutting across 
the base of the cervix, but above the bladder, and cutting away the mesometrium 
membrane holding the uterus to the body wall. Both uterine horns were cut just 
below the junction with the oviduct and the uterus was placed on clean tissue. The 
uterine horns were cut from the cervix and any remaining mesometrium or adipose 
tissue was trimmed away. A 25-gauge needle, attached to a syringe containing 
DMEM1Ø + antibiotics (see section 2.1.3), was inserted 2-3mm inside the tubal end of 
the uterine horn and was grasped firmly with forceps. Approximately, lml of 
medium was flushed through each horn and collected in a 6cm dish (Costar; 
Northumbria Biologicals Ltd.). 
The dish containing the uterine flushings was transferred to the 
dissecting microscope and under low magnification, was searched for embryos. 
Blastocysts were aspirated into a mouth-controlled, hand-pulled, plugged Pasteur 
pipette. This was constructed by rotating the pipette over a Bunsen burner, to firstly 
soften the glass. After withdrawal from the flame, the pipette was quickly pulled to 
produce a fine, square tipped capillary, approximately 6cm long and with an internal 
diameter of 150-200i.m. A modified Pasteur pipette bulb was utilised as an adaptor to 
connect the end of the pulled pipette to a length of rubber tubing with a fitted 
mouthpiece. Fine control over the movement of embryos within the pipette was aided 
by firstly aspirating several minute volumes of medium interspaced with air bubbles. 
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The embryos were then collected from the flushings and pooled into a 25j..tl drop of 
ES20 medium under oil. This helped their subsequent location, before random 
allocation to the various experimental treatments. 
2.3 ISOLATION OF MURINE EMBRYONIC STEM CELLS 
This section describes the procedures that were utilised to isolate ES cells from 
intact, blastocyst- stage mouse embryos; that is, both day 3.5 p.c. and delayed 
blastocysts (see chapter 3.2) as, apart from the timing of the disaggregation of the 1CM 
outgrowth, the procedures used were identical. The approach of isolating murine ES 
cells from day 5.5 p.c. primitive ectoderm is provided in chapter 4.2. ES cells are 
typified as small, rounded cells with a large nuclear to cytoplasmic ratio, containing 
one or more prominent nucleoli and no overtly specialised cellular structures. That is, 
characteristics of a typically undifferentiated cell morphology. 
ES20 medium (Table 2.1) was used for ES cell isolation. After embryo 
recovery, the blastocysts were co-cultured on STO feeder layers prepared in 
microdrops (section 2.1.3). The medium was changed on these microdrops two to 
three hours before the embryos were introduced. Using a sterile, hand-pulled Pasteur 
pipette, one blastocyst was transferred to each, coded microdrop. As the main 
statistic from these studies was the efficiency of ES cell isolation from the various 
treatments (see section 2.6), microdrops were an essential part of the experimental 
design; whereby the progress of each embryo was monitored individually. An 
additional advantage of using microdrops was that any ES cell colonies arising from a 
single embryo were pooled together, without the necessity for cloning as required for 
group-cultures. 
Blastocysts explanted into the microdrops, hatched from the zona pellucida and 
attached to the STOs after 24-36 hours by the outgrowth of the trophectodermal cells 
(figure 2.1 a). These cells spread out and differentiated, to form a monolayer of large, 
flat trophoblast cells. As a consequence of this disorganisation, the 1CM became 
exposed to the culture environment and appeared initially as a small nest of cells in the 
centre of the trophoblast outgrowth after two to three days (figure 2.1b). After 
embryo attachment, the medium on the microdrops was replaced daily. The 1CM cells 
continued to proliferate and the outgrowths were allowed to grow to a suitably large 
size (determined by experience; see figure 2. ic), but without signs of endoderm 
differentiation, before they were disaggregated. Such outgrowths were obtained after 
four to five days of culture with day 3.5 p.c. blastocysts. Delayed blastocysts, 
however, generally required a six day culture interval before they reached a suitable 











Figure 2.1: Attachment and outgrowth of day 3.5 p.c. blastocyst- stage mouse 
embryos on feeder cell layers. In the above panels, the 1CM is indicated by arrows 
and the trophoblast by arrowheads. Embryos hatch from the zona pellucida and attach 
to the STO feeder cells via the trophectoderm after 24-36 hours of culture (a). In the 
process of attachment the blastocysts collapse, sequestering the 1CM (a). 
Subsequently, the trophectoderm differentiates into giant trophoblast cells (a) which 
grow out radially to eventually expose the 1CM after two or three days (b). The 1CM 
outgrowth proliferates as a three-dimensional mass of cells and is disaggregated once it 
has reached a size similar to that in (c) after a total of four to five days in vitro. 1CM 
outgrowths were disaggregated before they had begun to differentiate into endoderm 
(d). Photographs were taken using phase contrast microscopy. (Magnification: xlOO) 
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embryos existed in the rate of 1CM growth and thus, each embryo was monitored and 
assessed daily, with the inverted microscope. If cultured without intervention, cells 
of the embryonic outgrowth differentiated (figure 2.1 d). 
2.3.1 Disaggregation of 1CM Outgrowths 
Two to three hours before 1CM outgrowths were disaggregated, the 
cultures were re-fed with fresh medium. The disaggregation procedure was 
performed by transferring the culture dish to the dissecting microscope and with a 
blunt glass probe, prepared from a flame-polished, hand-pulled Pasteur pipette, the 
1CM was "picked off" from the surrounding layer of trophoblast. With a mouth-
controlled, drawn-out Pasteur pipette, the 1CM was transferred to a 20.il wash-drop of 
TEG on a 6cm dish (Costar)(without oil) before being placed into a fresh drop of TEG 
and incubated at 37°C for five minutes. Returning the dish to the dissecting 
microscope, a finely pulled Pasteur pipette, with a tip diameter one-fifth the size of the 
1CM clump, was used to mechanically break-up the partially digested outgrowth into 
several small pieces, each comprising around 15 cells. All of the cellular pieces 
from one embryo were then transferred to a fresh STO microdrop containing ES20 
medium. The microdrop was labelled with the coded embryo number and this 
disaggregation was termed "passage one". 	Approximately six hours after 
disaggregation, the medium was changed on the culture to remove any dead cells and 
any residual traces of the trypsin solution. 
The majority of colonies arising from the disaggregated pieces of 1CM 
were of a differentiative morphology. Trophoblast and endodermal colonies were the 
most common (figure 2.2a), however, patches of fibroblast-like, neuronal and with 
extended culture, beating muscle, were also observed. Undifferentiated cells 
possessing an ES-like morphology (so-called at this stage, since many of the colonies 
initially displaying this cellular morphology had differentiated by the second or third 
passage) were identified as small, rounded cells with a large nuclear to cytoplasmic 
ratio and containing one or more prominent nucleoli (figure 2.2b). On the STO 
feeders, the ES cells grew in tightly-packed, three-dimensional colonies, where clear 
intercellular boundaries were difficult to distinguish (figure 2.2c). The first passage 
was used to screen out all of the differentiated colonies and select only those 
displaying a stable ES-like cell morphology. This was achieved by employing a 
relatively long culture interval of five to eight days, feeding the cultures initially every 
other day, but more frequently whenever the media became acidic. 
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Figure 2.2: Morphology of cell colonies following disaggregation of 1CM 
outgrowths. Giant trophoblast cells (T) and endodermal-like cells (E) were the most 
common cell colonies present in first passage cultures of disaggregated ICMs (a). 
However, some small ES-like colonies were present amongst the assortment of 
differentiated cells (a) (ES-like colonies are arrowed in all panels). 	Higher 
magnification of a small ES-like colony two days after the first passage (b) shows the 
typical undifferentiated cell morphology. ES cells grew in close opposition with one 
another, with each cell having a high nuclear to cytoplasmic ratio and one or more 
prominent nucleoli (b). After seven days of culture on the STO feeders, some cells of 
the disaggregated 1CM had grown into tightly-packed, three-dimensional ES-like 
colonies, where clear intercellular boundaries were difficult to distinguish (c). The 
colony shown in panel (c) was subsequently expanded and maintained as a permanent 
ES cell line. 
Photographs were taken using phase contrast microscopy. 
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2.3.2 Expansion of Embryonic Stem Cells 
The first passage cultures were monitored daily and disaggregated once 
ES-like cell colonies had attained a "suitably large size", without having commenced 
differentiation (e.g. figure 2.2c). Because not all of the colonies derived from each 
embryo were of a similar size, the approach to disaggregation at the second passage 
depended upon the number of stably growing colonies in each culture. If several ES-
like colonies were present in the first passage microdrop, then the entire microdrop 
was irypsinised. The old medium was aspirated, the cells washed in situ with PBS 
and 20p.l of TEG was introduced. Following three to five minutes at 37°C, the dish 
was transferred to the dissecting microscope and a fine, mouth-controlled, pipette used 
to further dissociate the colonies into single-cells. This was important, so as to 
prevent subsequent differentiation. The cell suspension was then transferred into a 
STO feeder well of a four-well plate, containing 1 ml of ES20 medium. After one or 
two days, small colonies of ES-like cells could be visualised in some of these cultures. 
If only one or two ES-like colonies in the first passage culture were 
ready for disaggregation they were picked out of the microdrop, while any remaining 
ES-like colonies, which were considered too small to readily survive the trypsinisation 
procedures, were left to proliferate further. The larger ES-like colonies were picked 
off the STO feeder layer with a blunt glass probe, washed briefly in TEG and then 
incubated at 37°C in a fresh drop of TEG for three minutes. After partial digestion, 
the colonies were disaggregated mechanically into single-cells with a fine pipette and 
introduced into a fresh STO microdrop, before being expanded into four-well plates, 
as described above. 
From the four-well plates, the ES-like cells were subsequently 
expanded into 25cm2 flasks containing a layer of STO feeder cells. The ES-like cells 
were cultured within the wells for four to five days, feeding as required, by which 
time the colonies may have merged to form a monolayer of cells. Working in the flow 
cabinet, the medium within the well was aspirated and the cells were washed with imi 
of PBS. Following a three to five minute incubation in 0.25m1 of TEG, a hand-pulled 
Pasteur pipette (tip diameter c.a. 1mm) and bulb were used to firstly introduce around 
0.5 ml of ES20 medium to neutralise the trypsin and then to vigorously pipette the 
suspension to disaggregate the cells. The single-cell suspension was then transferred 
into a flask containing lOml of ES20 medium. The flask was then cultured in the CO2 
incubator with either the cap loosened or, tightened after being gassed with a 5% CO2, 
20% 02  and 75% N2 mixture. 
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2.4 CULTURE OF ESTABLISHED MURINE EMBRYONIC STEM 
CELLS 
This section describes the procedures used for the routine maintenance of ES 
cells, the freezing and thawing of cell lines, the induction of in vitro differentiation 
and the karotype analysis of stem cells. 
2.4.1 Maintenance of Embryonic Stem Cell Lines 
Cell lines maintaining a stable ES cell morphology were routinely 
cultured in 25cm2 flasks. After the fifth passage, ES cells were both weaned from the 
STO feeder layer and the serum concentration in the medium reduced by half. ES 
cells were subsequently maintained on gelatin-coated flasks (Bernstein etal., 1973) in 
medium (ES10; Table 2.1) supplemented with human recombinant DIA/LIF (gift of 
Dr. J.P. Simons; Department of Molecular Genetics, IAPGR, Roslin) to prevent ES 
cell differentiation. Although the concentration of the DIA/LIF factor was not 
determined, a titration assay had shown that the addition of 0.1% (v/v) of the DIA/LIF 
supernatant to ES10 medium was sufficient to minimise ES cell differentiation (Dr. 
J.P. Simons, pers. comm.). 
Established ES cell lines were passaged every three to four days, 
changing the medium every other day, or whenever it became acidic. When 
confluent, the cells were re-fed two to three hours before the passage, to maximise the 
plating efficiency. The medium was then aspirated and the cells washed once in PBS. 
After removal of the PBS, 2m1 of TEG was added and the flask incubated at 37°C for 
three minutes. The extent of trypsinisation was periodically monitored under the 
inverted microscope. To minimise spontaneous differentiation of ES cells, the aim 
was to produce a single-cell suspension. To achieve this, it was sometimes necessary 
to knock the flask against the bench. Once the cells had been dissociated, the trypsin 
was neutralised with 3m1 of ES10 + DIA/LIF medium and the suspension mixed 
thoroughly. Routinely, the cells were sub-cultured by transferring a 1/10th aliquot of 
this suspension (i.e. 0.5m1) into a pre-gelatinised flask (0.1% (w/v) gelatin for around 
one hour) containing lOmi of fresh ES10 + DIA/LIF medium. The volume of the 
aliquot dispensed was varied depending on the requirement for ES cells, however, it 
was not reduced below a one in 10 ratio. 
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2.4.2 Freezing and Thawing of Embryonic Stem Cells 
Generally, three ampoules of each ES cell line were frozen at a low 
passage number (between four and seven) and stored under liquid nitrogen. The 
cryoprotectant used in the medium was dimethyl suiphoxide (DMSO; Sigma) at a final 
concentration of 10%. Although the procedures described here (based on Robertson, 
1987) are specifically for ES cells, similar methods were used for the freezing and 
thawing of STO cells. 
	
2.4.2.1 	Freezing Cells 
The ES cells from one confluent 25cm2 flask (c.a. 1 x io 
cells) were frozen in a 1 .Oml cryotube (Nunc; Life Technologies), by firstly harvesting 
the cells by trypsinisation (section 2.4.1). The cells were then pelleted in a conical, 
plastic universal (Sterilin) by centrifugation at 1000 r.p.m. for five minutes. The 
supernatant was aspirated and the cells resuspended in 0.5m1 ES10 + DIA/LIF 
medium. The final volume (i.e. 1 .Oml) was made up with 0.5ml of the freezing 
medium (20% (v/v) DMSO in ES10 + DIA/LIF medium) which was added slowly, 
while gently flicking the universal. The 1 .Ornl suspension was dispensed into the 
cryotube, which was then wrapped in two layers of paper tissue before being placed in 
the -70°C freezer overnight. For long-term storage, the cryotubes were clipped onto 
freezing canes and plunged into liquid nitrogen. 
2.4.2.2 	Thawing Cells 
Once retrieved from the liquid nitrogen, the cryotube was 
thawed quickly in a 37°C waterbath, until the ice crystals had all melted. The cryotube 
was sterilised by wiping with 70% alcohol. Working at room temperature within the 
flow cabinet, a sterile Pasteur pipette and bulb were used to transfer the cell 
suspension in the cryotube into 9m1 of ES10 + DIA/LIF medium in a conical universal. 
The cells were then pelleted at 1000 r.p.m. for five minutes. The supernatant was 
aspirated and the cells were resuspended in lOmi of ES 10 + DIA/LIF medium and 
transferred to a pre-gelatinised, 25cm2 tissue-culture flask and cultured in the CO2 
incubator. The medium was changed after approximately six hours to remove any cell 
debris. By seeding the thawed cells at high density, the flasks reached confluence 
within one to two days. 
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2.4.3 Induction of In Vitro Differentiation in Embryonic Stem 
Cells 
ES cells were induced to form cystic embryoid bodies by the 
suspension culture of cellular aggregates. Cystic embryoid bodies comprised of an 
inner layer of ectodermal-like cells, with a Reichert's membrane separating a presumed 
outer layer of parietal endodermal cells. 
Suspension culture was conducted in 6cm tissue-culture dishes (Costar) 
coated with agarose, as described by Handyside and co-workers (1989); rather than in 
bacteriological dishes. Two layers of agarose of different concentrations were used. 
The base layer consisted of 2% (w/v) agarose (Type 1; Sigma) in PBS (Table 2.2) 
which was dissolved by autoclaving. Approximately, 1.5m1 was added per 6cm dish 
to give an even layer and was left to set at room temperature. A second, thin layer 
was applied using 1% (w/v) agarose in PBS. Once this had set, 5m1 of DMEM10 
medium + 0. 1 m 13-mercaptoethanol (see section 2.1.3 and Table 2.1) was added to 
each dish and incubated, to allow equilibration. Before use, the medium was 
replaced. 
ES cells grown on gelatin-coated flasks were lightly trypsinised with 
2m1 TEG for one minute. Gentle rocking detached large clumps of cells and the 
trypsin was neutralised immediately with DMEM10 medium + B-mercaptoethanol. 
Approximately, a 1/20 aliquot of this aggregate suspension was dispensed into each 
agarose-coated dish. At higher seeding densities, the individual aggregates adhered to 
each other. Cultures were fed regularly, aspirating the old medium by either 
transferring the suspension firstly into a conical universal to allow the embryoid bodies 
to settle, or by simply tilting the dish, before fresh medium was added. Utilising 
these procedures, cystic embryoid bodies generally formed within seven to 10 days. 
2.4.4 Karyotype Analysis of Embryonic Stem Cells 
Metaphase spreads were prepared essentially as described by Robertson 
(1987) except that the cultures were not exposed to colcemid. Instead, 25cm2 flasks 
of ES cells were taken in an exponential phase of growth, in order to maximise the 
number of cells in mitosis. ES cells were trypsinised and pelleted in a 20ml conical 
universal as described previously (section 2.4.2.1). The medium was aspirated and 
the cell pellet disrupted, before using a Pasteur pipette and bulb to introduce dropwise, 
around 0.5m1 of a 0.56% (w/v) KC1 solution. Once mixed, excess hypotonic KC1 
solution was added to make lOmi and was left at room temperature for 15 minutes, to 
allow the cells to swell. Following centrifugation (1000 r.p.m. for five minutes) and 
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aspiration of the supernatant, freshly prepared fixative (three volumes of absolute 
methanol to one volume of glacial acetic acid) was slowly added dropwise, whilst 
flicking the tube. Excess fixative was added to make lOml and the cells were left for 
five minutes, at room temperature, before pelleting (1000 r.p.m. for five minutes) and 
aspiration of the supernatant. This cycle was repeated two further times, each time 
with freshly prepared fixative. The cells were finally suspended in around 0.5m1 of 
fixative and were then ready for producing mitotic spreads. 
Metaphase spreads of the fixed, swollen cells were made on clean, wet, 
glass microscope slides that had been chilled on ice. A quantity of the fixed 
suspension was drawn into a hand-pulled Pasteur pipette (tip diameter c.a. 1mm) with 
a bulb. Several drops of suspension were released onto the slide from a height of 
around 100cm. The undersurface of the slide was wiped dry and evaporation of the 
fixative was aided by warming the slide briefly in the flame of a Bunsen burner, as 
well as blowing across the surface of the slide. The height from which the cells fell 
and the rate of fixative evaporation, were both important variables in maximising the 
rupture of the swollen cells and hence, the spreading of the chromosomes. At least 
five slides per ES cell line were prepared in this manner. The slides were stored in a 
dust-free drawer for 10-14 days before G-banding. 
Slides were incubated in 2X standard saline citrate (SSC: 0.3M NaCl, 
0.03M trisodium citrate) at 60°C for one hour. The slides were then rinsed four to 
five times in distilled water and stored temporarily in a rack under water. Each slide 
was individually immersed in a 0.25% (w/v) trypsin (1:250 Difco; Difco Laboratories) 
solution in Gun's phosphate buffer (pH 6.8; BDH) for between 7-15 seconds at room 
temperature. The trypsin remaining on the slide after this digestion, was neutralised 
in Gun's buffer containing 5% (v/v) NCS. The slides were further rinsed in two 
changes of buffer before being stained in freshly prepared 5% (v/v) Giemsa Gun's R-
66 stain (BDH) in Gun's buffer (pH 6.8) for 8-10 minutes. Slides were finally 
rinsed in two changes of buffer, followed by two changes of distilled water and 
allowed to air thy. 
0-banded metaphase spreads were examined with a standard format, 
brightfield microscope utilising oil immersion, objective lenses (maximum 
magnification: xl000; Olympus BH-2). Chromosome numbers were counted and the 
sex of the cell line determined from at least 10 metaphase spreads prepared from cells 
between culture passages six and 15. Suitable spreads were photographed on 
Technical Pan, 25 ASA film (Kodak). G-banded chromosomes were identified 
according to the Standardised Genetic Nomenclature for mice (Nesbitt and Francke, 
1973). 
2.5 PRODUCTION OF CHIMAERIC MICE 
The in vivo pluripotency of isolated ES cell lines was tested by the production of 
chimaeric mice. This was achieved by utilising a micromanipulative technique, 
employing two micropipettes, to physically inject the ES cells into blastocyst-stage 
embryos in a method similar to that described by Bradley (1987). 
2.5.1 Donor and Recipient Mice 
Donor, day 3.5 p.c. blastocysts were obtained from albino, MF1 strain 
females mated to MF1 stud males. Procedures for superovulation (section 2.2.1) and 
embryo recovery (section 2.2.2) have been described previously. Following 
recovery, embryos were group-cultured in a drop of ESIO + DIA/LIF medium under 
oil, until they were required for manipulation. 
Pseudo-pregnant females were required to act as recipients for the 
surgically transferred, manipulated embryos. Recipients were obtained from natural 
matings between MF1 or F1 (C57BL/6 X CBA/Ca) females and vasectomised males. 
The approximate time of ovulation was determined by checking for copulation plugs 
the following morning, which was designated day 0.5 p.c.. These matings were set 
up so that the recipient females were one day less advanced (i.e. 2.5 days p.c.) than the 
donor embryos. 
2.5.2 Preparation of Embryonic Stem Cells 
ES cells for blastocyst injection were maintained on gelatin-coated 
flasks in ES10 + DIA/LIF medium as outlined in section 2.4.1. To maximise stem 
cell viability, the medium was changed every day and the cultures fed two to three 
hours prior to trypsinisation. The cells were cultured on a three day passaging 
regime, with ES cells being used for injection on days one or two of the growth cycle. 
The cells were trypsinised into a single-cell suspension and a small volume, containing 
several hundred cells, was introduced into the injection chamber (see section 2.5.4) on 
the microscope stage. After one to two hours of micromanipulation, these cells were 
discarded and a new injection chamber was prepared with freshly trypsinised ES cells. 
2.5.3 Preparation of Micropipettes 
Two micropipettes, constructed from glass capillary tubing, were 
utilised for the embryo manipulations. The blastocyst was immobilised by gentle 
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suction with a holding pipette and an injection pipette used to introduce the ES cells 
into the blastocoelic cavity. 
The holding pipette was constructed by heating a small section of a 
10mm long capillary tube (external diameter 1.0mm; GC100-10, Clark Electromedical 
Instruments) uniformly over the pilot flame of a propane gas burner. Once softened, 
the capillary was withdrawn from the flame and pulled quickly by hand, to produce a 
gradual taper over a 2-3cm length of glass. This pulled capillary was then broken at 
right angles on a microforge (Research Instruments Ltd.) at an external diameter of 90-
100m. This was achieved by positioning the capillary vertically on the microforge 
and placing the glass at the required diameter (determined by a graticular eyepiece) 
adjacent to the glass bead on the platinum wire, heating filament. With the glass bead 
heated slightly (the temperature was determined empirically) the capillary was then 
brought into contact so that the two just barely fused together. The filament was then 
switched off and at the same instant the spring-loaded connecting rod, holding the 
filament, was depressed and so, causing the capillary to break cleanly at the point of 
contact with the glass bead. The tip was then heat-polished by placing the tip above, 
but just clear of, the hot glass bead, causing the glass to melt and produce a concentric 
orifice of 20-25p.m in diameter. 
The injection pipettes were prepared by pulling thin-walled, 1.0mm 
diameter glass capillary tubing (GC100T-15; Clark Electromedical Instruments) on a 
horizontal pipette puller (model 753; Campden Instruments Ltd.). The settings were 
adjusted to produce a gradual taper over a 15mm length of glass, from the shoulder to 
the needle point. The microforge was then utilised to break the capillary at right 
angles at an external diameter of 1 8-20p.m, in a manner similar to that described above. 
The tip of the pipette was bevelled to an angle of 45°. This was accomplished by 
grinding the pipettes for three to five minutes each, on a slowly rotating (60 r.p.m.) 
aluminium oxide disc (1.tm grade; 3M) lubricated with distilled water and with a 
stream of air flowing through the inside of the pipette, to keep the internal bore free of 
debris. With the aid of the microforge, a sharp point was put onto the leading edge of 
the bevelled pipette. With the pipette positioned vertically, the filament was heated to 
a low temperature, at which the pipette tip just barely fused to the glass bead. Once 
fused, the pipette was raised away from the filament to draw out a short glass spike. 
To provide a "siliconising" effect, the tip of the pipettes were washed in a 1.25% (v/v) 
detergent solution of Tween-80 (Sigma) in distilled water and allowed to dry at room 
temperature, before use. 
Using the microforge, both the injection and holding pipettes were bent 
at an angle of around 30°, 5mm from the respective tips, to allow entry into the 
injection chamber (see figure 2.3). 
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2.5.4 Micromanipulator Assembly 
The injections were performed using two Leitz micromanipulators 
mounted on either side of a fixed-stage, inverted, phase contrast microscope 
(magnification: x40, xlOO; Nikon Diaphot). The two instrument holders were each 
connected to micrometer syringes (Hamilton) using thick-walled (Portex) tubing 
(internal diameter 2.5mm) filled with inert mineral oil (Fluorinert 77; Sigma). The 
holding pipette was held in the left-hand manipulator, with the corresponding (500tl) 
micrometer syringe positioned on the right-hand side. The reverse arrangement was 
established for the injection pipette and the associated (250.tl) micrometer syringe. 
Before fixing the pipettes into the respective tool holders, the tubing was purged of air 
bubbles using a 20m1 syringe filled with Fluorinert, which was connected into the 
hydraulic line via a three-way tap. The pipettes were locked into the tool holders and 
using the two reservoir syringes, each pipette was filled with 	Fluorinert. The 
pipettes were then aligned in the injection chamber so that the ends were parallel to the 
bottom surface (figure 2.3). Medium from the chamber was then drawn a short 
distance into the pipette using the reservoir syringes. The injection chamber was 
prepared by introducing a 250jfl drop of ES 10 + DIA/LIF + 20mM HEPES buffered 
medium, in the centre of a 90mm bacteriological dish (Sterilin) which was overlayered 
with paraffin oil. Several hundred ES cells were then introduced into the chamber and 
the manipulations were performed at room temperature. 
2.5.5 The Blastocyst Injection Procedure 
Groups of five embryos were transferred from the incubator into the 
injection chamber. The injection pipette was lowered to the base of the chamber and 
ES cells for one injection were individually selected and gently drawn into the pipette, 
one behind the other. The expanded blastocysts were held by suction onto the 
holding pipette. By patiently blowing and sucking medium, through the holding 
pipette, the embryo was eventually orientated in the desired position, with the 1CM 
region over the orifice of the pipette (figure 2.3). Focusing, at xlOO magnification, 
on a "junction" between where two trophectodermal cells joined together, around the 
equatorial plane of the embryo, the injection pipette was then raised to the same focal 
level. The injection pipette was then brought to a point just adjacent to this cellular 
junction (figure 2.3). With a rapid movement forward on the manipulation joystick, 
the pipette was pushed into the blastocoelic cavity. The ES cells were gently blown 
out of the injection pipette and into the embryo. Between 10 and 15 healthy ES cells 
were introduced. The injection pipette was carefully withdrawn from the blastocyst 
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Figure 2.3: Orientation of micropipettes within the manipulation chamber. A 
holding pipette (a) was used to immobilise the blastocyst by gentle suction, while an 
injection pipette (b) was used to introduce the ES cells into the blastocoelic cavity of 
the embryo. 
and the injected blastocyst was released from the tip of the holding pipette. Shortly 
thereafter, the blastocysts generally collapsed due to the punctured trophectoderm. 
They were then transferred to the incubator in a droplet of ESIO + LIF medium under 
oil, where they slowly began to re-expand. Injected embryos were cultured for 
between 30 minutes and three hours before being transferred to recipients, regardless 
of whether or not the blastocysts had fully re-expanded. 
2.5.6 Embryo Transfer 
The injected blastocysts were surgically transferred into the uterine 
lumen of day 2.5 p.c. pseudo-pregnant recipients. Typically, 10 embryos were 
transferred unilaterally. Surgical operations were conducted in a laboratory within the 
mouse house. Thus, females did not leave the facility and were returned the the same 
cage-rack after the transfer. This minimised animal stress and losses due to 
embryonic resorptions. 
Recipients were anaesthetised with a 0.15 to 0.20m1 intraperitoneal 
injection of a Hypnorm (Janssen Pharmaceuticals) and Hypnovel mixture (Roche 
Products). This anaesthetic was prepared by mixing separately, lml of Hypnorm 
(containing 0.3 15mg fentanyl citrate and 10mg fluanisone) and imi of Hypnovel 
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(containing 5mg midazolam hydrochloride) each with 2m1 of distilled water, before 
combining the two solutions together. The anaesthetic was stored at room 
temperature and replaced after four weeks. 
Once unconscious, the back of the mouse was wiped with 70% alcohol. 
A pair of blunt forceps were used to pick up the skin and dressing scissors were used 
to make a 10mm lateral incision across the midline, posterior to the last rib. Paper 
tissues, moistened with 70% alcohol, were used to open the wound and remove any 
cut hair, by wiping in a head to tail direction. Sliding the skin from side to side, the 
position of the right-hand ovary was located beneath the body wall. The region 
directly overlying the ovary was grasped with pointed watchmakers forceps and a 
5mm incision was made in the body wall with sharp iris scissors. By exerting gentle 
pressure on both sides of the incision, the ovarian fat pad was exteriorised and grasped 
with blunt forceps. Very carefully, the associated ovary, oviduct and the top of the 
uterine horn were also pulled out. The weight of the fat pad was generally sufficient 
to keep the ovary from slipping back inside the abdominal cavity. The mouse was 
then transferred, on absorbant tissues, to the stage of a binocular dissecting 
microscope (Olympus SZH), with a fibre-optic incident light source (Schott, 
KL1500). 
In 	another dissecting microscope (Olympus SZ), with transmitted 
illumination, the embryos to be transferred were aspirated into a hand-pulled Pasteur 
pipette, with an internal diameter just larger than the embryos themselves and with a 
square tip. The pipette was pre-loaded with alternate media and air bubbles, which 
allowed fine control over the movement of the embryos. Embryos were drawn up 
into the pipette closely one behind the other and so, the minimum of medium was 
introduced into the uterus when the embryos were transferred. 
Focusing on the region of the uterotubal junction (magnification c.a. 
xlO), a pair of watchmakers forceps grasped the top of the uterine horn gently and 
lifted it up slightly to allow a 25-gauge hypodermic needle to puncture the uterine wall 
and enter the lumen. Whilst still holding the top of the uterus and observing down the 
microscope, the transfer pipette containing the embryos was picked up and the tip 
inserted 5mm inside the uterine lumen, through the hole produced with the needle. 
The embryos were gently blown into the uterine lumen using the air bubbles along the 
pipette as markers. After transfer, the pipette was checked to ensure that all of the 
embryos had been expelled. 
The reproductive organs were returned to the abdominal cavity by 
lifting up one edge of the incision and pushing in the ovarian fat pad with blunt 
forceps. The incision in the body wall was closed with a single suture (5/0 Mersilk; 
Ethicon), while three sutures were used to close the skin. Mice were allowed to 
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recover on a heated blanket before they were returned to the cage-rack. If pregnant, 
they littered 17 days later. 
2.5.7 Analysis of Chimaeras 
All of the ES cell lines isolated in these studies were of a 129/Sv-CP or 
F2 (C57BL/6 X CBA/Ca) genotype; that is, they possessed homozygous dominant, 
pigmented coat colour alleles. The 129/Sv-CP strain used here has a black agouti (BB 
AA) phenotype, whereas the F2 embryos, produced by crossing F1 [C57BL/6 (black, 
non-agouti: BB aa) X CBA/Ca (black agouti: BB AA)] parents, will segregate into 
both black agouti (AA, Aa) and black non-agouti (aa) phenotypes in the ratio of 3:1. 
As donor blastocysts were obtained from the homozygous recessive, albino (c/c) MF1 
strain, it was a simple matter to assess chimaerism and germline transmission of the 
ES cells on the basis of coat colour markers. 
Overt chimaeras, in some instances, were determined at birth from eye 
colour or three to four days later, by the presence of pigment in the skin. An estimate 
of the percentage contribution of ES cells to the skin was also taken. The sex of the 
chimaeras was assessed at weaning; at three to four weeks of age. 
With XY ES cell lines, male chimaeras were backcrossed by mating to 
MR (albino) females to assay for germline transmission. This was detected by the 
presence of pups with an entirely pigmented coat, from the dominant alleles carried by 
the cultured stem cells. With XX ES cell lines, female chimaeras were mated to MF1 
males to test for ES cell-derived oocytes. 
2.6 STATISTICAL ANALYSES 
In this thesis, murine ES cell lines are defined as cell lines from individual 
embryos which maintained a stable ES cell morphology for at least 10 passages in 
culture and possessed the capacity to form cystic embryoid bodies following in vitro 
differentiation. During preliminary studies, it was found that in the tissue-culture 
facility utilised throughout this thesis, colonies derived from day 3.5 p.c. mouse 
embryos from the 129/Sv-CP strain and identified as possessing an ES cell 
morphology at the third passage, were subsequently expanded into permanent ES cell 
lines. Thus, in the experimental studies reported in this thesis, ES cell colonies 
(derived from 129/Sv-CP blastocysts) which had been stably maintained up to at least 
the third passage but which were subsequently lost to rare cases of infection, were still 
classed as ES cell lines. Any embryos or cultures which were lost to infection before 
the third passage were eliminated from the data. During the initial phases of 
establishment of ES cell lines, between the disaggregation of the 1CM and before 
passage three, colonies possessing a stem cell morphology are referred to as "ES-like" 
to signify the fact that many of these colonies were morphologically unstable at these 
early stages of culture. 
In studying the factors which influence the capacity of embryos to yield ES cell 
lines, the data are presented in two formats in this thesis. Firstly, as the efficiency of 
ES cell isolation from a particular experimental treatment; expressed as the percentage 
of the number of embryos yielding an ES cell line divided by the total number of 
embryos cultured. Secondly, the results are also presented as "survival profiles" 
showing the proportion of embryos giving rise to ES-like colonies at each successive 
passage in vitro, until the establishment of permanent ES cell lines. Only colonies 
which maintained a stable ES-like cell morphology throughout each passage were 
included in the data. The survival profiles were expressed percentages, at each 
passage, of the number of embryos yielding ES-like colonies divided by the total 
number of embryos cultured for each treatment. 
Most experiments were repeated with a number of different batches of embryos, 
cultured on different occasions. These served as replicates of the experiment from 
which the standard error of the means (s.e.m.) were calculated, according to the 
following formulae: 
In 
2' s=/ 	(xi - X)/(n 1) 
V i=1 
s.e.m. = 
Where: S =sample standard deviation 
=summation 
n = number of samples 
i 	= the ith sample 
X =sample value 
X = sample mean 	 (from: Snedecor and Cochran, 1980) 
M. 
The statistical analyses of the data were accomplished with the chi-squared test, 
comparing two proportions. The proportions were arranged initially in a four-fold 
table as illustrated below (e.g. comparing the efficiency of ES cell isolation between 
treatments a and b): 
Treatments 
a 	b 	Total 
Number of embryos giving ES cell lines 	 n11 	"12 	ni. 
Number of embryos giving only differentiated colonies n21 n22 n2•  
Total number of embryos cultured 
	
n 1 	n 2 	n•• 
(from: Fleiss, 1973) 
From the above fourfold table, the magnitude of the chi-squared (x2) statistic 
was calculated according to the formula: 
n (Iniin - n12n211 - 0.5n)2 
(from: Fleiss, 1973) 
When the chi-squared statistic exceeded 3.84, a statistically significant difference 
(at the P<0.05 level) between the two proportions was said to exist. 
CHAPTER 3 
INFLUENCE OF MOUSE GENOTYPE AND 
IMPLANTATIONAL DELAY 
ON THE EFFICIENCY OF 
EMBRYONIC STEM CELL ISOLATION 
3.1 INTRODUCTION 
There are limited reports in the literature quantifying the potential of embryos 
from different mouse strains to generate ES cell lines. While ES cells have been 
isolated from a wide range of genetic backgrounds (see chapter 1.3.3.2) it is not clear 
whether some mouse genotypes are more "permissive" than others. The effect of 
mouse genotype has been confused as many workers have utilised a variety of 
crossbred embryos for ES cell isolation. Furthermore, despite the use of similar 
isolation methods, there have been some conflicting reports on the effect of mouse 
genotype; perhaps highlighting the influences of unknown variables in the tissue-
culture conditions between different laboratories. In a study primarily examining the 
effect of feeder cell layers (Suemori and Nakatsuji, 1987) there was no difference in 
the proportion of embryos from the 129 (/J and /SvJ) and C57BL/6 inbred strains 
giving rise to ES cell lines (both 18%; 36/201 and 30/167, respectively). Doetschman 
and associates (1985), however, reported that embryos from the C57BL/6 strain 
generated ES cell lines at twice the frequency (10%) as embryos from the 129/Sv 
strain (5%), although data on the numbers of embryos cultured and the significance of 
these results were not reported. Although no specific mouse strains were mentioned, 
one study has reported that mouse strains could be classed as possessing either a high 
or a low potential to give rise to ES cells in culture (Martin et al., 1984). 
Subsequently, it was reported by this group that mutations at the mouse t-locus have 
significant effects on the frequency at which ES cells can be established. The 1CM 
from embryos homozygous for the to haplotype are unable to proliferate in vitro and 
give rise to ES cells (Martin et al., 1987). A laboratory experienced in isolating ES 
cells from a range of mouse strains has not, however, published the associated 
efficiencies (Robertson et al., 1983b). This group have reported that none of the 
strains they examined could be classed as "non-permissive" and routinely expect 
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approximately 10% of all day 3.5 p.c. blastocyst-stage embryos explanted into culture 
to yield ES cell lines (Robertson and Bradley, 1986). 
Female mice have a facultative form of implantational delay, one which is 
imposed by lactation (Bergstrom, 1978). Implantational delay may also be induced 
experimentally in females three days after mating, by surgical removal of ovarian 
tissue, in combination with post-operative administration of a synthetic progesterone 
(Bergstrom, 1978). The embryos progress to the hatched blastocyst-stage and 
although they remain viable, their development thereafter is arrested as a consequence 
of these procedures. It has been reported that "delayed" embryos, produced 
experimentally, have a greater capacity to yield ES cell lines than non-delayed, day 3.5 
p.c. embryos (Robertson and Bradley, 1986). The mechanism responsible for this 
effect of implantational delay is not understood. 
The 129/Sv-CP mouse strain used in these studies was similar to that originally 
employed by Evans and Kaufman (129/Sv//Ev: 1981). The 129 strain has not been 
demonstrated to yield ES cell lines at a significantly higher efficiency compared to 
other mouse genotypes. However, it is a strain that is commonly favoured for ES cell 
isolation and lines derived from the 129 strain have been utilised extensively for gene 
targeting experiments (reviewed by Baribault and Kemler, 1989). 
In preliminary experiments, the isolation of ES cells from crossbred F2 
(C57BL/6 X CBA/Ca) embryos had proved very difficult, compared to embryos from 
the inbred 129/Sv-CP strain. The objective of this study was to investigate whether a 
significant difference existed between the potential of embryos from these two mouse 
genotypes to yield ES cells, in addition to examining the effect of imposing an artificial 
period of diapause on the embryos from these two genotypes. This study validated 
the reliability of the culture methods utilised in this thesis. 
3.2 EXPERIMENTAL METHODS 
The efficiency of ES cell isolation from two mouse genotypes was compared 
between normal day 3.5 p.c. blastocysts and blastocysts that had undergone a three or 
five day period of implantational delay. Embryos were recovered from both 129/Sv-
CP females mated to 129/Sv-CP males (i.e. 129/Sv-CP embryos) and from F1  
(C57BL/6 X CBA/Ca) females mated to F1 (C57BL/6 X CBA/Ca) males (i.e. F2 
embryos). The general procedures utilised for the superovulation of females and the 
isolation, maintenance and manipulation of ES cells were the same as those described 
in chapter two. 
"I] 
3.2.1 Production of Implantationally Delayed Blastocysts 
Ovariectomy was performed on superovulated females 2.5 days p.c. 
(Bergstrom, 1978). The procedures for anaesthesia and the exteriorisation of the 
ovary from the abdominal cavity were the same as those described previously (see 
chapter 2.5.6). The mouse was then transferred, on absorbent tissues, to the stage of 
a binocular dissecting microscope (Olympus SZH), with a fibre-optic incident light 
source (Schott, KL 1500). Focusing on the ovary at low magnification (c.a. xlO), 
two watchmakers forceps were utilised to delicately tear open the ovarian bursa, 
encapsulating the ovary and the oviduct. With the ovary released, a small, pre-tied 
loop (c.a. 5mm diameter) of fine suture cotton (5/0 Mersilk; Ethicon) was slipped 
between the ovary and the oviduct and pulled tight with forceps, to ligate the ovarian 
blood vessels. All of the ovarian tissue was then cut away, using iris scissors. 
The fat pad and oviduct were replaced inside the abdominal cavity by 
lifting up one edge of the incision and pushing in the fat pad with blunt forceps. The 
ovariectomy was then repeated on the other side. The incisions in the body wall were 
closed with single sutures (5/0 Mersilk; Ethicon) while the skin was closed with three 
sutures. 
While the female was still unconscious, 0.1ml of a 10mg/mi 
progesterone (4-pregene-3, 20-dione; Sigma) solution, dissolved in absolute alcohol, 
was injected subcutaneously into the flank region. The mouse was placed onto a 
heated blanket to aid post-operative recovery. 
The delayed blastocysts were recovered from the uterine horns as 
outlined in chapter two (section 2.2.2). Embryos from the 129/Sv-CP strain were 
flushed on days 6.5 and 8.5 p.c. (i.e. four and six days after ovariectomy; or, three 
and five days, respectively, after blastocyst formation) and F2 (C57BL/6 X CBA/Ca) 
embryos were recovered 8.5 days p.c.. 
3.3 RESULTS 
3.3.1 Embryo Recovery 
The average yield of embryos from superovulated 129/Sv-CP females 
recovered on day 3.5 p.c. was 7.8 ± 0.9 (n = 18). The ovariectomy procedure, 
utilised to produce implantationally delayed blastocysts, did not alter the recovery of 
129/Sv-CP embryos when the uterine tracts were flushed 6.5 days p.c. (8.4 ± 1.5; n = 
11). 	However, when other 129/Sv-CP females from the same batch of 


















Day 3.5.p.c. 	Day 6.5 p.c. Day 8.5.p.c. 
(e=150) (e=121) (e=87) 	(e=30) (e=19) 
(n=3) (n=4) (n=4) (n=3) (n=3) 
Delayed Embryos 
Day of Embryo Recovery 
Figure 3.1: The effects of mouse genotype and implantational delay on the 
efficiency of ES cell isolation. (mean ± s.e.m.; e = embryos; n = replicates). 
a = P<0.001 compared to day 3.5 p.c. F2 embryos. 
b = P<0.001 compared to day 3.5 p.c. 129/Sv-CP embryos. 
b = P<0.01 compared today 6.5 p.c. 129/Sv-CP delayed embryos. 
c = Pcz0.001 compared to day 3.5 p.c. F2 embryos. 
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embryos recovered (1.9 ± 0.6; n = 10) was significantly less (P<0.001). This effect 
of the period of delay, was not observed in the recovery of F2 (C57BL/6 X CBA/Ca) 
embryos; where the yield was not different between day 3.5 p.c. (14.0 ± 3.0; n = 12) 
and ovariectomised F1 females, flushed on day 8.5 p.c. (10.0 ± 0.6; n = 3). 
3.3.2 The Effects of Mouse Genotype and Implantational Delay 
on the Efficiency of Embryonic Stem Cell Isolation 
Significant and reproducible trends in the effects of mouse genotype 
and implantational delay on the efficiency of ES cell isolation were observed (figure 
3.1). The standard error of the means in figure 3. 1, reflected the slight variability 
between the different batches of embryos cultured throughout the course of this 
experiment; each treatment was repeated either three or four times. 
Day 3.5 p.c. blastocysts from the 129/Sv-CP mouse strain yielded 
significantly (P<0.001) more ES cell lines (16/121=13.2 ± 2.3%) than embryos of the 
F2 (C57BL/6 X CBA/Ca) genotype (2/150=1.3 ± 0.6%; figure 3.1). The effect of 
implantational delay on the efficiency of ES cell isolation, depended upon the time the 
blastocysts remained dormant within the uterus. When "delayed" embryos of the 
129/Sv-CP mouse strain were cultured following recovery on day 6.5 p.c., there was 
no significant difference in the yield of ES cell lines (14/87=16.1 ± 4.4%) compared to 
day 3.5 p.c. embryos. Extending the period of implantational delay of blastocysts to 
five days, however, (i.e. embryo recovery was on day 8.5 p.c.) significantly increased 
the capacity of the 129/Sv-CP strain embryos to give rise to ES cell lines (9/19=47.4 ± 
7.8%) compared to both day 3.5 p.c. embryos (Pcz0.001) and delayed embryos 
recovered on day 6.5 p.c. (P<0.01). Similarly with the F2 embryos, a significant 
increase was observed with delayed blastocysts recovered 8.5 days p.c. (8/30=26.7 ± 
2.3%; P<0001) compared to non-delayed, day 3.5 p.c. F2 embryos (figure 3.1). 
Furthermore, the proportional increase in the efficiency of ES cell isolation resulting 
from embryonic delay (with embryo recovery on day 8.5 p.c.) was significantly 
(P<z0.01) greater with F2 embryos, compared to the 129/Sv-CP embryos (figure 3.1). 
The percentage survival of ES-like colonies derived from either delayed 
(day 8.5 p.c. only) or non-delayed (day 3.5 p.c.) embryos, of both 129/Sv-CP and F2 
(C57BL/6 X CBA/Ca) genotypes, after each successive passage in culture, is plotted 
in figure 3.2. The graph shows the progressive decline at each passage in the 
proportion of original embryos giving rise to colonies of ES-like morphology, until the 
eventual establishment into culture of stable ES cell lines. The loss of some ES-like 
colonies after each passage was due to either differentiation, with the colonies 
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Figure 3.2: The survival profiles showing the effects of mouse genotype and 
implantational delay on the percentage of individual embryos giving rise to colonies 
with an ES-like morphology after repeated passage in culture. After passage five, ES 
cells derived from both 129/Sv-CP and F2 (C57BL/6 X CBA/Ca) embryos were 
maintained as permanent ES cell lines. (mean ± s.e.m.; e = embryos). 
a = P<0.001 compared to the percentage of non-delayed day 3.5 p.c. F2 embryos 
yielding first passage ES-like colonies. 
b = P<0.001 compared to the percentage of non-delayed day 3.5 p.c. 129/Sv-CP 
embryos yielding third passage ES-like colonies. 
c = P<0.001 compared to the percentage of day 3.5 p.c. F2 embryos yielding first 
passage ES-like colonies. 
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displaying an altered cell morphology or, occasionally, to the failure of the cells to 
survive the trypsinisation protocol. 
From figure 3.2, between 5-10% of all the embryos explanted into 
culture did not produce an outgrowth that was subsequently disaggregated. In the 
case of day 3.5 p.c. expanded blastocysts, this loss was commonly due to failure of 
the embryos to hatch from the zona pellucida. Instead, some blastocysts collapsed 
and senesced inside the zona. 	Occasionally, outgrowths did not possess a 
progressively growing 1CM. Rather, they may have simply flattened early in the 
process of outgrowth and only formed trophectoderm. Losses were not a 
consequence of allowing 1CM outgrowths to become extensively differentiated, with 
the formation of endoderm. Explanted day 3.5 p.c. embryos, of both mouse 
genotypes, were disaggregated after three to five days in culture, with the period being 
extended to four to seven days for delayed embryos. Monitoring outgrowths over 
these periods allowed each embryo to be disaggregated once it reached an "optimal" 
size. 
With the F2 embryos, a significantly greater (Pcz0.001) proportion of 
delayed embryos gave rise to ES-like colonies at the first passage, compared to non- 
delayed, day 3.5 p.c. embryos (16/30=53.3 ± 9.8% vs 35/150=23.3 ± 1.3%; figure 
3.2). This was a difference that was maintained throughout the subsequent passages. 
With the 129/Sv-CP strain, however, there was no significant difference, at the first 
passage, in the proportion of embryos yielding putative ES cell colonies between 
delayed and non-delayed blastocysts (13/19=68.4 ± 5.5% vs 70/121=57.9 ± 12.3%). 
In fact, the difference between delayed and non-delayed 129/Sv-CP embryos was not 
significant until the third passage (P<0.001) and resulted from the significantly 
(P<0.005) greater loss of putative ES cell colonies to differentiation with cultures 
derived from non-delayed day 3.5 p.c. embryos (figure 3.2). Comparing day 3.5 p.c. 
embryos from both genotypes, a significantly (Pcz0.001) greater proportion of 
disaggregated 129/Sv-CP embryonic outgrowths gave rise to ES-like colonies at the 
first passage than F2 (C57BL/6 X CBA/Ca) outgrowths (57.9 ± 12.3% vs 23.3 ± 
1.3%, respectively). 
At the third passage, colonies derived from 129/Sv-CP embryos and 
identified as having an ES cell morphology, were stably maintained thereafter and 
expanded into permanent stem cell lines. ES-like colonies from the F2 (C57BL/6 X 
CBA/Ca) embryos appeared to be slightly less stable in culture than those from the 
129/Sv-CP strain (figure 3.2), with one or two "potential cell lines" being lost to 
differentiation (typically of a trophectodermal lineage) at the fourth and fifth passages. 
Thereafter, F2 ES cell colonies were maintained as stable cultures. 
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Apart from maintaining a stable ES cell phenotype in vitro, the other 
criterion used for defining ES cells was their capacity to form cystic embryoid bodies 
when cultured in suspension. 	ES cell lines, classified on the basis of cell 
morphology, from delayed and non-delayed embryos of both F2 and 129/Sv-CP 
genotypes, all appeared to be equally capable of differentiation in vitro. 
3.3.3 Production and Analysis of Chimaeras 
The pluripotency of one male ES cell line derived from an F2 delayed 
blastocyst (designated F218) was tested in vivo. Approximately 74% (14/19) of the 
metaphase spreads examined from the F218 cell line at passage six had an apparently 
normal 40XY chromosome constitution, with the remainder being pseudodiploid. 
The stem cells were injected into MF1 strain, host blastocysts between passages eight 
to 12. Of the manipulated embryos transferred to recipient females, 60% (53/89) 
survived to term (Table 3.1). Of these pups, 28% (15/53) were overtly chimaeric on 
the basis of coat colour. The extent of ES cell contribution to the skin of the 
chimaeras was variable, ranging between estimates of 20-90%. There was a slight 
shift in the sex ratio amongst the chimaeric population, with two-thirds of the 
chimaeras being phenotypic males (Table 3.1). Two overt hermaphrodites, with both 
male and female external gentitalia, were produced in this series of blastocyst 
injections. The limited test breeding of seven chimaeric males did not demonstrate 
transmission of the ES cell-derived F2 (C57BL/6 X CBA/Ca) genotype through the 
germline, in a total of 226 pups born from 20 litters. 
Table 3.1: Production of chimaeras from an embryonic stem cell line 
derived from an F2 (C57BL/6 X CBA/Ca) delayed blastocyst. 
ES 	Sex Blastocysts Pups Born (%) Chimaeras (%) Sex Ratio 
Line Injected 






The findings presented in this chapter have demonstrated the significant effects 
of mouse genotype and implantational delay on the efficiency of ES cell isolation. 
The proportion of intact day 3.5 p.c. embryos from the 129/Sv-CP strain yielding ES 
cell lines in this study (13.2 ± 2.3%) was comparable to the levels reported previously 
in experienced hands (Robertson and Bradley, 1986). The F2 embryos, produced by 
crossing F1 (C57BL/6 X CBA/Ca) males and females, possessed a significantly lower 
potential to give rise to stem cells in this study (1.3 ± 0.6%) compared to 129/Sv-CP 
embryos. 
The genetic basis for the difference between the 129/Sv-CP and F2 embryos is 
not clear. There was no obvious difference in the rate of blastocyst outgrowth 
between the 129/Sv-CP and F2 embryos, as might have been expected between 
embryos of different genotypes. Disaggregation of the 1CM outgrowths from both 
strains, was equally distributed over the three to five day period after explanting the 
embryos into culture. There was no consistent difference in the size of the 1CM 
before the first signs of differentiation, nor any apparent correlation between 1CM size 
and the occurrence of ES-like primary colonies. The significant difference, between 
the two mouse genotypes, was in the proportion of embryos giving rise to ES-like 
colonies at the first passage (figure 3.2). The 1CM cells of the F2 embryos appeared 
to be more predisposed to differentiation in vitro, especially to trophectodermal and 
endodermal cell lineages. 
Early studies on the formation of teratocarcinomas, following the transplantation 
of embryos to extra-uterine sites, have shown differences in the permissiveness of 
embryos from different strains to teratocarcinogenesis (Solter et al., 1979) and this 
may be related to the efficiency of ES cell isolation. Although this process depends 
upon the use of syngeneic or histocompatible F1 hybrid, graft-receiving host animals, 
there also appears to be an effect of the genotype of the mouse embryo. Embryos 
from the 129/Sv strain are highly permissive to teratocarcinogenesis when transplanted 
to an ectopic site (Stevens, 1970c). Furthermore, the 129/Sv strain are a line of mice 
in which the males have a high incidence of spontaneous testicular teratoma (Stevens 
and Little, 1954). The genes Si (Steel), C (full pigment) and P (non-pink-eye), 
introduced into the 129/Sv genetic background, increased the incidence of teratomas in 
the 129/Sv-Sl sub-strain (to 7%), largely due to the influence of the mutant Steel gene 
(Stevens and Mackensen, 1961; Stevens, 1962). However, the 129/Sv-CP genotype 
used in these studies no longer has the Steel gene, but the males would still be 
expected to have a high relative incidence of spontaneous teratomas (around 1.0%: 
Stevens and Little, 1954). Although not attributable to the Steel gene, there may be 
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some other genetic basis explaining the permissiveness of primordial germ cells or 
early embryos to develop into malignant tumours and the capacity of embryos from the 
129 strain to be isolated as immortal, undifferentiated ES cells in tissue-culture. 
The C57BL/6 strain has been shown to be teratocarcinoma-nonpermissive, 
whereas CBA/J embryos yield a high proportion of teratocarcinomas (Solter et al., 
1979). The low yield of ES cell lines from F2 embryos in this study may have been 
due to the fact that to produce the F1 generation, C57BL/6 females were mated to 
CBA/Ca males. Evidence from F1  crosses has suggested that embryos are only 
permissive to teratocarcinogenesis if the mother of the F1 hybrid embryo is of a 
permissive strain (Damjanov and Solter, 1982). Thus, the F2 (C57BL/6 X CBA/Ca) 
embryos might have been expected to produce teratocarcinomas at a low frequency and 
perhaps also, have limited stem cell potential in vitro. This could be further 
examined by culturing embryos from the reciprocal cross (i.e. CBA/Ca X C57BL/6) to 
capitalise on any maternal epigenetic effect, by utilising the more permissive CBA 
strain as the dams for the original F1 stocks. Caution is required when extrapolating 
from teratocarcinomas to ES cells, as the embryos of the C57BL/6 mouse strain have 
been found to yield ES cell lines at a high efficiency (10%) compared to the 129/Sv 
strain (5%; Doetschman et al., 1985). 
It may be informative to culture embryos obtained from reciprocal 129/Sv-CP X 
F1 (C57BL/6 X CBA/Ca) matings. If such a genetic comparison were to be 
conducted, however, it would be sensible to use inbred mouse strains with high and 
low potentials to give rise to ES cells for the reciprocal matings. Utilising the 
C57BL/6 X CBA/Ca crossbred animals would make any interpretation of the data 
ambiguous, because of the large genetic heterogeneity in the F1 and F2 generations. 
If embryos produced from such reciprocal matings are no longer non-permissive, in 
terms of ES cell isolation, it may indicate the presence of dominant alleles (of maternal 
or paternal significance) from the 129/Sv-CP genome which may have genetic (and/or 
epigenetic) influences on the capacity of the cells of the 1CM to proliferate in an 
undifferentiated state in vitro. 
Embryos that had undergone a period of implantational delay were originally 
utilised by Evans and Kaufman (1981) to isolate undifferentiated stem cells into 
culture. The culture of delayed embryos has been reported to yield a three-fold 
increase in the efficiency of ES cell isolation compared to non-delayed embryos 
cultured in that laboratory by different people (Robertson and Bradley, 1986). An 
increase of a similar magnitude with delayed embryos was found in this study. Evans 
and Kaufman (1981) recovered embryos four to six days following ovariectomy (i.e. 
6.5 to 8.5 days p.c.), however, they did not specify any differences in ES cell isolation 
with regard to the length of the implantational delay. Here, it was found that a 
significant increase was obtained only after a six day interval following ovariectomy. 
An important observation from the use of the F2 (C57BL/6 X CBA/Ca) embryos in 
this study, was that the naturally low capacity of the ICMs from this genotype to 
proliferate in culture was largely overcome following a period of implantational delay. 
It is possible that the increase in the potential of delayed embryos to yield ES 
cells may have arisen either as a consequence of an increase in the number of cells in 
the 1CM, or as a result of some epigenetic change in gene expression. 
It is not known whether ES cells originate from a sub-population of the 1CM or 
if all of the cells of the 1CM have the potential to proliferate in vitro. The chimaeric 
clonal analysis of day 4.5 P.C. primitive ectodermal cells suggests that the majority, if 
not all, these cells are equally pluripotent (Gardner et al., 1985). Thus, it might be 
expected that all 20 cells of the day 3.5 P.C. 1CM (Copp, 1982) have an equal chance 
of being maintained as ES cells. However, in view of the findings presented in 
chapter five, suggesting that an epigenetic modification is required for the 
establishment of ES cells, not all of the cells of the 1CM may undergo the modification 
necessary to maintain the stem cell phenotype in vitro. The calculations performed by 
Suda and colleagues (1987) on the increase in the population of undifferentiated cells 
from the embryonic outgrowth to the first passage colonies, have suggested that the 
ES cells in the cultures were originally derived from at least four cells of the day 3.5 
P.C. 1CM. 	Observations made here have recorded very few instances where 
disaggregated ICMs have resulted in the majority of colonies in the first passage 
cultures possessing an ES-like morphology. Typically, only one or two colonies may 
possess the stem cell phenotype, the remainder having differentiated. Increasing the 
number of cells in the 1CM component, may increase the likelihood of establishing a 
progressively growing ES cell culture. One test of whether the cell number of the 
1CM does have a significant effect on the isolation of ES cells, could be to aggregate 
several cleavage-stage embryos together to produce "giant blastocysts", with a larger 
1CM component. 
In delayed blastocysts, studies have shown there to be a small, but significant, 
increase in the 1CM number compared to non-delayed, day 3.5 P.C. blastocysts (Copp, 
1982). Over the period of the implantational delay there was a slow, gradual increase 
in the number of cells in the 1CM, up to a maximum of around 32 cells five days after 
ovariectomy (compared to around 21 cells on day 3.5 p.c.). The absolute cell number 
of the 1CM declined thereafter, due to the decreasing mitotic rates and to the high cell 
death rates (Copp, 1982). However, in these experiments no mention was made of 
the presence of endodermal cells. Gardner and co-workers (1988) have shown that 
the delamination of primitive endoderm, from the 1CM, had occurred in all delayed 
blastocysts examined and in this regard they were similar to the day 4.5 P.C. embryo 
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(Gardner and Rossant, 1979). It therefore seems unlikely that all of the cells counted 
in the 1CM by Copp were pluripotent. 
The effect of implantational delay on ES cell isolation may have been due to a 
change in the pattern of gene expression. Although primitive endoderm has formed in 
the implantationally delayed embryo, a parietal endodermal layer has not been 
observed and no further differentiation of the 1CM occurs (Gardner et al., 1988). 
Therefore, the normal pattern of expression of genes responsible for the differentiation 
of the 1CM is halted, possibly by a uterine inhibitor of blastocyst activity (Aitken, 
1977). And so, the embryos enter a period of diapause within the uterine lumen. 
When these delayed embryos are recovered and placed into suitable culture conditions, 
although the serum proteins in the culture medium may be sufficient to terminate the 
diapause (Aitken, 1977), perhaps the genes responsible for differentiation are not 
activated by transcriptional factors. This disruption in the normal developmental 
sequence of gene expression, may be an essential feature in the establishment of ES 
cell lines in vitro; and may explain the observations of the higher proportions of both 
first passage colonies and permanent cell lines of undifferentiated morphology, from 
cultures of delayed embryos compared to non-delayed day 3.5 p.c. embryos (figure 
3.2). The hypothesis that an epigenetic modification may be a pre-requisite for the 
isolation of ES cells into culture is a subject that is discussed further in chapter five. 
One ES cell line isolated from an F2 delayed embryo was shown to be 
pluripotent in vivo, forming chimaeric offspring. The frequency of chimaerism from 
the F218 line (28%) was significantly lower (P<0.05) than that for all seven ES cell 
lines derived from day 3.5 p.c. blastocysts from the 129/Sv-CP mouse strain which 
were tested in chapter five (see Table 5.1). As only one F2 cell line was examined 
here, it can not be generalised that the capacity to participate in normal embryonic 
development is lower with ES cells derived from the C57BL/6 X CBA/Ca genotype. 
The slight shift in the sex ratio in favour of males indicated probable instances of "sex 
conversion", where XY stem cells injected into XX embryos resulted in the 
development of phenotypic males (Robertson, 1986). In two instances the 
reproductive organs of both sexes developed and resulted in the formation of overt 
hermaphrodites. This presumably occurred as a consequence of insufficient XY stem 
cells migrating to the female germinal ridge, to completely transform the sex of the 
developing foetus. 
There have been only two basic mouse strains cited in the literature from which 
germline ES cell-derived chimaeras have been produced; namely, 129 (including a 
number of sub-strains; e.g. 129/Sv//Ev: Bradley et al., 1984) and CD-1 (Suda et al., 
1987). The limited breeding trials conducted in this study with chimaeras produced 
from one 4OXY ES cell line, derived from an F2 (C57BL/6 X CBA/Ca) embryo, failed 
MCI 
to demonstrate that the F2 derived stem cells had colonised the germ cell lineage. 
However, there is no biological reason to assume that karyotypically normal ES cells 
derived from any mouse genotype would not have the potential to form functional 
gametes. The extent of colonisation of the germ cell lineage may depend upon the 
competitive interactions between the cells from the two different mouse genotypes 
used to produce the chimaera (McLaren, 1976; Schwartzberg et al., 1989). 
The results presented in this introductory chapter have shown the ES cell culture 
system utilised here, to be both efficient (comparable to other laboratories) and 
reliable. Although there were some variations in the efficiency of ES cell isolation 
between different batches of embryos cultured, overall, the results were consistent. 
Thus, this chapter provides a baseline for the comparison of the results in the 
subsequent experimental chapters on murine and ovine ES cells. 
CHAPTER 4 




Experiments have been carried out to determine whether ES cells can be isolated 
from post-implantation-stage mouse embryos. Although there have been no previous 
reports, a number of findings have suggested that it might be possible to establish stem 
cells from such advanced developmental stages. Firstly, pluripotent cells are present 
within the developing mouse embryo up to day 7.5 p.c. (see chapter 1.1) and 
malignant teratocarcinomas have been produced from ectopic transplants of these 
embryonic stages (see chapter 1.2.3). Furthermore, EC cell lines have been isolated 
into tissue-culture from teratocarcinomas derived from embryos up to day 7.5 p.c. 
(McBurney, 1976). And, biochemical analyses have suggested that cultured 
pluripotent stem cells may share the greatest homology to the day 5.5 p.c. primitive 
ectoderm of the post-implantation-stage embryo (Martin et al., 1978; Evans et al., 
1979; Lovell-Badge and Evans, 1980; Evans and Kaufman, 1983). 
Commonly, ES cells have been isolated from the 1CM of either day 3.5 p.c., or 
implantationally delayed, blastocyst-stage mouse embryos. The only other embryonic 
stage from which munne ES cells have been isolated, has been from the individual 
blastomeres of decompacted morulae (Eistetter, 1989). 
4.2 EXPERIMENTAL METHODS 
Primitive ectoderm from day 5.5 p.c. post-implantation-stage embryos was 
isolated from superovulated six to eight week old virgin 129/Sv-CP females mated to 
129/Sv-CP stud males, utilising procedures similar to those described by Hogan, 
Costantini and Lacy (1986a). 
Females were sacrificed by cervical dislocation and the belly region swabbed 
with 70% alcohol. The abdominal cavity was then opened to reveal the reproductive 
tract. In turn, each uterine horn was cut just below the uterotubal junction. Grasping 









the mesometrium. Next, the uterine horn was opened by sliding the tip of a pair of 
iris scissors down along the anti-mesometrial wall of the uterus, moving towards the 
cervix. Keeping the uterus pulled taunt, forceps were used to "shell" the decidua 
(containing the embryos) out of the uterus. The decidua were placed into a dish 
containing DMEM with 10% bovine serum, antibiotics (50 lU/mI penicillin and 50 
.tg/m1 streptomycin; Sigma) and 20mM HEPES buffer, added to maintain the pH 
during subsequent manipulations outside the incubator. 
Under a dissecting microscope, each deciduum was teased apart with flame 
sterilised watchmakers forceps, to dissect out the early egg cylinder-stage embryo; 
easily identified as a dark speck from the trophoblast tissue. A representative 
illustration of the dissected embryo is shown in figure 4.1. The trophoblast and 
parietal endoderm tissues were torn away from the implantation site during the 
dissection procedure and hence, appeared ragged. A pro-amniotic cavity had often 
developed by this stage and a clear division between the primitive ectoderm and the 
irnitive ectoderm 
Figure 4.1: Representative illustration of a day 5.5 p.c. egg cylinder-stage mouse 
embryo following dissection from the deciduum, showing the position of the lateral 
cut made in order to isolate the embryonic portion of the embryo. (Adapted from: 
Rossant, Gardner and Alexandre, 1978). 
icental cone 
o-amniotic cavity 
extra-embryonic ectoderm (of trophectodermal origin) was often observed. 
Isolation of pure primitive ectoderm tissue was accomplished by firstly, cutting 
away the the extra-embryonic regions of the egg cylinder utilising a fine glass 
microneedle constructed from a hand-pulled, Pasteur pipette ("cut" in figure 4.1). 
Then, the overlying layer of visceral endoderm was removed with an enzymatic pre-
treatment. After rinsing in phosphate buffered saline (PBS), the tissue was placed in 
Ca2 and Mg2 free PBS containing 2.5% (w/v) pancreatin (porcine; Sigma), 0.5% 
(w/v) trypsin (porcine 1:250; Sigma) and 0.5% (w/v) polyvinylpyrolidone (Mr 10 
000), further supplemented with 0.1% (w/v) D-glucose, 1% of a 100X stock solution 
of non-essential amino acids (Flow Laboratories) and 20mM HEPES buffer (pH 7.4: 
Hogan et al., 1986b). The tissue was incubated for five minutes in a drop of this 
pancreatin-trypsin solution at 4°C. The dish was then flooded with DMEM containing 
10% bovine serum to neutralise the crude proteases and the tissue transferred to a fresh 
droplet of ES20 medium (see chapter two, Table 2.1) under paraffin oil and incubated 
for one hour at 37°C. Following this recovery period, the endoderm layer was cleanly 
separated from the primitive ectoderm by gently aspirating the tissue up and down 
inside a fine, flame-polished Pasteur pipette. This treatment yielded relatively pure 
clumps of ectoderm which were then either explanted intact into tissue-culture for ES 
cell isolation, or were firstly disaggregated into small pieces, comprising 	several 
cells each, by incubating the ectoderm in TEG (chapter two, Table 2.2) for three to 
five minutes at 37°C followed by mechanical dissociation, using a fine pipette. 
Apart from the timing of the first passage, methods for the establishment and 
maintenance of primitive ectoderm-derived ES cells were identical to those described 
previously (see chapters 2.3 and 2.4). 
4.3 RESULTS 
Two permanent ES cell lines were established from a total of 79 day 5.5 p.c. 
primitive ectoderm cultures. These experiments were conducted at the same time as 
those reported in chapter three, utilising the same batches of media and STO feeder cell 
layers. Thus, comparing the respective efficiencies of ES cell isolation for the 
129/Sv-CP mouse strain, primitive ectoderm (2.5%) was a significantly (P<z0.025) 
less efficient embryonic stage of development than day 3.5 p. c. embryos (13.2%). 
Primitive ectoderms, from individual embryos, were explanted intact in 47 of the 
79 original cultures whereas in the remaining 32, the ectoderm was firstly trypsinised 
and disaggregated mechanically into smaller cellular pieces. One ES cell line was 
obtained from each method. The isolation history for both of these lines was similar 
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Figure 4.2: Establishment of the ECTO 3a ES cell line from day 5.5 p.c. primitive 
ectoderm. Egg cylinder-stage embryos were dissected from the decidua on day 5.5 
p.c. (a). Primitive ectoderm (PE) tissue (b) was isolated from the embryos by firstly 
cutting away the extra-embryonic region along the dotted line in (a) and then utilising 
an enzymatic procedure to remove the overlying visceral endoderm (YE). Ectoderm 
was then explanted onto the STO feeder cells (c). From the undifferentiated outgrowth 
(arrowed) in (c), colonies of ES cell morphology were observed at the second passage 
(d) and subsequently expanded into a permanent stem cell line. (Magnification: xlOO) 
ectoderm. The day 5.5 p.c. egg cylinder-stage embryo in figure 4.2a shows the 
position of the cut made to remove the extra-embryonic region and location of the 
visceral endoderm tissue overlying the primitive ectoderm. The primitive ectoderm 
was isolated as described in section 4.2 and resulted in relatively pure clumps of tissue 
(figure 4.2b) which were then explanted onto STO feeder layers prepared in 
microdrops. After two or three days of culture, undifferentiated outgrowths were 
commonly observed (as with ECTO 3a: figure 4.2c) which were then lightly 
disaggregated with TEG, before any obvious signs of differentiation, into several 
small pieces each comprising around 10-15 cells. Despite this early first passage, 
extensive differentiation often resulted in the cultures, with many endodermal and 
flattened epithelial-like colonies developing; however, trophoblast colonies were rarely 
observed. After a six to seven day culture interval, first passage colonies which had 
remained undifferentiated were trypsinised into single-cells and passaged. From these 
cells, second passage colonies of typical ES cell morphology grew in the ECTO 3a 
culture (figure 4.2d). In the course of cell expansion, the ECTO 3a line became 
infected with bacteria, but was recovered by sub-cloning, producing the line 
designated ECTO 3a. 1. 
In suspension culture, the primitive ectoderm-derived ES cells differentiated into 
complex embryoid bodies. Based on cell morphology, these embryoid bodies 
comprised an inner layer of cuboidal ectoderm-like cells separated from an outer layer 
of presumed parietal endoderm, by a Reichert's membrane. With prolonged culture, 
these embryoid bodies became cystic. 
In the ECTO 3a. 1 cell line, 69% (25/36) of the cells examined at passage 15 
were classified as having an apparently normal 40XX chromosome constitution (figure 
4.3); with the remaining cells being pseudodiploid. The other primitive ectoderm-
derived ES cell line was also female, however, by the 11th passage 85% (16/20) of the 
cells examined appeared to have lost one X chromosome (i.e. XX/XO). 
To test whether these primitive ectoderm-derived cells, which appeared 
morphologically identical to 1CM-derived ES cells, were truly pluripotent in vivo, they 
were re-introduced into early mouse embryos and assessed for chimaerism. Cells of 
the ECTO 3a.1 ES cell line, between passages eight and 10, were injected into MF1 
strain, host blastocysts. The data are presented in table 4.1. Based on skin and coat 
pigmentation, 75% (12/16) of the pups were judged to be chimaeric. The contribution 
of ES cells to the skin was variable, ranging between 10-75%. A typical primitive 
ectoderm-derived ES cell (female) chimaera is shown in figure 4.4. Breeding from 
both male and female chimaeras to albino, MF1 mates has not demonstrated the 








Figure 4.3: 	0-banded metaphase spread of the ECTO 3a.1 ES cell line at the 15th 
passage, showing an apparently normal 40XX chromosome constitution. The X 
chromosomes are indicated by the arrowheads. 	 (Magnification: x1000) 
Table 4.1: Production of chimaeras from a primitive ectoderm-derived 
ES cell line 





Line Injected 	(%) (%) male:female 
Ecto 3a.1 XX 	56 	171 (30) 	12 (75)1 	8:4 
1 Of these offspring, only 16 survived to an age to permit analysis for coat colour 
chimaerism. 
L. 
Figure 4.4: Day 5.5 p.c. primitive ectoderm-derived embryonic stem cells are 
tripotent. 	The figure shows a female somatic chimaera produced following the 
injection of ES cells derived from the primitive ectoderm of a female day 5.5 p.c. 
129/Sv-CP mouse embryo, into a day 3.5 p.c. albino, MF1 strain host blastocyst. 
1 	From the chimaera illustrated in figure 4.4, the primitive ectoderm-derived ES cells 
isolated from a 129/Sv-CP strain mouse embryo have contributed to three cell types 
based on pigmentation. Firstly, the melanocytes (derived from the neural crest) of the 
skin secrete eumelanin granules to produce the pigment in the hair. The agouti hair 
colour indicates an ES cell-derived mesodermal component in the hair follicles which 
transiently inhibits the production of the black pigment by the melanocytes, resulting in 
the sub-apical band of yellow. The third ES cell-derived component is observed from. 
the pigmented melanocytes of the retina, formed from the neural ectoderm (Hogan et 
al., 1986). To establish whether these primitive ectoderm-derived ES cells are 
pluripotent, a GPI isoenzyme analysis could be performed on various internal organs 
dissected from chimaeric mice. 
Table 4.2: Breeding data from MF1-ECTO 3a.1 chimaeras backcrossed to 
the albino, MF1 mouse strain 
Offsoring 
Litters Offspring Albino Black Transmission 
Agouti 	(%) 
Female Chimaera 
ECTO 3a.1 a 	2 16 16 0 	0 
ECTO3a.1 b 1 15 15 0 0 
ECTO3a.1 c 	5 60 60 0 	0 
Totals 	 8 91 91 0 0 
Male Chimaera 
ECTO3a.1 p 	6 	71 	71 	0 	0 
ECTO3a.1 q 8 73 73 0 0 
Totals 	 14 	144 	144 	0 	0 
4.4 DISCUSSION 
This study has established that it is possible to isolate stable cell lines of ES cell 
at least 
morphology from day 5.5 p.c. primitive ectoderm, which are / tripotent1 and capable 
of forming somatic chimaeras. This is the first report of isolation of ES cells from 
post-implantation-stage mouse embryos. 
The findings here and those of Eistetter (1989) indicate that there is a period of 
development, from day 2.5 to day 5.5 p.c., from which pluripotent cells present within 
the murine embryo can be successfully isolated and maintained in culture. It may be 
possible to extend this upper limit and isolate ES cells from the primitive ectoderm of 
the day 7.5 p.c. embryo. A small number of primitive ectoderms (13) isolated from 
day 6.5 p.c. embryos were cultured here (data not presented), but only gave rise to 
well differentiated outgrowths and no progressively growing cultures; similar to earlier 
reports working with this stage and older day 7.5 p.c. embryos (Evans, 1981). 
Although day 5.5 p.c. primitive ectoderms often gave rise to outgrowths that appeared 
remarkably like established ES cells from the outset (as has been reported for 
immunosurgically isolated 1CM outgrowths; Martin, 198 1) most of these differentiated 
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extensively upon disaggregation. As the day 5.5 p.c. primitive ectoderm no longer 
has the potential to develop trophectoderm (Gardner, 1985) the rare instances were 
trophoblast colonies were observed, presumably arose from occasional contamination 
of cultures with extra-embryonic ectoderm, of irophectodermal origin (Rossant et al., 
1978). Because of the relatively large number of cells in the day 5.5 p.c. primitive 
ectoderm (approximately 120: Snow, 1977) and the problem of differentiation, some 
isolated ectoderms were lightly disaggregated prior to culture. However, this was no 
more successful in isolating cells of an undifferentiated morphology. 
The findings of Gardner and colleagues (1985) have suggested that all of the 
cells of the day 4.5 p.c. primitive ectoderm may be equally pluripotent. However, it is 
not known whether this is true also for the day 5.5 p.c. primitive ectoderm and if all of 
the cells have the potential to give rise to ES cells. 
The activity of the X chromosomes was not analysed in these studies. By day 
5.5 p.c. it is generally accepted that in the female primitive ectoderm, inactivation of 
one X chromosome has been completed (Rastan, 1982). Many female ES cell lines 
isolated from the day 3.5 p.c. 1CM have a partial deletion, or loss, of one X 
chromosome, thought to be a compensatory mechanism for the presence of two active 
X chromosomes (Robertson et al., 1983a; Robertson and Bradley, 1986). The 
expectation that one X chromosome had been inactivated in the primitive ectoderms 
cultured here, might explain why one of the day 5.5 p.c. female ES cell lines 
possessed a high proportion of cells with a 40XX chromosome constitution. 
However, in the other female stem cell line the majority of the cells were XO. 
The embryonic survival to term following the transfer of embryos injected with 
ES cells was low (30%) in these experiments. This was probably attributable to 
operator inexperience in embryo transfer, as the ECTO 3a.1 line was the first of the ES 
cell lines to be tested for in vivo pluripotency in this thesis. The proportion of pups 
which were overtly chimaeric, however, was relatively high (Evans et al., 1985) and 
comparable to the frequencies obtained with ES cell lines derived from day 3.5 
p.c.embryos of the 129/Sv-CP mouse strain tested in this thesis (see chapter five, 
Table 5.1). 
As the ectoderm-derived ES cell lines are female, it has been difficult to detect 
germline transmission. The results from test breeding two male chimaeras suggests 
XX cells are incapable of producing functional spermatozoa (McLaren, 1976). The 
failure to detect germline transmission through the female chimaeras, could have 
simply been due to the fact that only one ES cell line was examined and from the low 
numbers of females tested (3) and the number of progeny born (91); rather than any 
actual restriction in the developmental potential of primitive ectoderm-derived ES cells. 
It has been demonstrated that female ES 
cells, derived from a day 3.5 p.c. 129/Sv-CP strain embryo, are capable of entering the 
female germline when injected into MF1 host blastocysts (see chapter five, Table 5.2). 
It is unlikely that the germ cell lineage has differentiated from the primitive ectoderm 
by day 5.5.p.c. (Ginsburg etal., 1990; and see chapter 1.4.1). And hence, it is also 
unlikely that the lack of germline transmission here was due to the chance that the ES 
cell line was derived from a theoretical sub-population of the primitive ectoderm no 
longer possessing the capacity to contribute to the gametes. 
It is well documented that ES cells can contribute to all tissues in the chimaeric 
animal, including the gametes (Evans et al., 1985). Examination of the full 
developmental potential of 1CM-derived ES cells (Beddington and Robertson, 1989; 
Suemori et al., 1990) has revealed that ES cells are also capable of colonising the 
trophectodermal and primitive endodermal lineages of the extra-embryonic 
membranes. These are tissues which mature ICMs are incapable of colonising 
(Gardner, 1985). Hence, it appears as though there may be some de-differentiation of 
1CM-derived ES cells in vitro. It would be informative to compare the capacity of ES 
cells derived from both earlier and later embryonic stages to colonise extra-embryonic 
tissues in chimaeric foetuses. This could determine whether the in vivo potential of 
the cell lines, derived from the three sources (individual blastomeres, 1CM and 
primitive ectoderm), are "frozen" at their respective developmental stage of origin, or if 
they have converged in culture to the same cell lineage. The expectation, from the 
limited studies with EC cells, might be that the cell lines would be of differing 
pluripotency (see chapter 1.4.1). Thus, the primitive ectoderm-derived ES cell lines 
would not be expected to colonise the primitive endodermal and trophectodermal 
lineages (Gardner, 1985), if the cells are a true representation of the the developmental 
stage from which they are derived. However, from the in vitro differentiation data, 
these ectoderm-derived ES cell lines have the capacity to differentiate into embryoid 
bodies, apparently with an outer layer of parietal endoderm, presumed from the 
presence of an underlying layer of Reichert's membrane. This suggests that like 
1CM-derived ES cell lines, a de-differentiation event may also have occurred during 
the isolation of primitive ectoderm ES cell lines (Beddington and Robertson, 1989). 
If this is indeed the case, then there must have been some change in the pattern of gene 
expression during isolation. Perhaps this may be necessary for the isolation and 
91 
stable maintenance of ES cells in culture. Because the ectoderm-derived cell lines may 
not be representative of the day 5.5 p.c. primitive ectoderm within the embryo, this 
may limit any applications for the study of the molecular events of cellular 
differentiation at this stage of development. Nevertheless, the possibility of changes 
in the pattern of gene expression during ES cell isolation is intriguing and is a theme 
that is expanded in chapter five. 
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CHAPTER 5 
THE EFFECT OF TREATMENTS EXPECTED 
TO PERTURB GENE EXPRESSION 
ON THE EFFICIENCY OF 
MURINE EMBRYONIC STEM CELL 
ISOLATION 
5.1 INTRODUCTION 
Broadly, there are two interpretations proposing how pluripotent cells can be 
diverted initially from their normal fate of differentiation within the early mouse 
embryo and maintained instead, as stable ES cell lines in vitro (discussed by Martin, 
1980; Robertson and Bradley, 1986; see chapter 1.4). Either, ES cells may represent 
a normal embryonic lineage that is naturally programmed to continue dividing until 
appropriate developmental signals induce the cells to differentiate; and in the cellular 
disorganisation resulting from the outgrowth of embryos in culture, the cells may 
"escape" from these regulatory signals and continue to proliferate. Alternatively, 
some form of reversible, epigenetic modification may be required for the isolation of 
ES cells into culture. In this chapter, treatments expected to perturb the normal pattern 
of gene expression have been utilised to test this latter hypothesis indirectly. The 
specific treatments that were used in this study include the exposure of embryos to 
hyperthermia, puromycin or 5-azacytidine. 
5.1.1 The Heat Shock Proteins 
Following exposure to temperatures a few degrees above the 
physiological optimum, the cellqall organisms exhibit similar massive changes in the 
patterns of transcription and translation; whereby they preferentially synthesise a 
specific set of evolutionary conserved polypeptides: the heat shock proteins (HSPs: 
Schlesinger, Aliperti and Kelley, 1982; Pelham, 1985; Lindquist, 1986). The pattern 
of induced protein synthesis varies between species, however, virtually every species 
examined has HSPs in the 60-70 and 80-90 kiloDalton (kD) range (Schlesinger et al., 
1982; Pelham, 1985). These proteins shall be termed HSPs in this chapter although 
they should strictly be termed general "stress proteins", as treatments other than heat 
shock produce a similar cellular response; however, not all of the HSPs may be 
released in response to these different agents (Welch, 1990). Other inducers of the 
HSPs include agents which, like heat, directly damage proteins, such as heavy-metal 
ions, arsenite, amino acid analogues incorporated into peptides (Pelham, 1985) and the 
antibiotic puromycin (Hightower, 1980). Other stresses such as ethanol, glucose 
starvation followed by re-feeding the cells and hypoxia, are thought to perturb the 
intracellular environment and cause similar protein damage indirectly (Pelham, 1985). 
Unstressed eight-cell, blastocyst and day 7.5 p.c. primitive ectoderm 
mouse embryonic cells all synthesise high levels of 89kD and 70kD proteins belonging 
to the heat shock family (Bensaude and Morange, 1983; Morange et al., 1984). This 
spontaneous synthesis occurs via the constitutive expression of heat shock cognate 
genes which produce mRNAs distinct, but closely related, to those from the heat 
shock-inducible genes accounting for HSP synthesis during stress. In the mouse 
blastocyst, there are two major proteins of the "70kD HSP family". One (the 68kD 
protein) is not constitutively expressed at this stage but is strongly heat-inducible, 
while the other (the 70kD protein) is spontaneously synthesised and is only slightly 
heat-inducible (Morange et al., 1984). There are also two distinct but related 89kD 
HSPs produced in the mouse blastocyst from differential gene expression. Both are 
synthesised in unstressed cells, however, only one is strongly induced by heat shock 
(Barnier et al., 1987). 
The function of the heat-induced HSPs appears to be in the protection 
and repair of the cellular damage (especially of ribosomes) caused by the otherwise 
lethal effects of heat. The 70kD HSP family of proteins are thought to aid the 
reassembly of thermally damaged ribonuclear proteins within the nucleolus (Pelham, 
1985; Welch and Suhan, 1986). During recovery from the stress, the 70kD HSP 
proteins leave the nucleolus and are localised instead on the cytoplasmic ribosomes, 
where they may play some role in repairing the translational apparatus (Welch and 
Suhan, 1986). The 90kD HSP family have been postulated to bind to denatured 
proteins in the cytoplasm, preventing them from forming insoluble and potentially 
harmful precipitates (Pelham, 1985). 
The molecular mechanisms regulating the heat shock response have 
been studied most extensively in the fruit fly Drosophila and it is with this genus that 
particular reference is now made. As there is strong evidence to suggest that the 
mechanism of activation of the heat shock genes is highly conserved between species, 
it is likely that similar mechanisms exist in mammalian cells (reviewed by Pelham, 
1985). The heat shock genes may begin to rapidly transcribe mRNAs for the new set 
of proteins within four minutes of cells experiencing stressful conditions from 
exposure to elevated temperatures (Lindquist, 1986). The activation of the heat shock 
genes appears to be mediated by the binding and phosphorylation of a heat shock 
transcription factor (HSTF) to a heat shock element (HSE) in the promotor of the heat 
shock gene (Pelham, 1985; Sorger, 1991). In Drosophila, it has been proposed that 
the activity of a pre-existing pool of HSTF is repressed in unstressed cells, by binding 
to existing HSPs (Sorger, 1991). During heat shock, the HSPs competitively bind to 
the denatured proteins, produced in high levels from the stress, which results in the 
dissociation of the HSTF-HSP complex. This in turn allows the HSTF to bind to the 
HSE, promoting increased HSP production (Sorger, 1991). During the period of 
heat stress, the cellular machinery is directed to producing the HSPs as rapidly as 
possible. As the heat shock genes are activated, transcription of most previously 
active genes is repressed (Spradling, Pardue and Penman, 1977). Pre-existing RNA 
messages are (reversibly) inactivated and sequestered from translation during heat 
shock, while the HSP mRNAs are translated very efficiently (Storti et al., 1980). 
Once the cells are returned to their normal growth temperature and the HSPs have 
aided the repair of the cellular, thermally-induced damage, the excess HSPs may then 
bind to the HSTFs and therefore shut down the activity of the heat shock genes 
(Sorger, 1991). The time taken for general transcription and translation to return to 
what may the pre-heat shock pattern, depends upon the degree of severity of the 
preceding heat shock (Lindquist, 1986). 
The high constitutive expression of the 70kD and 89kD heat shock 
cognate genes in early mouse embryos and EC cells (Bensaude and Morange, 1983; 
Morange et al., 1984) and the strongly conserved structure of these two major HSPs 
between different species (Schlesinger et al., 1982) suggests that these HSPs may 
have some general role in regulating the cellular processes in the cells of all species. 
The constitutive expressive of some HSPs appears to be developmentally regulated. 
When murine EC cells from the F9 cell line were induced to differentiate in vitro to 
form parietal endoderm, the spontaneous synthesis of the 89-HSP markedly decreased 
(Barnier et al., 1987). Another link between HSP expression and differentiation was 
suggested from the resultswherethe steroid molting hormone ecdysterone, increased 
the synthesis of low molecular weight HSPs in embryonic Drosophila cells (Ireland 
and Berger, 1982). Following genome activation in the mouse, the 68kD HSP is not 
spontaneously synthesised in the conceptus until day 8.5 p.c. and only in the placenta 
(Morange et al., 1984; Kothary et al., 1987). Subsequently, the 68kD HSP is 
synthesised in the yolk sac on day 11.5 p.c. and not in murine embryonic tissues until 
on day 15.5 p.c. and only in the kidney of the adult (Kothary et al., 1987). Thus, 
the pattern of constitutive expression of the 68kD HSP suggests it has a role in 
development. 
5.1.2 DNA Methylation 
DNA methylation is an epigenetic regulatory mechanism thought to play 
a part in cell determination and differentiation (Jones and Taylor, 1980). DNA in 
early embryos is highly methylated at many cytosine residues, to form 5-
methylcytosine (reviewed by Razin and Riggs, 1980). Hypomethylation within 
certain G-C rich promoters is generally correlated with the activation of the affected 
genes (reviewed by Razin and Riggs, 1980; Doerfler, 1983) although this is not 
universal (Hsiao et al., 1984). 
The 5-methylcytosine analogue 5-azacytidine can be incorporated into 
DNA during replication. However, 5-azacytidine cannot be methylated since the 
compound is substituted with a nitrogen atom at the 5 position of the pyrimidine ring 
and thus, cannot accept a methyl group (Jones and Taylor, 1980). 5-azacytidine also 
directly inhibits methyl-transferase activity; where only a 0.3% substitution of 5-
azacytidine for cytosine in DNA may reduce the DNA methyl-transferase level by more 
than 95% (Creusot, Acs and Christman, 1982). 
Treatment of tissue-cultured cells with 5-azacytidine during DNA 
synthesis, therefore, causes random hypomethylation of DNA and has resulted in 
clonally heritable changes in the activity of genes and differentiative programmes 
(reviewed by Doerfier, 1983). For example, the mouse embryonic fibroblast cell line 
C3H1OT1/2 has differentiated into chondrocytes, adipocytes and skeletal muscle 
following exposure to this cytosine analogue (Konieczny and Emerson, 1984). 5-
azacytidine has also reactivated suppressed genes present on an inactive human X 
chromosome in a mouse-human somatic cell hybrid tissue-culture line (Mohandas, 
Sparkes and Shapiro, 1981). It has been reported that there is no evidence to suggest 
a mutational basis for the 5-azacytidine-induced biological effects in mammalian cells 
(Doerfier, 1983), however, the analogue has been shown to cause the neoplastic 
transformation of mouse fibroblast cells (Benedict et al., 1977). 
Experiments were carried out here to investigate the effect of treatments 
which are expected to perturb gene expression (heat shock, puromycin and 5-
azacytidine) on the isolation of murine ES cells. 
5.2 EXPERIMENTAL METHODS 
The general procedures utilised in this chapter for the isolation and maintenance 
of ES cells from blastocyst- stage mouse embryos were the same as those described 
previously (chapter 2.3 and 2.4). Embryos were recovered 3.5 days p.c. and both 
expanded and hatched blastocysts were cultured in these experiments. The specific 
treatments that were utilised are detailed below. 
5.2.1 Heat Shock Treatment 
Day 3.5 p.c. blastocyst-stage embryos were recovered from the uteri of 
two mouse strains: from 129/Sv-CP females mated to 129/Sv-CP males and from F1  
(C57BL/6 X CBA/Ca) females mated to F1 (C57BL/6 X CBA/Ca) males (i.e. F2 
embryos). Hyperthermia was achieved by transferring embryos into a 0.5ml 
Eppendorf tube containing 0.25ml of pre-heated ES20 medium (see chapter two, Table 
2.1) in a waterbath (model SE15: Grant Instruments, Cambridge, U.K.) set at the 
experimental temperature. This treatment was conducted immediately after embryo 
recovery, but before the embryos were placed into tissue-culture. 129/Sv-CP strain 
embryos were heat shocked for 10 minutes at either 40°C, 42°C or 44°C, whereas F2 
(C57BL16 X CBA/Ca) embryos were heat shocked for 10 minutes at 42°C. Control 
embryos were handled in the same fashion and incubated in the waterbath at 37°C, for 
10 minutes. After treatment, the embryos were retrieved from the Eppendorf tubes 
and each embryo was randomly allocated, along with control (non-heat shocked) 
embryos, to a coded STO feeder microdrop for culture. 
5.2.2 Glycerol Pre-Treatment 
Prior to heat shock, day 3.5 p.c. 129/Sv-CP strain blastocysts were 
exposed at room temperature to ES20 medium (with 20mM HEPES buffer) containing 
glycerol (Sigma) in two increasing concentration steps of 0.5M and 1 .OM glycerol, for 
15 minutes each. Following hyperthermia at 42°C for 10 minutes, the glycerol was 
diluted out of the embryos at room temperature in four 10 minute steps, decreasing the 
glycerol concentration in the medium by 0.25M each time. Embryos from the three 
treatment groups; those that had been heat shocked (positive control), glycerol pre-
treated prior to heat shock, or non-heat shocked (negative control) embryos, were 
randomly allocated to individually coded microdrops for culture. 
5.2.3 Puromycin Treatment 
Day 3.5 p.c. embryos from the 129/Sv-CP strain were pre-incubated for 
45 minutes in ES20 medium containing 0, 25, 75 or 150 J.Lg/ml of puromycin 
dihydrochloride (Sigma) at 37°C. A 2.5mg/ml stock solution of puromycin was 
prepared in phosphate buffered saline, stored at 4°C and replaced after three weeks. 
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Media, containing the experimental concentrations of puromycin, were prepared 
immediately prior to use. After incubation, the embryos were then rinsed twice in 
fresh ES20 medium before being explanted into tissue-culture. In this experiment, the 
embryos from the four treatments were not randomly allocated to the STO microdrops. 
5.2.4 5-Azacytidine Treatment 
Day 3.5 p.c. 129/Sv-CP strain embryos were incubated for 24 hours in 
ES20 medium containing a range, from 10, 1, 0.5, 0.1, 0.05, 0.01 to 0.001 p.M 
concentrations of 5-azacytidine (Sigma) to initially test the toxicity of this drug. A 
1mM stock solution of 5-azacytidine was prepared in phosphate buffered saline and 
stored at 4°C for three weeks before it was replaced. Media, containing the required 
final concentration of 5-azacytidine, were prepared immediately before use. 
Following incubation, the embryos were then rinsed twice in fresh ES20 medium 
before being randomly allocated to coded STO feeder microdrops. Subsequent 
experiments, with both 129/Sv-CP and F2 (C57BL/6 X CBA/Ca) embryos, were 
conducted with medium containing 0.1 or 0.05p.M 5-azacytidine. 
5.3 RESULTS 
5.3.1 The Effect of Heat Shock on the Efficiency of ES Cell 
Isolation 
The efficiency of ES cell isolation was increased by subjecting day 3.5 
p.c. embryos, from the 129/Sv-CP mouse strain, to a short period of heat shock, 
immediately prior to culture (figure 5.1). When the embryos were exposed to an 
increase in temperature from 37°C to 42°C for 10 minutes, the yield of ES cell lines 
was significantly (P<0.025) increased compared to control embryos (13/48=27.1 ± 
0.9% vs 7179=8.9 ± 1.5%; n=3). No significant increase in the frequency of ES cell 
isolation was observed following a 10 minute exposure of embryos to 40°C 
(3/28=10.7%; this treatment was included in only one replicate of the experiment). 
The yield of ES cell lines resulting from a heat shock at 44°C was highly variable 
amongst the three batches of embryos exposed to this treatment (11/69=15.9 ± 7.2%) 
and was not significantly different compared to control embryos (figure 5.1). This 
variability was due partially to the effect the treatment had in causing a high relative 
incidence of embryonic death within the zona pellucida. In addition, heat shock at 
44°C frequently resulted in outgrowths without, or very slowly growing, ICMs. 
These losses accounted for 24% of embryos in one replicate of the experiment. 
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1': Control 	40°C 	42°C 	44°C 
* 
(e=79) (e=28) (e=48) (e=69) 
(n=3) 	(n=1) 	(n=3) 	(n=3) 
Heat Shock Temperature 
Figure 5.1: The effect of heat shock on the efficiency of ES cell isolation from day 
3.5 p.c. embryos of the 129/Sv-CP mouse strain. 
(mean ± s.e.m.; e = embryos; n = replicates) * P<z0.025 compared to control 
The survival profiles showing the proportion of control embryos and 
embryos exposed to a 42°C heat shock yielding ES-like colonies at each passage in 
culture, are shown in figure 5.2. The increase in ES cell isolation resulting from 
embryos heat shocked at 42°C did not become statistically significant until the third 
passage; where all but one heat shock-derived cell "line" was stably maintained 
thereafter. In the course of establishment of the 42°C heat shock-derived ES cell 
lines, there were small increases which accumulated over the early phases of isolation 
and ultimately resulted in the significant difference compared to controls (figure 5.2). 
The heat shocked embryos produced on average a slightly higher proportion of 1CM 
outgrowths, which additionally resulted in more ES-like colonies at the first passage 
than from control embryos (24/48=50.0 ± 6.6% vs 30179=38.0 ± 2.7%, respectively; 
P>0.05). Furthermore, these heat shock-derived ES cell primary colonies were of a 
significantly (P<0.05) more stable morphology in vitro than those derived from 
control embryos. Of the 30 control embryos giving rise to first passage cultures 
containing ES-like colonies, only colonies from seven embryos (or 23.3%) maintained 
a stable ES cell morphology over the following three passages and were expanded into 
permanent ES cell lines (figure 5.2). The first passage ES-like colonies from the 
remaining 23 control embryos were lost to differentiation. With blastocysts that had 
been heat shocked at 42°C, however, permanent ES cell lines were derived from 13 of 
the 24 original heat shocked embryos which yielded ES-like colonies at the first 
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Figure 5.2: The survival profiles showing the percentage of control (37°C) and heat 
shocked (42°C) 129/Sv-CP strain mouse embryos giving rise to ES-like colonies after 
repeated passage in culture. After passage five, ES cells derived from both treatment 
groups were maintained as permanent ES cell lines. 
(mean ± s.e.m.; e = embryos; n = 3) a P<z0.01 and b P<z0.025 compared to control 
Because of the significant result obtained from applying heat shock to 
129/Sv-CP strain embryos, the effect of elevating temperature on day 3.5 p.c. F2 
embryos, of the C57BL/6 X CBA/Ca genotype, was examined. No significant 
increase in the efficiency of ES cell isolation was observed between F2 embryos that 
had been heat shocked at 42°C for 10 minutes (2/104=1.9%) and controls (0/107) in a 
single batch of embryos cultured. This result was not significant because of the low 
numbers of embryos cultured, given that the C57BL/6 X CBA/Ca genotype appears to 
be non-permissive in terms of ES cell isolation (chapter three). Both F2 heat shock-
derived ES cell lines were isolated from hatched blastocysts (2/39). Studies with 
129/Sv-CP strain embryos heat shocked at 42°C following recovery on day 3.5 p.c. 
Control 	Heat Shock 	Glycerol + 
Heat Shock 
(e=20) 	(e=19) 	(e=28) 
have shown a small, although not significant, increase in the frequency of ES cell 
isolation from expanded (8/26=30.8 ± 3.0%) compared to hatched blastocysts 
(5/22=22.7 ± 1.8%; n=3). No significant embryo stage differences were observed 
with control 129/Sv-CP strain embryos from the same experiment (figure 5.1), where 
a similar proportion of expanded and hatched blastocysts yielded ES cell lines 
(5/60=8.3 ± 1.9% and 2/19=10.5 ± 4.6%, respectively; n=3). 
Pre-treatment of day 3.5 p.c. embryos, from the 129/Sv-CP strain, with 
glycerol (acting as a thermo-protectant) prior to heat shock at 42°C, appeared to block 
the heat shock effect (figure 5.3). The yield of ES cell lines from embryos treated 
with glycerol + heat shock (2/28=7.1%) was no different compared to the negative 
control (2/20=10.0%), but was less than the heat shocked, positive control embryos 
(5/19=26.3%). The results from this single, small trial were not significant. 
However, as the proportions of embryos giving rise to ES cell lines in the positive and 
negative control groups were comparable to the levels described previously (see figure 
5.1) the effect of the glycerol pre-treatment may have been real. 
Embryo Treatment 
Figure 5.3: The effect of pre-treating day 3.5 p.c. 129/Sv-CP strain mouse 
blastocysts with glycerol prior to heat shock, at 42°C for 10 minutes, on the efficiency 
of ES cell isolation. (e = embryos; n = 1; P>0.05) 
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5.3.2 The Effect of Puromycin on the Efficiency of ES Cell 
Isolation 
A 45 minute pre-incubation of day 3.5 p.c. embryos, from the 129/Sv-
CP mouse strain, in medium containing the antibiotic puromycin significantly 
(P<0.05) increased the efficiency of ES cell isolation, at an optimal concentration of 
25p.g/ml (10/41=24.4%) compared to control embryos (5/61=8.2%; figure 5.4) in a 
single experiment. Treatment of embryos with higher concentrations of puromycin 
did not increase the proportion of embryos giving rise to ES cell lines above the yield 
obtained from the controls. A brief incubation of embryos in medium containing 75 
or 150.tg/ml of puromycin resulted in 11.6% (5/43) and 9.3% (4/43) of embryos 




1 1:  
[0] 	[25] 	[75] 	[150] 
(e=61) (e=41) (e=43) (e=43) 
Concentration of Puromycin [tg/ml} 
Figure 5.4: The effect of the pre-treatment of day 3.5 p.c. 129/Sv-CP strain mouse 
embryos with varying concentrations of puromycin on the efficiency of ES cell 
isolation. (e = embryos; n = 1) * P<0.05 compared to [0] control 
The survival profiles of ES-like colonies derived from control embryos 
and those pre-incubated in 25.tg/m1 of puromycin are presented in figure 5.5. They 
both show a very similar pattern, however, a significantly (P<0.025) greater 
proportion of embryos gave rise to ES-like colonies at the first passage from the 
puromycin-treated group, compared to the control embryos (22/41=53.7% vs 
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18/61=29.5%, respectively). This was a difference which was maintained throughout 
the subsequent culture history (figure 5.5). There was no significant difference 
between the treatments with regard to the morphological instability of primary ES-like 
colonies in culture. Before the establishment of permanent ES cell lines at the third 
passage, a similar proportion of first passage ES-like colonies were lost to 
differentiation in both puromycin-treated and control embryo groups (12/22=54.6% 
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Figure 5.5: The survival profiles showing the percentage of control and puromycin 
[25p.g/ml] treated 129/Sv-CP strain mouse embryos giving rise to ES-like colonies 
after repeated passage in culture. After passage five, ES cells derived from both 
treatment groups were maintained as permanent ES cell lines. (e = embryos; n = 1) 
a P'cz0.025 and b P<0.05 compared to control 
5.3.3 The Effect of 5-Azacytidine on the Efficiency of ES Cell 
Isolation 
Preliminary studies, where 129/Sv-CP strain embryos were incubated 
in medium containing one of seven different concentrations of 5-azacytidine, ranging 
from 0001iM to lOp.M (see section 5.2.4), indicated that the optimal concentration, 
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increasing the frequency of ES cell isolation, was between 0.05 and 0.1 .tM. Higher 
concentrations resulted in the expanded blastocysts collapsing within the zona 
pellucida and eventually dying, two or three days alter the removal of the embryos 
from the 5-azacytidine medium. Lower concentrations of 5-azacytidine appeared 
ineffective in increasing the capacity of embryos to give rise to ES cell lines, compared 
to controls. 
As there was no significant difference in the proportions of embryos 
yielding ES cell lines following incubation in either 0.05 or 0. 1 g 5-azacytidine for 
24 hours, the data from the two groups has been combined. From three batches of 
129/Sv-CP strain blastocysts treated in this experiment, a twofold increase in the 
efficiency of ES cell isolation was observed with 5-azacytidine-treated embryos 
(13/57=22.8 ± 4.7%) compared to control embryos (5/49=10.2 ± 0.2%; P>0.05). 
From the encouraging results presented above, day 3.5 p.c. F2 
(C57BL/6 X CBA/Ca) embryos were also treated with 0.1.tM 5-azacytidine. This 
experiment was repeated twice and similar observations were made on each occasion. 
Although the blastocyst- stage embryos appeared to develop during the 24 hour 
incubation in the 5-azacytidine medium (becoming very expanded, with some embryos 
hatching from the zona), they failed to outgrow normally after being explained onto the 
STO feeder cell layers. Many of the outgrowing embryos did not have an actively 
proliferating 1CM and after four to six days of culture, two-thirds (32/51) of the 
outgrowths were composed entirely of flattened, giant trophoblast cells. The 
remaining outgrowths that were disaggregated did not produce any progressively 
growing ES-like cultures at the first passage. 
5.3.4 Production and Analysis of Chimaeras 
ES cells from lines derived from heat shocked, puromycin-treated or 5-
azacytidine-treated embryos, plus one "control" (non-perturbed) stem cell line, were 
injected into the blastocoelic cavity of day 3.5 p.c. MF1 strain embryos, to examine 
their in vivo developmental potential. All stem cell lines studied here were isolated 
from 129/Sv-CP strain embryos and were injected between passages eight and 13. 
The results are summarised in Table 5.1 (refer to the legend for ES cell line 
nomenclature). All of the ES cell lines tested here produced chimaeric mice at a high 
frequency. An average of 75% of the pups, which survived to an age to permit 
assessment, were chimaeric. There were no significant differences between the seven 
independently derived lines in the proportion of offspring which were chimaeric, 
which varied from 63% to 92%. All but one of the cell lines showed a similar 
distribution in the contribution the (10 to 15) injected stem cells made to the coat of the 
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chimaeras, varying between 10-90%. The skin of many of the animals comprised of 
an estimated 50% ES cell component. The one exception was the 129 AC19 ES cell 
line, where none of the chimaeras produced had a greater than 30% stem cell 
contribution to the coat. 
Two of the ES cell lines injected into blastocysts were female: 129 
HS4214 and 129 P[25]4a. Both female stem cell lines contained substantial 
populations of cells with chromosomal abnormalities, however, this did not preclude 
the ES cells from forming somatic chimaeras at a high efficiency (92% and 82%, 
respectively; Table 5.1). Approximately, 87% (13/15) of the cells of the 129 HS4214 
line (at passage nine) have a 75% deletion of one X chromosome distal to the region 
A3 (Nesbitt and Francke, 1973), with the remaining cells having completely loss the X 
chromosome. In the 129 P[25]4a line, approximately 47% (16/34) of the cells (at 
passage eight) have an apparently normal 40 XX chromosomal Constitution (figure 
5.6), with the remaining cells having either lost (39) or gained (41/42) chromosomes, 
in roughly equal proportions. The 129 P[25]4a line colonised the germline in one of 
the five female chimaeras that were test bred (Table 5.2), having produced one 
offspring with the black agouti coat colour, indicative of the 129/Sv-CP derived stem 
cells (figure 5.7). 
The other five ES cell lines that were injected into blastocysts were 
male and contained high proportions of cells (between 67% and 95%; n ~! 10) which 
possessed an apparently normal 40 XY chromosomal constitution, between passages 
eight and 11 in culture (Table 5.1 and see figure 5.8). The remaining cell populations 
in each of these cell lines were pseudodiploid; no tetraploid cells were observed in the 
metaphase spreads. Generally, there was a shift towards phenotypic males in the 
chimaeric population following the injection of male ES cells, most noticeable with the 
129 HS4220 cell line (Table 5.1). 
Male chimaeras derived from the XY ES cell lines 129 HS4220, 129 
AC10 and 129 Cl were mated to MF1 strain female mice to test for germline stem cell 
contributions. The results are presented in Tables 5.3, 5.4 and 5.5 for the three cell 
lines, respectively. Germline transmission was demonstrated in at least two 
chimaeras from these male ES cell lines, derived from either heat shocked, 5-
azacytidine-treated or control embryos. 
Two classes of germline male chimaeras were demonstrated. Two 
chimaeras (129 HS4220v and 129 AC10q; see Tables 5.3 and 5.4, respectively) 
transmitted the dominant black agouti coat colour phenotype to all of their progeny (see 
figure 5.9). The remaining male germline chimaeras transmitted the 129/Sv-CP stem 
cell genotype in only a proportion of their sperm. Nine of the 22 phenotypic male 






Figure 5.6: G-banded metaphase spread of the 129 P[25]4a ES cell line at the eighth 
passage, showing an apparently normal 40XX chromosome constitution. The X 
chromosomes are indicated by the arrowheads. 	 (Magnification: x1000) 
Table 5.2: Breeding data from MF1-129 P[25]4a female chimaeras 
backcrossed to albino, MF1 strain males 
Offsnrin g 
Female 	Litters Offspring Albino Black Transmission (%) 
Chimaera - 	Agouti 
129 P[25]4a a 	2 	19 	19 	0 	 0 
129 P[25]4a b 3 26 26 0 0 
129 P[25]4a c 	3 	17 	16 	1 	 5.9 
129 P[25]4a d 2 14 14 0 0 
129 P[25]4a e 	2 	22 	22 	0 	0 
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Figure 5.7: Female germline chimaera and offspring. The chimaera was produced 
following the injection of ES cells at the eighth passage from the female 129 P[25]4a  line 
into a host MF1 strain blastocyst. Transmission of the black agouti 129/Sv-CP stem 
cell-derived genotype, through the female germline, was demonstrated in one pup in a 
litter of six resulting from mating with an albino, MF1 strain male. 
9 
4 
Figure 5.8: G-banded metaphase spread of the 129 HS4220 ES cell line at the 11th 
passage, showing an apparently normal 40XY chromosome constitution. The X 
chromosome is indicated by the arrowhead and the Y chromosome by the arrow. 
(Magnification: x 1000) 
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Table 5.3: Breeding data from MF1-129 HS4220 male chimaeras 
backcrossed to albino, MF1 strain females 
Offspring 
Male 	Litters Offspring Albino Black Transmission (%) 
Chimaeras 	 Agouti 
129 HS4220 p 	Did not breed 
129 HS4220 q Did not breed 
129 HS4220 r 2 	19 
129 HS4220 s Did not breed 
129 HS4220 t 2 	20 
129 HS4220 u 4 45 
129 HS4220 v 2 	20 
129 HS4220 w 9 86 
129 HS4220 x 13 	125 
129 HS4220 y Did not breed 
129 HS4220 z Did not breed 
129 HS4220 pp  2 	25 
129 HS4220 qq Did not breed 
129 HS4220 rr Did not breed 
129 HS4220 ss Did not breed 
129 HS4220 tt 3 	25 
129 HS4220 uu 1 7 
129 HS4220 vv 3 	25 
129 HS4220 ww 1 3 
129 HS4220 xx 1 	9 
129 HS4220 yy Did not breed 
129 HS4220 zz 3 	34 
19 0 0 
20 0 0 
44 1 2.2 
0 20 100 
86 0 0 
125 0 0 
24 	1 	 4.0 
25 0 0 
7 0 0 
25 0 0 
1 2 66.7 
9 0 0 
34 0 0 
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Table 5.4: Breeding data from MF1-129 AC10 male chimaeras 
backcrossed to albino, MF1 strain females 
Offsnring 
Male 	Litters Offspring Albino 	Black Transmission (%) 
Chimaeras 	 Agouti 
129 AC10 p 	4 	44 	39 	5 	11.4 
129 AC10 q 1 15 0 15 100 
129 AC1O r 	Did not breed 
129AC10 s 1 	14 	14 	0 	0 
Table 5.5: Breeding data from MF1-129 Cl male chimaeras backcrossed 
to albino, MF1 strain females 
Offsoring 
Male 	Litters Offspring 	Albino 	Black Transmission (%) 
Chimaeras 	 Agouti 
129C1 p 5 58 57 1 1.7 
129C1q 4 41 41 0 0 
129C1r 3 20 20 0 0 
129C1s 4 44 44 0 0 
129C1t 4 45 45 0 0 





females, did not breed (Table 5.3). After autopsy, these nine chimaeras were found 
to have abnormal reproductive tracts, possessing both male and female sex organs. 
Of the fertile 129 HS4220 male chimaeras, 31% (4/13) transmitted the stem cell 
genotype through their gametes. 
5.4 DISCUSSION 
The original hypothesis examined (indirectly) in this chapter was whether an 
epigenetic alteration is required for pluripotent cells from early mouse embryos to be 
established in culture as stable ES cell lines. Embryos were challenged with 
treatments, either hyperthermia, puromycin- or 5-azacytidine-containing medium, 
known to interfere with gene expression. The increased frequency of isolation of ES 
cells resulting especially from exposure to heat shock or puromycin, might suggest 
that the isolation of stem cells may depend upon reversible changes in the pattern of 
gene expression and the treatments utilised here may have helped to promote these 
changes in culture. 
At present, the molecular mechanism(s) behind the action of these treatments are 
not understood. Although the results presented in this chapter have yet to be 
substantiated with protein synthesis and DNA methylation data, the following 
discussion shall assume that the heat shock and puromycin treatments did indeed result 
in the enhanced expression of the HSPs, as expected (Morange et al., 1984; Lee and 
Dewey, 1987). 
It is possible that by exposing embryos to a brief period of heat shock, the 
increase in the yield of ES cells occurred as a result of some change in the pattern of 
gene expression. Either genes necessary for the in Vitro establishment of stem cells 
were activated or alternatively, genes responsible for the differentiation of the 1CM 
were not transcribed and the normal sequence of gene activation in the embryo was 
interrupted by this treatment. By stressing the embryo with elevated temperature, the 
cells respond by transiently repressing general (37°C) protein synthesis (both 
transcription and translation) and instead activate the heat shock genes (Schlesinger et 
al., 1982). The mRNAs are then rapidly and efficiently translated to produce the 
HSPs. In the mouse blastocyst, a 68kD HSP is induced by the short period of 
hyperthermia (Morange et al., 1984) but whether differences exist between the 
trophectoderm and the 1CM in the synthesis of the HSPs is not known. The broad 
function of these HSPs appears to be in protecting and repairing the ribosomes 
damaged from the stressful conditions (Pelham, 1985). 
There is no evidence to suggest that the HSPs themselves are directly 
responsible for influencing the pattern of gene activation, once the temperature of the 
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cells has returned to 37°C and general protein synthesis has resumed. Some of the 
biochemical events associated with heat shock include a rapid decline in intracellular 
pH and a corresponding increase in cytosolic calcium levels (reviewed by Welch, 
1990). These cellular changes may have roles in activating "second messengers" 
leading to the activation of gene transcription. Although changes in intracellular pH 
and calcium have been shown not to be required for activation of the heat shock genes 
(Welch, 1990) such cellular conditions may have the potential to modify the pattern of 
gene expression during the recovery of the cells. 
In studies where rat foetuses (Higo et al., 1989), human HeLa cells (Andrews 
et al., 1987) and cardiac muscle (Izumo, Nadal-Ginard and Mahdavi, 1988) were 
stressed (by various agents) expression of the heat shock genes was accompanied by 
elevated expression of various proto-oncogenes. Proto-oncogenes are believed to 
have a role in controlling cell proliferative and differentiative processes (Bishop, 
1983). One proto-oncogene (c-myb) has been shown to be expressed at high levels in 
EC cells and was rapidly inactivated following the induction of differentiation by 
retinoic acid (Lockett and Sleigh, 1987). It would be interesting to examine the 
pattern of proto-oncogene expression following the heat shock of blastocysts. The 
activation of certain proto-oncogenes may result in compensatory proliferation of the 
1CM, in response to the damage caused by the stress (as hypothesised for other 
cellular systems; Higo et al., 1989). Although no actual measurements were taken of 
the size of the 1CM outgrowth, there did not appear to be any obvious increase in this 
parameter after heat shock compared to control embryos. 
As discussed above, the heat shock effect could have been due to enhancing the 
activation of certain genes (perhaps proto-oncogenes) responsible for maintaining the 
undifferentiated phenotype in vitro; or alternatively, the effect may have been due to 
genes responsible for differentiation not being transcribed, once the cellular genome 
was reactivated during recovery from the stress. This latter view could form part of 
the so-called "embryonic stress hypothesis of teratogenesis" with hyperthermia 
interfering with the normal sequence of gene expression during development (German, 
1984). According to this hypothesis, early in teratogenesis there may be a failure of 
essential genes, required for subsequent differentiation, to be transcribed at some 
critical point in development because the cellular machinery has been diverted by the 
cellular stress into producing the HSPs instead. There are numerous reports of 
various developmental defects resulting from heat stressing mammalian foetuses in 
utero, dependent upon the developmental stage at which the stress was imposed 
(reviewed by Edwards, 1986). In most of these cases, hyperthermia acted as a 
teratogen by causing general cell death. However, there is some evidence to suggest 
that anatomical malformations may also be due to the induction of the HSPs, inhibiting 
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transcription of developmentally regulated genes in Drosophila (Mitchell and Lipps, 
1978) and rat foetuses (Higo et al., 1988). Perhaps exposing day 3.5 p.c. mouse 
embryos to heat shock at 42°C resulted in the production of the HSPs for a sufficiently 
long period to perturb the normal developmental sequence of transcription, preventing 
the activation of genes responsible for the differentiation of the 1CM and so, increased 
the capacity of these cells to remain undifferentiated in vitro. This may be analogous 
to the view proposed as to why delayed blastocysts (where differentiation of the 1CM 
has been arrested) result in higher frequencies of ES cell isolation than non-delayed 
embryos (see chapter three). The heat shock of embryos resulted in significantly 
greater morphological stability of first passage ES-like cell colonies during the 
isolation of stem cell lines; that is, they appeared to be less pre-disposed to 
differentiation compared to non-heat shocked control embryos (see figure 5.2). Such 
an effect may be very dependent upon the embryonic stage at which the stress is 
imposed. Following heat shock, there was a slightly lower (although not significant) 
yield of ES cell lines from hatched blastocysts (where some cells of the 1CM may have 
already formed primitive endoderm; Nadijcka and Hillman, 1974) compared to 
expanded blastocysts. 
Exposing blastocysts to heat shock may have enhanced the expression of the 
heat shock genes, which then indirectly disturbed the normal pattern of embryonic cell 
differentiation. In Drosophila, there is evidence to suggest a correlation between the 
degree of inhibition of differentiation in cultured embryonic cells and the level of 
induction of the HSPs in response to various stress agents (Bournias-Vardiabasis and 
Buzin, 1986). The production of the HSPs is positively correlated with the degree of 
stress induced (DiDomenico, Bugaisky and Lindquist, 1982). The three temperatures 
used in these studies may have resulted in different levels of HSP synthesis. The 
mild heat shock resulting from the 10 minute exposure of embryos to 40°C, may not 
have stressed the cells sufficiently to result in the production of the HSPs for the 
length of time required to block the transcriptional activation of genes causing the 1CM 
to differentiate. Hyperthermia at 44°C, on the other hand, may have excessively 
prolonged the period of HSP production, killing the cells (Welch and Suhan, 1986). 
This may explain the observation that a substantial number of outgrowths from 
embryos heat shocked at 44°C did not contain an 1CM component, as treatment at the 
high temperature may have caused cell death within the 1CM. Heat shock at 42°C 
appeared to be optimal for inducing a sufficiently high heat shock response to perturb 
the normal programme of differentiation, but which was not deleterious to cell 
survival. 
Pre-treatment of embryos with glycerol blocked the increase in the frequency of 
stem cell isolation resulting from heat shock (see figure 5.3). Glycerol has previously 
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been shown to block the release of the HSPs during hyperthermia in cultured chicken 
embryonic cells (Edington, Whelan and Hightower, 1989). 	Glycerol, as a 
polyhydroxyl alcohol, is thought to stabilise proteins by strengthening the hydrogen 
bonds of water molecules and hence, strengthening the hydrophobic interactions of 
proteins (Gekko and Koga, 1983). The chicken embryonic cells were therefore not 
stressed by the elevated temperature, as the glycerol protected heat sensitive targets 
from thermal damage. Thus, the transcriptional activation of the heat shock genes, 
both during and alter the period of elevated temperature, were blocked (Edington et 
al., 1989). 
It is not clear whether the transcription and translation of normal (37°C) proteins 
would have been active during heat shock with glycerol-treated embryos. If general 
protein synthesis had been repressed during exposure to the elevated temperature and 
then reactivated once the embryos were returned to 37°C (without the release of the 
HSPs) this might imply that the heat shock effect, increasing ES cell isolation, may be 
due specifically to the HSPs themselves and not a general effect of disruption in the 
pattern of gene expression. If on the other hand, 37°C protein synthesis had 
continued during the heat shock of glycerol-treated embryos, it would not be obvious 
whether the phenomenon was due to the HSPs or a change in gene expression upon 
genome reactivation. An experiment which may clarify the point would be to treat the 
embryos, prior to culture, with a general, but reversible, inhibitor of transcription. A 
likely candidate would be the use of the antibiotic actinomycin-D, which is capable of 
penetrating intact cells, binding to DNA and preferentially blocking mRNA chain 
elongation (Lehninger, 1975a). DNA synthesis is not substantially affected by this 
drug (Lehninger, 1975a) and the actinomycin-D molecule may dissociate from the 
DNA upon replication and be diluted out of the embryonic cells. Therefore, 
actinomycin-D may be useful to block general transcription over the period when 
genes responsible for differentiation would normally becoming transcriptionally active 
in the 1CM. Once the actinomycin-D is removed from the cells, the pattern of gene 
reactivation may not include those genes required for differentiation and consequently, 
this may confer some advantage towards the isolation of ES cells. 
The brief incubation of mouse blastocysts from the 129/Sv-CP strain in medium 
containing 25xg/ml of the antibiotic puromycin resulted in a significant, three-fold 
increase in the efficiency of ES cell isolation compared to controls (see figure 5.4). 
This was similar to the effect of heat shock. The antibiotic puromycin is an analogue 
of aminoacyl-tRNA, blocking translation and resulting in the production of aberrant 
polypeptides. Puromycin interupts peptide chain elongation by its capacity to bind to 
the aminoacyl site on the ribosome when the peptidyl site is occupied with a tRNA 
(Lehninger, 1975b). A covalently bound peptidyl-puromycin derivative is formed 
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and dissociates from the ribosome, since it does not have the correct structure to move 
along to the peptidyl site to further elongate the peptide (Lehninger 1975b). The 
abnormal proteins formed from puromycin treatment have resulted in the induction of 
the HSPs in Escherichia coli (VanBogelen and Neidhardt, 1990), avian (Hightower, 
1980) and mammalian cells (Lee and Dewey, 1987). Very high concentrations of 
puromycin (100.tg/ml), similar to the highest treatments used in this study, are 
unlikely to result in the production of the HSPs because of the high frequency of 
peptide chain termination preventing their synthesis (Lee and Dewey, 1987). In 
accord with the classical heat shock response, general protein synthesis was reduced 
by up to 80% with treatment of Chinese hamster ovary cells with 30pg/ml puromycin 
(Lee and Dewey, 1987) and in the course of the response, general transcription would 
also be expected to have been transiently repressed, as a secondary effect. So, the 
increase in ES cell isolation resulting from puromycin-treated embryos (at a 
concentration of 25.tg/ml) cannot be distinguished between an effect of the HSPs, or 
due to some change resulting from the general reactivation of the genome. However, 
since there was no increase in ES cell isolation from high concentrations of puromycin 
and as such treatment may not have caused the production of the HSPs but may have 
repressed transcription as a secondary effect, perhaps the increase in ES cell isolation 
observed at the lower concentration of puromycin was in some way due to the HSPs. 
Although not significant, the incubation of blastocysts from the 129/Sv-CP 
mouse strain for 24 hours in medium containing 0.1 .tM 5-azacytidine, doubled the 
proportion of embryos yielding ES cell lines compared to control embryos. There 
appeared to be a difference between mouse strains in the cytotoxicity of this drug on 
pre-implantation embryos. In many instances, the treatment of embryos from the F2 
(C5713116 X CBA/Ca) genotype with 0.1MM 5-azacyticline resulted in cell death in the 
1CM, whereas detrimental effects of the drug on embryos from the 129/Sv-CP strain 
were only observed at between 10- to 100-fold higher concentrations. As a 
comparison of the DNA methylation status of control and 5-azacytidine-treated 
embryos, and ES cell lines, was not undertaken in these studies, it remains to be 
determined whether the increase in ES cell isolation from the 129/Sv-CP mouse strain 
was indeed due to hypomethylation and hence, gene activation. Exposure to 5-
azacytidine has been shown to induce the HSPs in Drosophila embryonic cells 
(Bournias-Vardiabasis and Buzin, 1986). Substantially lower concentrations of 5-
azacytidine (between 10- to 100-fold lower) were used in the studies here to allow for 
the survival of the 1CM (from the 129/Sv-CP strain) compared to what previous 
workers have utilised in other in vitro systems to cause hypomethylation of DNA and 
gene activation (Mohandas et al., 1981; Konieczny and Emerson, 1984). The lower 
concentrations of 5-azacytidine used here may not have caused hypomethylation, but 
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instead only stressed the cells sufficiently to induce the heat shock response. Thus, 
the mechanism responsible for the increase in ES cell isolation with 5-azacytidine may 
have been via a similar (but unknown) pathway as that for the hyperthermia and 
puromycin treatments. 
If the 5-azacytidine treatment had caused random hypomethylation of DNA, it 
might have been expected to have resulted in mutations in vivo. If mutations were 
induced by the 5-azacytidine treatment, they were not of a dominant nature as chimaeras 
and F1  ES cell-derived progeny were all normal and healthy. However, as the F1  
progeny were not intercrossed, the possibility of recessive mutations cannot be 
excluded. It could also 	be possible that any gene sequences that were perturbed 
by the 5-azacytidine treatment were modified in vivo to the correct methylation pattern, 
as has been suggested elsewhere (Frank etal., 1991). 
If some form of epigenetic change has occurred during the establishment of ES 
cells derived from embryos exposed to the heat shock, puromycin or 5-azacytidine 
treatments, these changes must have been of a reversible nature, as under appropriate 
environmental conditions the stem cells retained the capacity for both in Vitro and in 
vivo differentiation; that is, the stem cells remain developmentally labile. These 
perturbation treatments have not produced an epigenetic change which has arrested the 
cells in an undifferentiated state in vitro, since within two passages following the 
removal of STO feeder cells and DIA/LIF from the medium, heat shock-derived ES 
cells differentiated into cells with a flattened epithelial-like morphology in monolayer 
culture. Furthermore, when aggregates of heat shock-derived ES cells were cultured 
in suspension, they formed cystic embryoid bodies. The most compelling evidence 
for a fully reversible epigenetic change, comes from the finding that all six of the ES 
cell lines which were injected into host blastocysts and derived from either heat shock, 
puromycin or 5-azacytidine treatments, produced somatic chimaeras at a high 
frequency. More importantly, since EC cells possessing grossly abnormal karyotypes 
have still retained the capacity to participate in apparently normal embryo development 
(Ilimensee and Croce, 1979), in at least two chimaeras from cell lines derived from 
each of the three perturbation treatments, the ES cells colonised the germ cell lineage 
and formed functional gametes. This fact and the data from the limited karyotype 
analyses completed to date, strongly suggests that the treatments have not 
"transformed" the cells by altering the chromosomal constitution. Rather, these 
perturbation treatments may have had a more subtle role in modifying the profile of 
gene expression and so, increasing the capacity of pluripotent cells within the mouse 
embryo to be diverted from differentiation and established into culture, as ES cells. 
Following blastocyst injection of ES cells, derived from either control embryos 
or embryos exposed to one of the three perturbation treatments, somatic chimaeras 
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were formed at a high efficiency compared to other studies (cf. Table 5.1 and Evans et 
al., 1985). This was possibly due to the injection of stem cell lines at a low passage 
number, which had not accumulated large populations of cells with chromosomal 
abnormalities. Furthermore, stem cells from each of the four ES cell lines examined 
for germline transmission in these studies were capable of forming functional gametes 
in chimaeras. From the male ES cell lines, two classes of germline male chimaeras 
were observed; those which either partially or absolutely transmitted the ES cell 
genotype. Those male chimaeras which only transmitted the 129/Sv-CP genotype in a 
small fraction of their sperm, would have arisen in the case were male ES cells were 
injected into a male host embryo (Robertson, 1986). The two absolute transmitters 
produced in these studies, where all of their sperm were of the 129/Sv-CP genotype, 
presumably resulted as a consequence of male stem cells being injected into a female 
host embryo which converted the sex of the resultant animal (Robertson, 1986). 
From the sex ratio with the 129 HS4220 male ES cell line (see Table 5.1) it is 
estimated that half of the female embryos injected with stem cells were sex converted 
to phenotypic males. Of these sex converted chimaeras, 90% (9/10) did not breed and 
on autopsy were shown to be sterile hermaphrodites. This presumably occurred from 
a low contribution of male ES cells to the female germinal ridge during 
embryogenesis, which only exerted a mild masculinising influence. 
These studies have demonstrated the potential of female ES cells to colonise the 
female germline (figure 5.7). Although cultured female EC cells have produced 
germline female chimaeras (Stewart and Mintz, 198 1) there are no previous reports of 
germline transmission from female ES cells; if only because this event has not been 
assayed extensively (see chapter 1.3.6). Because the female 129 P[25]4a ES cell line 
tested in this study had populations of cells with a 40 XX and 39 XO chromosome 
constitution, it is not known which cells produced the stem cell-derived oocyte. XO 
ES cells (from a male cell line where the Y chromosome had been lost from 
approximately 50% of the cells) have been shown competent to colonise the germline 
in female chimaeras (Kuehn et al., 1987). 
In summary, these studies show that treatments expected to perturb gene 
expression increase the efficiency of ES cell isolation, suggesting that the isolation of 
stem cells may depend upon changes in the pattern of gene expression. ES cell lines 
derived from embryos exposed to either heat shock, puromycin- or 5-azacytidine-
containing medium, have retained the capacity to colonise the germline in some 
chimaeric mice, suggesting any epigenetic change in culture to be fully reversible in 
vivo. Other methods of modifying gene expression may aid in the understanding of 
the molecular basis behind the action of these treatments. 
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CHAPTER 6 
EXPRESSION OF CELL SURFACE 




During murine embryogenesis, the nature of the carbohydrate chains of 
glycolipids and glycoproteins at the cell surface undergo a sequence of changes. Anti-
carbohydrate antibodies, recognising specific oligosaccharide determinants (antigens), 
have been utilised to characterise changes in core structure synthesis, branching pattern 
and terminal chain modification (Pennington et al., 1985). Particular carbohydrate 
chains have been demonstrated on the cell surface of mouse embryos throughout the 
pre-implantation period, whereas others may appear in a stage-specific manner. 
Furthermore, these carbohydrate determinants may subsequently become restricted to 
certain tissues, however, not necessarily in a lineage-related manner (Kimber, 1990). 
Nevertheless, some cell surface carbohydrate antigens have provided tissue-specific 
markers in mouse pre- and post-implantation-stage embryos (reviewed by Kimber, 
1990), ES cells and their differentiated derivatives (Brown et al., 1991; Kimber et al., 
1991). The expression of some carbohydrate antigens is developmentally regulated, 
coinciding with differentiative events. Thus, some carbohydrate determinants may 
have important roles in cell-cell interactions and in mediating cell migration and 
morphogenesis during embryo development. 
The carbohydrate determinants on the cell surface of mouse embryos may be one 
of four main types: 1) branched or linear poly-N-acetyl lactosamine-containing chains, 
2) fucosylated lactosamine-containing chains, 3) oligosaccharides related to globoside, 
or 4) sialylated glycoconjugates (Kimber, 1990). The two basic carbohydrate families 
detected on mouse embryos, the lactoseries and the globoseries families, originate 
from a common precursor, lactosylceramide (Richa and Solter, 1986). The 
lactoseries carbohydrate chains contain repeated N-acetyl lactosamine units which may 
be one of two isomeric forms: either type I chains, with galactose linked 13(1-3) to N-
acetyl glucosamine, or type II chains, where galactose is instead in a 13(1-4) linkage to 
the N-acetyl glucosamine unit (Kimber, 1990; see Table 6.2). In the mouse, type I 
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lactosamine-containing chains were not found on the cell surface of pre-implantation 
embryos (Pennington et al., 1985), however, a sialylated and fucosylated type I chain 
determinant has been detected at the compacted morula-stage (Kimber et al., 1991). 
Type I core structures may be also present on the extra-embryonic visceral endoderm 
and yolk sac endoderm on days 6.5 and 7.5 p.c., respectively (Pennington et al., 
1985). Type II lactosamine-containing chains, identified immunologically with 
certain human auto-antisera (from cold haemagglutinin disease), may be of either 
branched (I-antigen) or linear (i-antigen) type chains (Feizi, 1982; see Table 6.2). 
Branched carbohydrate chains (detected by anti-I antibodies) are present at all stages of 
pre-implantation development in the mouse, however, following implantation these 
structures are gradually lost from the primitive ectoderm (Feizi, 1982; Kimber, 1990). 
Linear chains (detected by anti-i antibody) first appear at the time of implantation in the 
mouse on the surface of visceral and parietal endoderm cells (Pennington et al., 
1985). 
The globoseries carbohydrate chains are based on terminal modifications of the 
core globoside structure (N-acetyl-galactosamine-B( 1 -3)-galactose-ct( 1 -4)-galactose-
B(1-4)-glucose-ceramide; Richa and Solter, 1986). One antigen of this family, SSEA-
3 (galactose-13(1-3)-globoside; see Table 6.2) has been detected on mouse embryos 
with a monoclonal antibody produced by immunising a rat against four- to eight-cell 
mouse embryos (Shevinsky et al., 1982). SSEA-3 is present on mouse oocytes and 
subsequently becomes restricted firstly to the 1CM of the blastocyst and then to the 
primitive endoderm (Shevinsky et al., 1982). During implantation, SSEA-3 is a 
marker of visceral endoderm (Fox et al., 1984). SSEA-3 is present on human, but 
not mouse, EC cells (Shevinsky et al., 1982) and it has been suggested that the 
differentiation of human EC cells and embryos involves the transition from globoseries 
to lactoseries carbohydrate chains (Kannagi et al., 1983). This is not the case for 
murine embryos, as both the globoseries SSEA-3 antigen and the lactoseries I-antigen 
are present from the oocyte-stage onwards (Shevinsky et al., 1982; Kimber, 1990). 
However, during murine embryogenesis, certain tissue types may only express one of 
these two core carbohydrate structures (reviewed by Kimber, 1990). 
The addition of simple sugar residues to terminal N-acetyl lactosamine 
oligosaccharides converts these core carbohydrate structures into many new antigens, 
including the X- and Y-antigens and antigens of the ABH blood group system (see 
Table 6.2). The addition of fucose in an a(1-2) linkage to the terminal galactose 
residue of a lactosamine chain results in the formation of the so-called H-antigen. The 
A-antigen and the B-antigen are formed when the above fucosylation is followed by 
the respective addition of either an N-acetyl lactosamine unit or a galactose sugar, both 
in a x(1-3) linkage, to the terminal galactose of the carbohydrate chain (reviewed by 
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Richa and Solter, 1986). The X-antigen (otherwise known as SSEA-1: stage-specific 
embryonic antigen-1; Softer and Knowles, 1978) is derived from an cx(1-3) 
fucosylation of N-acetyl glucosamine (Gooi etal., 1981). A second fucosylation in 
an a(1-2) linkage to the terminal galactose converts the determinant into the 
difucosylated Y-antigen (Abe et al., 1983). A high proportion of lactosamine-
containing type II chains are capped with sialylic acid (N-acetyl-neuraminic acid) 
during the first two days of pre-implantation development (Kimber, 1990). These 
terminal chain modifications depend upon the activities of the various specific 
galactosyl, sialyl and fucosyl transferase and glycosidase enzymes, which may be 
regulated by both the control of gene expression and by the competition for mutual 
substrates (Fenderson et al., 1986; Kimber, 1990). 
Neither the A- nor the H-antigen have been demonstrated on the surface of cells 
during the first eight days of murine embryonic development (Pennington et al., 
1985). The B-antigen has been reported to appear at the late morula-stage and is 
present on the trophectoderm (Kimber, 1990). There appear to be uterine factors 
responsible for the expression of the Y-antigen on the cell surface of eight- to 16-cell 
embryos and early blastocysts, before the antigenic determinant is synthesised by the 
embryo itself (Fenderson et al., 1986). Expression of the X-antigen (SSEA-1) 
occurs from the eight-cell-stage, coinciding with the process of compaction (Solter and 
Knowles, 1978). 	The observation that lacto-N-fucopentaose III (a milk 
oligosaccharide with a structure identical to the terminal portion of the X-antigen) 
decompacted mouse morulae has suggested that the X-antigen may be involved in cell-
cell adhesion (Bird and Kimber, 1984). It has been proposed that the X-antigen is 
involved in secondary stabilisation of interacting membranes, following the initial 
Ca2+ dependent and uvomorulin (cell adhesion molecule) phases of compaction 
(Kimber, 1988). Determinants carrying the H-antigen on the surface of uterine 
epithelial cells (Kimber, Lindenberg and Lundblad, 1988) have been implicated in the 
heterophilic binding to receptors on the trophectoderm in the initial phases of 
implantation of mouse blastocysts (Lindenberg et al., 1988; Lindenberg, Kimber and 
Kallin, 1990). 
Expression of the X-antigen has been correlated with developmental 
pluripotency in the mouse; appearing on the cell surface of the 1CM, primitive 
ectoderm, primordial germ cells, EC cells (Fox etal., 198 1) and ES cells (Martin and 
Lock, 1983). However, the X-antigen is weakly expressed on tissues unrelated to the 
pluripotent lineage and is also found on the cells of the yolk sac, trophoblast giant 
cells, brain and kidney (Fox et al., 1981; Pennington etal., 1985). 
Much is now known in the mouse about the expression of carbohydrate antigens 
on the embryonic cell surface during early development, although little is understood 
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about the functional significance of these carbohydrates. The purpose of this study 
was to examine the temporal and spatial patterns of expression of cell surface 
carbohydrates on ovine pre-implantation embryos, using anti-carbohydrate antibodies 
of known specificity. The patterns of antigen expression were investigated over two 
developmental events; namely, the processes of compaction leading to the formation of 
the blastocyst and the differentiation of the 1CM into the primitive ectoderm and 
primitive endoderm tissues. An additional objective was to identify tissue-specific 
markers on the cell surface of early sheep embryos. 
6.2 EXPERIMENTAL METHODS 
Superovulated Scottish Blackface ewes were artificially inseminated with semen 
collected from either Scottish Blackface or Welsh Mountain rams. Embryos were 
surgically recovered from ewes at one of eight embryonic stages, spanning eight days 
of pre-implantation development; from four day old eight- and 16-cell embryos, 4.5 
day old 32-cell morulae, day five compacted morulae, day seven, eight and nine 
blastocyst- stage embryos, through to day 11 hatched blastodermic vesicles (day 0 is 
the day of onset of oestrus). Immunohistology was performed on either whole or 
cryosectioned embryos. Fluorescent labelling of specific carbohydrate antigens was 
accomplished with a double-layer antibody technique. 
6.2.1 Superovulation and Artificial Insemination of Ewes 
Oestrus cycle synchronisation of donor ewes was achieved by 
intravaginal positioning of progestagen sponges (Veramix; each containing 60mg 
medroxyprogesterone acetate; Upjohn, Crawley, U.K.) for 12 days. Ewes were 
induced to superovulate with twice daily subcutaneous injections of ovine follicle 
stimulating hormone (oFSH: Ovagen; Immuno-Chemical Products, Auckland, NZ) 
over four days (0.125 units of oFSH per injection). The progestagen sponge was 
withdrawn at the time of the seventh oFSH injection. Ovulation was induced with a 
single intramuscular injection of 0.008mg of gonadotrophin releasing hormone 
equivalent (GnRH: Receptal; Hoechst Animal Health, Milton Keynes, U.K.) 24 hours 
after sponge withdrawal. At this time ewes were also tested for oestrus and this was 
designated day 0 of embryo development. 
Fertilisation was accomplished by artificially inseminating super-
ovulated donor ewes, with a laparoscopy technique (Evans and Maxwell, 1987) 12-18 
hours after the administration of GnRH. Ewes were held in a recumbent position and 
a local anaesthetic (Lignocaine A: 30mg/mi lignocaine hydrochloride and 0.0125mg/mi 
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adrenalin; Univet, U.K.) was injected at two points immediately anterior to the udder. 
Two incisions were then made in the skin and underlying abdominal wall, through 
which the laparoscope and a glass pipette (5mm diameter; Scotia Glass Technology, 
Sterling, U.K.) containing the semen, were introduced. 0.2ml of freshly collected 
semen diluted in phosphate buffered saline (2:1) was injected into the tip of each 
uterine horn. Following insemination, the skin incisions were closed with (18mm) 
Martin Michel clips. 
6.2.2 Embryo Recovery 
Before surgery, donor ewes were penned indoors without access to 
feed and water for 24 hours. A surgical plane of anaesthesia was induced by an 
intravenous injection of 10% (w/v) sodium thiopentone (Intraval; RMB Animal 
Health, Dagenham, U.K.). The ewes were then placed in a recumbent position and 
the abdomen was prepared by clipping belly wool. The area was washed with a 
Savlon disinfectant (7.5% w/v chiorhexidine gluconate; ICI, U.K.) solution, followed 
by a Hibitane spray (5% w/v chiorhexidine gluconate; ICI, U.K.) used to sterilise the 
skin. A Magills endotracheal tube was inserted and anaesthesia maintained with an 
oxygen, nitrous oxide and halothane (Flurothane; ICI, U.K.) mixture, utilising a semi-
closed circuit system. 
A mid-ventral laparotomy was performed under aseptic conditions by 
making a mid-line incision just anterior to the udder. The uterine horns, oviducts and 
ovaries were exteriorised. These organs were kept moist by periodically irrigating 
with warm medium. The ovaries were inspected to determine the number and site of 
recently formed corpora lutea. 
Embryos were recovered by "flushing" media through the reproductive 
tract ipsilateral to the corpora lutea. Four to six day old embryos were recovered by 
flushing both the oviducts and the uterine horns. The base of the uterine horn wall 
was punctured, a latex Foley catheter (Ch 10; Rusch) inserted and its cuff inflated until 
the lumen of the uterine horn was occluded. A blunt 18 gauge hypodermic needle 
was then inserted into the infundibulum and 20m] of warm (37°C) phosphate buffered 
saline supplemented with 0.0036% (w/v) sodium pyruvate, 0.1% (w/v) D-glucose, 
0.4% (w/v) bovine serum albumin, 0.0025% (w/v) kanamycin sulphate and phenol 
red (Ovum Culture Medium: Flow Laboratories) was injected through the oviduct and 
the uterus and was collected via the catheter, into sterilised concave glass dishes (5cm 
diameter). Embryonic stages from day seven onwards were recovered by only 
flushing the uterine horns. A Foley catheter was inserted into the base of the uterine 
horn as described above. For day 10 and 11 embryos, a size Ch 12 Foley catheter 
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(Rusch) was used. A blunt 18 gauge hypodermic needle was inserted into the tip of 
the uterine horn, near the utero-tubal junction and 20m1 of warm (37°C) Ovum Culture 
Medium was injected into the uterine horn, taking care to occlude the oviduct by 
grasping it between fingers and thumb. This bolus of medium was gently massaged 
along the uterine horn and collected into sterilised concave glass dishes via the 
catheter. The flushings were examined with a binocular dissecting microscope to 
locate and recover the embryos. 
The donor ewe's reproductive tract was returned to the abdominal 
cavity and the body wall incision was closed with absorbable polyglycolic acid sutures 
(Dexon 4-metric; Davis-Geck, U.K.). The skin was closed with several (18mm) 
Martin Michel clips. At the end of the operation the administration of the anaesthetic 
was discontinued and a 2m1 subcutaneous injection of penicillin (Duphapen LA: 
150mg/ml procaine penicillin and 1 12.5mg/ml benzathine penicillin; Duphar 
Veterinary, U.K.) was administered. 	During post-operative recovery, the 
endotracheal tube remained in place until the return of swallowing reflexes. 
6.2.3 Anti-Carbohydrate Antibodies 
Eleven antibodies of known carbohydrate specificity (see Tables 6.1 
and 6.2) were generously provided by Dr. Susan Kimber (Department of Cell and 
Structural Biology, University of Manchester). All were monoclonal antibodies 
(mAb), except for two (anti-I and anti-i) which were auto-antibodies from polyclonal 
human sera. Of the nine mAbs, seven were of a mouse 1gM isotype, one was a 
mouse IgG and one was a rat 1gM (Table 6.1). The mAbs were provided as 
hybridoma supernatants, with an approximate concentration of 100.tg 
immunoglobulin/mi. 
The mAbs used in this study were specific for carbohydrate antigens 
which could be divided into four families (see Table 6.1). Antibodies were used to 
immunostain sheep embryos which recognised branched (anti-1) and linear (anti-i) 
type II lactosamine-containing chains and linear type I lactosarnine-containing chains 
(MC2303). A number of mAbs were used which were known to recognise various 
fucosylated lactosamine antigens, including the H-antigen (667/9E9: specific for type I 
chains), the X-antigen (630/7H1), the Y-antigen (shared by the mAbs HOOl, H004 
and AH6) and the B-antigen (B006). One mAb (19.9) was known to be specific for 
lacto-N-fucopentaose H chains capped with sialylic acid. And anti-SSEA-3 antibody 
was known to bind to a globoside-related determinant. The actual carbohydrate 
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Any binding of these primary antibodies to specific cell surface 
determinants was detected by overlayering a fluorescein isothiocyanate (FITC) 
conjugated, anti-species second antibody. If bound, the FITC compound fluoresced 
green when excited with light in the 450-490nm range. The second antibodies (for 
the anti-human polyvalent immunoglobulins and the anti-mouse IgMs and IgGs) had 
been raised in the goat (Sigma) except for the anti-rat 1gM, which was raised in the 
rabbit (gift of Dr. S.J. Kimber). 
6.2.4 Immunohistology of Whole-Mounted Embryos 
This technique was applied for immunostaining cleavage-stage 
embryos and for the outer trophectodermal staining of blastocyst-stage embryos. 
6.2.4.1 Preparation of Embryos 
The zona pellucida was removed mechanically from early 
embryonic stages. This was achieved with the aid of two micromanipulators (Leitz, 
Germany) mounted on each side of an inverted phase contrast microscope (Nikon 
Diaphot). Manipulations were performed in a 250.il droplet of medium on a 90mm 
plastic dish (Sterilin) under paraffin oil. The medium utilised was phosphate buffered 
saline supplemented with 0.0036% (w/v) sodium pyruvate, 0.1% (w/v) D-glucose and 
0.4% (w/v) bovine serum albumin (PB 1: Whittingham and Wales, 1969) but without 
phenol red. While the embryo was immobilised by suction on the tip of a flame-
polished holding pipette (external diameter c.a. 150tm) a stout, pointed needle, 
mounted on the opposite manipulator, was used to initially create a tiny tear in a region 
of the zona adjacent to the holding pipette. It was possible to gradually create a slit 
around approximately two-thirds the circumference of the zona. By reducing the 
suction pressure a fraction, the tearing action of the needle slightly rotated the embryo 
across the orifice of the pipette. This enabled the needle to repeatedly tear a new 
section of the zona and thus, progress slowly around the embryo. Producing the slit 
around the zona with expanded blastocyst- stage embryos was facilitated by initially 
puncturing the blastocoelic cavity, so that the embryo partially collapsed. 
The embryo was removed through the large slit created in 
the zona by gently aspirating the embryo into a mouth-controlled Pasteur pipette, with 
the glass capillary drawn out so as to have a diameter approximately the same size as 
the embryo. Zona-free embryos were then ready for immunostaining. 
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6.2.4.2 Immunostaining Whole Embryos 
Zona-free embryos were washed once in PB 1 medium (see 
6.2.4.1) + 0.02% (w/v) sodium azide, but without phenol red (Lindenberg, Kimber 
and Kallin, 1990). All antibodies and sera were diluted in this buffer. Embryos 
were incubated at room temperature for 20 minutes in a 1:20 dilution of normal serum 
of the species of the second antibody - goat or rabbit serum (Sera-Lab) - to prevent 
non-specific binding. mAbs were diluted 1:10, except for anti-SSEA-3 (1:20) and a 
1:40 dilution was used for anti-I and anti-i antibodies. Embryos were then introduced 
by mouth pipette, in the minimum of buffer, into a 25p.l drop of the primary antibody 
under paraffin oil in a clean, solid watchglass and were incubated at room temperature 
for one hour. Control embryos were incubated in the buffer without primary 
antibody. Following this, embryos were washed six to eight times in fresh droplets 
of buffer on the lid of a plastic dish (Sterilin). They were then stained in 25t1 
droplets of FITC-conjugated second antibody (1:80 dilution) under oil, for one hour at 
room temperature. The embryos were finally washed six to eight times in buffer 
before being mounted. 
6.2.4.3 Mounting Whole Embryos 
Embryos were mounted in optically-true glass microslides 
(CAMLAB) allowing the embryos, in the buffer, to move up inside the microslide by 
capillarity. Both ends of the microslides were then sealed carefully with plasticine. 
Using a drop of Super-Glue (active ingredient: cyanoacrylate), the microslide was 
fixed to an ordinary glass microscope slide. Embryos were viewed immediately 
afterwards for fluorescence. 
Microslides with different luminal sizes were utilised to 
accommodate different stage embryos; for example, 0.1mm microslides for eight-cell 
embryos and up to 0.4mm slides for some day nine blastocysts. Larger blastodermic 
vesicles were mounted instead in the depressions within tissue-typing slides (BDH) 
with an overlaid coverslip. 
6.2.5 Immunohistology of Cryosectioned Embryos 
Blastocyst-stage embryos were sectioned in order to examine the 
pattern of antigen expression on the cell surface of ICMlprimitive ectoderm and 
primitive endoderm tissues. 
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6.2.5.1 	Preparation of Tissue 
Embryos were mounted as quickly as possible after surgical 
recovery in O.C.T. embedding compound (comprised of water soluble glycols and 
resins; BDH) contained within imi conical cryotubes (Nunc; Life Technologies) which 
were used as moulds. These cryotubes had been vertically scored on two opposing 
sides with a hot scalpel blade, to facilitate subsequent opening of the mould. A small 
drop of the O.C.T. compound was placed at the bottom of the cryotube, taking care 
not to trap air bubbles. A mouth-controlled, finely pulled Pasteur pipette was then 
used to introduce the embryos (in the absolute minimal volume of PB 1 medium; 
without phenol red) into the O.C.T., positioning the (one to four) embryos as closely 
as possible to the bottom of the tube. Working quickly, the embryos were snap-
frozen in iso-pentane (BDH), pre-cooled on liquid nitrogen and stored at -80°C until 
required for sectioning. 
6.2.5.2 Cryosectioning 
When required, the cryotube was transferred into the 
cabinet of the cryostat (Brights; Huntingdon, U.K.), set at -15°C. Using two 
haemastats, the plastic cryotube was broken and the frozen O.C.T. plug, containing 
the embryos at (or near) the apex, was fixed onto the chuck of the cryostat with a drop 
of O.C.T.. Sections were cut 7-10m in thickness. The cut section, lying on the 
cold knife, was picked up with a clean, warm, glass microscope slide by gently 
pressing the slide evenly against the knife. To improve adherence of the tissue to the 
glass, the slides had been dipped into a solution containing 0.1% (w/v) gelatin and 
0.01% (w/v) chromium potassium sulphate in distilled water and allowed to air-dry 
to 
before use (Goldman, 1968). The embryo sections were alloweddry at room 
temperature on the glass slides before being fixed for 10 minutes in acetone at 4°C. 
They were then ready for immunostaining. 
6.2.5.3 Immunostaining Cryosectioned Embryos 
Fixed sections were allowed to dry at room temperature 
before being hydrated for three to five minutes in phosphate buffered saline (with Ca2 
and Mg2 ) containing 0.1% (w/v) bovine serum albumin and 0.05% (v/v) Tween-20 
(Sigma) (pH 7.2: Kimber, Lindenberg and Lundblad, 1988). All antibodies and sera 
were diluted in this buffer. The sections were incubated at room temperature for 30 
minutes in a 1:20 dilution of normal serum of the species of the second antibody - goat 
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or rabbit serum (Sera-Lab). The primary antibodies were diluted in the buffer to the 
same ratios as described in section 6.2.4.2. After draining the serum and drying 
around the sections with paper tissues, 10p.1 of the diluted primary antibody solution 
was placed over the sections and incubated overnight in a humidified chamber at 4°C. 
Controls, used to assess non-specific binding, involved the incubation of some 
sections in the buffer without any antibody. Only one section per embryo was tested 
with each antibody. Following the overnight incubation, the sections were rinsed 
four to five times in buffer and then incubated at room temperature for 10 minutes in a 
1:20 dilution of normal goat serum. They were then stained in a 1:80 dilution of 
FITC-conjugated second antibody for one hour at room temperature. The sections 
were then finally rinsed several times in buffer and mounted in 0.25% (w/v) 1,4- 
diazobicyclo-(2,2,2)-octane (DABCO; Sigma) in 90% (v/v) glycerol in phosphate 
buffered saline (pH 8.6; stored at -20°C), to help prevent fading of fluorescence 
(Johnson et al., 1982). The coverslips were then sealed with nail varnish. 
6.2.6 Epi-fluorescence Microscopy 
Immunostained sections and embryos were viewed in a Leitz 
Ortholux epi-fluorescence microscope with a mercury lamp for illumination and 
excitation filter BP 450-490 (i.e. blue light). Fluortar (x25 and x50) water immersion 
objective lenses were used. Specimens were viewed the day of preparation. Fading 
was a particular problem associated with whole-mounted embryos and thus, it was 
important not to expose the embryos to the light beam for too long. A three grade 
system was adopted to quantify the level of antigen expression on the cell surface as 
detected by antibody binding. Both brightfield and epi-fluorescence photographs 
were taken on Tmax 400 ASA film (Kodak). Epi-fluorescence exposure times were 
between 15-30 seconds for whole-mounted embryos and 30-60 seconds for sectioned 
material. 
6.3 RESULTS 
The panel of antibodies used in this study have demonstrated four different 
patterns of antigen expression during ovine pre-implantation embryo development. 
Antigens were either (1) present on the surface of all cell types at all of the embryonic 
stages examined or (2) were not expressed at all; alternatively other antigens were 
either (3) present during early cleavage-stages and then subsequently became restricted 
to specific cell types after differentiation or (4) first appeared on a specific cell type at a 
particular stage after differentiation had occurred. A summary of developmentally 
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n = embryos; only one section per blastocyst-stage embryo was stained with each 
antibody. 
regulated antigen expression during ovine embryogenesis (patterns 3 and 4) is 
presented in Table 6.3. 
Antigens containing branched (I) and linear (i) type II poly-N-acetyl lactosamine 
oligosaccharides and the globoside-related SSEA-3 determinant (see Tables 6.1 and 
6.2) were strongly detected at all developmental stages studied, from eight-cell 
embryos through to the day 11 blastoderinic vesicles and on all tissues; that is, 
trophectoderm, 1CM/primitive ectoderm and primitive endoderm. Between two and 
10 embryos or cryosections were stained per embryo stage with the anti-I, anti-i and 
anti-SSEA-3 antibodies and controls were negative in all instances. 
The pattern of expression of the I-antigen is shown in figure 6.1. The I-antigen 
was detected uniformly over the cell surface of each blastomere from at least the eight-
cell-stage (n=2) onwards (figure 6.1 a,b). Higher magnification (x500) of morula-
stage embryos (n=5) showed the punctate staining pattern of the anti-I antibody on the 
cell surface (figure 6.1 c,d). The I-antigen appeared to be relatively more abundant 
on the trophectodermal cells of blastocy st- stage embryos (n=10), than at earlier 
cleavage-stages (figure 6.1 e,f). The immunostaining of sectioned embryos 
demonstrated the expression of the I-antigen on the surface of cells of the 1CM from 
day seven and day nine blastocyst- stages (n=6) (figure 6.1 g). 	Following 
differentiation of the 1CM, the I-antigen was present on the surface of both primitive 
ectodermal and primitive endodermal cells of the so-called "embryonic disc" in the day 
11 embryo (n=2) (figure 6.1 h). The anti-I antibody also bound strongly to 
cytoplasmic components in all tissues exposed by the sectioning procedure (figure 6.1 
g,h). 
The mAb 63017H1, which recognises the X-antigen in the mouse (see table 6.2), 
did not bind to the cell surface of ovine embryos, at any of the eight developmental 
stages which were studied. Between two and five embryos or sections per embryonic 
stage were examined with 63017H1. The mAb MC2303, which recognises type I 
oligosaccharide chains (see Table 6.2), also did not bind to sheep embryos. No 
staining with MC2303 was detected at the 16-cell-stage (n=2), nor on day nine hatched 
blastocysts (n=3) or on the trophectoderm, primitive ectoderm and primitive endoderm 
of day 11 blastodermic vesicles (n=2). 
Antigens containing type I carbohydrate chains which were modified with either 
a terminal fucose residue forming the H-antigen (detected by the mAb 667/9E9) or 
were both fucosylated and sialylated (detected by the mAb 19.9; see Tables 6.1 and 
6.2) were expressed only on the trophectoderm of blastocyst- stage embryos at 
relatively moderate levels (Table 6.3). Neither 667/9E9 nor 19.9 bound to cleavage-
stage embryos. The LNF I determinant (recognised by 667/9E9) was not detected 
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Figure 6.1: The I-antigen is expressed on the surface of all embryonic cells from 
day four to day 11 of ovine pre-implantation development. The anti-I antibodies 
bound to determinants present on blastomeres from eight-cell embryos (a,b), 
compacting morulae (c,d) and on the outer trophectoderm of day eight blastocyst-stage 
sheep embryos (e,f). Immunostaining cryosectioned embryos demonstrated the 
expression of the I-antigen on the trophectoderm and inner cell mass (1CM) of the day 
nine hatched blastocyst (g) and the trophectoderm, primitive ectoderm and primitive 
endoderm of the day 11 blastodermic vesicle (h). See the legend below illustrating the 
arrows identifying the different embryonic tissues. 
Photographs were taken using brightfield (a,c,e) or epi-fluorescence 
(b,d,f,g,h) microscopy. 
Whole embryos (a,b,c,d,e,tT) and cryosectioned embryos (g,h) 
Magnification: x250 (a,b,e,f) or x500 (c,d,g,h) 
= Trophectoderm 
= Inner Cell Mass (1CM) 
= Primitive Ectoderm 
= Primitive Endoderm 
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subsequent blastocyst, at least by day seven. Expression of the sialylated LNF II 
determinant (recognised by 19.9) was not detected on the trophectoderm until after the 
blastocyst had hatched from the zona on day nine and then, in only 20% (1/5) of the 
embryos examined at this stage (Table 6.3). With both 667/9E9 and 19.9, the mAbs 
tended to bind to the mural trophectoderm in some of the blastocysts studied (3/10 and 
1/3 of positive staining blastocysts, respectively), as illustrated for 667/9E9 in figure 
6.2a,b. Neither sialylated nor fucosylated type I carbohydrate chain determinants 
were expressed on the cells of the 1CM/primitive ectoderm or primitive endoderm 
tissues (Table 6.3). 
The mAbs AH6, HOOl and H004 have in common the recognition of the 
difucosylated Y-antigen (LNnD I) although they detect this determinant with differing 
specificity (Tables 6.2 and 6.3). These differences in specificity were demonstrated 
in the stage at which these antibodies first bound to the cell surface of sheep embryos 
(Table 6.3). The mAb AH6, which only recognises LNnD I (type II chains), did not 
bind to embryos until the 32-cell-stage and only bound weakly to some (4/15=27%) 
morulae. After the first differentiative event, AH6 bound only to the trophectoderm. 
However, AH6 bound to only half (4/8) of the day seven blastocysts examined. In 
later developmental stages, the Y-antigen was detected by AH6 on the trophectoderm 
of the majority (10/12) of eight, nine and 11 day old blastocysts and was not present 
on other embryonic tissues at these stages (Table 6.3). 
The mAb HOOl, which recognises both difucosylated type I (Lewisb antigen) 
and type II (Y-antigen) oligosaccharide chains (Tables 6.1 and 6.2) showed a similar 
staining pattern as AH6 (Table 6.3). The determinant(s) detected by HOOl were not 
expressed until the 32-cell-stage, although only one of the nine embryos examined 
stained positive at the morula-stage. After blastocyst formation, HOOl bound 
specifically to the trophectoderm in all embryos examined. 
The mAb H004, which recognises a monofucosylated structure (the H-antigen) 
in addition to the difucosylated Y-antigen (both type II chains; Tables 6.1 and 6.2), 
bound to embryos from the 12- to 16-cell-stage onwards; not being detected at earlier 
embryonic stages (Table 6.3; figure 6.3 a-d). The determinant(s) were present on all 
of the blastomeres in the majority of cleavage-stage embryos studied (16/20=80%). 
After the formation of the blastocyst, H004 binding was restricted solely to the 
trophectodermal tissue (Table 6.3; figure 6.3 g,h). In a few blastocysts (2/13), H004 
appeared to bind to determinants that were only present over the polar trophectodermal 
regions (figure 6.3 g). However, this was not the case for the majority of 
blastocysts, where H004 binding was observed as a discrete, punctate staining pattern 
over the entire surface of all trophectodermal cells in whole-mounted and 
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Figure 6.2: Expression of the H-antigen (type I chains), detected by the mAb 
667/9E9, on the mural trophectoderm of a day nine sheep blastocyst. Photographs 
were taken using brightfield (a) or epi-fluorescence (b) microscopy. 	(Mag.: x250) 
137 
Figure 6.3: The antibody H004 detects a determinant(s) with a stage- and tissue-
specific pattern of expression on the surface of embryonic cells during ovine pre-
implantation development. H004 does not bind to eight-cell embryos (a,b), but does 
label the blastomeres of 12- to 16-cell embryos (c,d). After blastocyst formation, 
H004 binds specifically to the trophectoderm in the day seven embryo (g; see the 
legend below illustrating the arrows identifying the different embryonic tissues). The 
cryosectioned embryo illustrated in (g) demonstrated a rare instance where only the 
polar trophectoderm, overlying the negative staining 1CM, reacted with H004. In the 
majority of blastocysts, H004 bound to determinants present over the entire surface of 
all trophectoderm cells in a discrete, punctate staining pattern; as exemplified in the day 
nine embryo (e,f). The primitive ectoderm and primitive endoderm tissues of the 
embryonic disc in the day 11 blastodermic vesicle did not express the antigen(s) 
recognised by H004 on the trophectoderm (h). 
Photographs were taken using brightfield (a,c,e) or epi-fluorescence 
(b,d,f,g,h) microscopy. 
Whole embryos (a,b,c,d,e,f) and cryosectioned embryos (g,h) 
Magnification: x250 (a,b,e) or x500 (c,d,f,g,h) 
= Trophectoderm 
= Inner Cell Mass (1CM) 
= Primitive Ectoderm 
= Primitive Endoderm 
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ciyosectioned embryos (figure 6.3 e,f,h). There was minimal cytoplasmic staining of 
cells with the mAb H004 in sectioned embryos (figure 6.3 h). 
There appeared to be subtle differences in the spatial pattern of antibody staining 
on the cells of the trophectoderm with the AH6, HOOl and H004 antibodies. The 
antigens detected by H004 appeared to be evenly distributed over the entire cell surface 
in a discrete punctate pattern (figure 6.3 f,h). The mAb AH6 bound to the Y-antigen 
which was expressed in a similar punctate staining pattern, but which appeared to be 
associated slightly more with the intercellular boundaries between trophectodermal 
cells than H004 (figure 6.4 a). This intercellular pattern of immunostaining was more 
noticeable with the determinants on the trophectodermal cell surface recognised by the 
mAb HOOl (figure 6.4 b). 
The expression of the B-antigen, detected by the mAb B006, was first observed 
(weakly) on the blastomeres of 16-cell-stage sheep embryos (Table 6.3 and figure 6.5 
a,b). The relative level of expression of the B-antigen, as indicated by B006 binding, 
appeared to increase as cleavage progressed, reaching a maximum on the outer 
trophectoderm of blastocyst- stage embryos (figure 6.5 c,d). The B-antigen was 
expressed on cells of the early 1CM (figure 6.5 e), however, the intensity of B006 
immunostaining decreased on cells of the 1CM from more advanced day eight and nine 
blastocyst- stages (Table 6.3). In the day 11 embryo, the B-antigen was not expressed 
on the primitive ectodermal cells while at least some cells of the primitive endodermal 
layer did appear to express this antigen very weakly (figure 6.2 f). 
In summary, of the 11 anti-carbohydrate antibodies used in this study, six 
antibodies bound to determinants which became developmentally restricted on the cell 
surface of the trophectoderm in the ovine pre-implantation embryo; although one of 
these six antibodies (13006) recognised the B-antigen which additionally appeared to be 
weakly expressed on the primitive endoderm. 
6.4 DISCUSSION 
There are a number of similarities and differences between the mouse and the 
sheep in the profile of carbohydrate antigens expressed during pre-implantation 
embryo development. With regard firstly to core carbohydrate structures, there is an 
abundance of branched poly-N-acetyl lactosamine (I-containing) chains on the cell 
surface of early ovine embryos, as in the mouse (Pennington et al., 1985). Linear 
lactosamine (i-containing) chains do not appear in the mouse until after implantation 
(Pennington et al., 1985), however, these structures are present on pre-implantation 
sheep embryos. As in murine embryogenesis (Kimber, 1990), carbohydrate chains 
of both the lactoseries and globoseries families are present at all early embryonic stages 
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Figure 6.4: The spatial patterns of antigen expression detected on the ovine 
trophectoderm in day eight and day 11 whole embryos by mAbs AH6 (a) and HOOl 
(b), respectively. The Y-antigen (detected by AI-16) is expressed in a discrete punctate 
pattern over the cell surface, but appears to be associated slightly more with 
intercellular boundaries (a). 	HOW bound to a determinant(s) expressed 
predominantly along the intercellular boundaries of trophectodermal cells (b). Note 
that in the day 11 blastodermic vesicle illustrated in panel (b), the primitive ectoderm of 
the embryonic disc (arrowed) is exteriorised, no longer having an overlying layer of 
trophectoderm, and is negative for HOOl. 








Figure 6.5: The B-antigen is expressed in a stage- and tissue-specific manner 
during ovine pre-implantation embryogenesis. The mAb B006 does not bind to sheep 
embryos until the 16-cell-stage, on day four of development (a,b). The B-antigen is 
expressed strongly on the outer trophectoderm of the day nine hatched blastocyst (c,d; 
panel d shows the upper surface of the embryo in panel c). After blastocyst 
formation, the B-antigen is expressed on the cells of both the 1CM and trophectoderm 
in the day seven embryo (e; see the legend below illustrating the arrows identifying the 
different embryonic tissues). As differentiation of the 1CM proceeds, the B-antigen is 
lost from the surface of the primitive ectodermal cells by day 11, although there is 
evidence of very weak expression on the cell surface of the primitive endoderm at this 
stage (f). The cryosectioned blastodermic vesicle shown in panel (f) collapsed during 
the embedding procedure and hence the convoluted nature of the positive staining 
trophectoderm tissue. Also note that in this embryo, the trophectodermal cells 
overlying the primitive ectoderm of the embryonic disc have sloughed off by day 11. 
Photographs were taken using brightfield (a,c) or epi-fluorescence 
(b,d,e,f) microscopy. 
Whole embryos (a,b,c,d) and cryosectioned embryos (e,f) 
Magnification: x250 (c,f) or x500 (a,b,d,e) 
= Trophectoderm 












in the sheep. The globoside-related SSEA-3 antigen did not become restricted to the 
primitive endoderm of ovine embryos, as occurs in the mouse (Shevinsky et al., 
1982; Fox et al., 1984). 
Unmodified type I lactosamine-containing chains do not appear to be present in 
either murine (Pennington et al., 1985) or ovine pre-implantation embryos (with no 
binding with the mAb MC2303). However, two antigenic determinants based on type 
I core structures, but with terminal chain modifications (detected by mAbs 667/9E9 
and 19.9) were expressed in the ewe. 	The mAb 667/9E9 identifies the 
monofucosylated, type I chain, H-antigen (LNF I; Lindenberg et al., 1988) which 
appears specifically on the trophectoderm, after the first embryonic differentiation. 
The H-antigen (in either type I or type II isomeric forms) has not been demonstrated 
on the cell surface of pre-implantation mouse embryos (Fenderson et al., 1986; 
Lindenberg et al., 1988). The sialylated LNF II type I chain determinant, recognised 
by the mAb 19.9 (Magnani et al., 1982), is first expressed at the time of compaction 
in the mouse (Kimber et al., 1991) but was not detected in the sheep until after the 
blastocyst had hatched from the zona pellucida. 
Type II lactosamine-containing chains that are terminally-modified with fucose, 
representative of the Y-antigen and the B-antigen, appear on ovine embryos in a stage-
related manner and subsequently become restricted to specific tissues. In the mouse, 
the B-antigen appears at the compacted morula-stage (Kimber, 1990). In the ewe, 
however, the B-antigen is first expressed at the 16-cell stage, which is the equivalent 
of two cleavage divisions earlier than in the mouse. The B-antigen is present on the 
murine trophectoderm (Kimber, 1990), however, it has not been reported whether the 
mAb B006 also binds to the murine 1CM. B006 did react with the early ovine 1CM. 
Thereafter, the cells of the 1CM gradually lost the B-antigen from their surfaces over, 
at most, four days following the formation of the blastocyst- stage embryo. By day 
11, the pluripotent primitive ectoderm of the blastodermic vesicle is negative for the B-
antigen, while some of the cells of the primitive endodermal layer, lining the 
blastocoelic surface of the ectoderm and, by this stage, the trophectoderm also, weakly 
express this determinant. It is known that the differentiation of the primitive 
endoderm cells, from the 1CM, can occur in some sheep embryos as early as day 
seven of development (Handyside etal., 1987; McWhir eral., 1991). The primitive 
endodermal layer may not, however, begin to proliferate rapidly and line the 
trophectoderm until day 10 (McWhir et al., 1991). The technical limitations of the 
cryosections obtained in this study from early blastocyst-stages, obscured the presence 
of primitive endodermal cells delaminated from the 1CM and thus, it was difficult to 
positively determine their antigenicity. In the results, therefore, the endoderm tissue 
from day nine hatched blastocysts has been grouped with the primitive ectoderm and 
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termed the "1CM" (see Table 6.3). Although the expression of the B-antigen on the 
primitive endodermal cells from the day nine sheep embryos is not clear, the results 
have shown that the B-antigen is lost from the cells of the primitive ectoderm around 
the time gastrulation occurs in the sheep (McWhir etal., 1991). 
The mAb AH6 specifically recognises the difucosylated Y-antigen (LNnD I; Abe 
et al., 1983). In the mouse, the Y-antigen is first expressed on the blastomeres of 
uncompacted eight-cell embryos, however, only one-third of embryos appear to stain 
with AH6 at this stage (Fenderson et al., 1986). Following compaction, the Y- 
antigen is present on the surface of all pre-implantation embryos in the mouse 
(Fenderson et al., 1986). This pattern of expression is similar to that in sheep 
embryos. The Y-antigen (detected by A116) was stage-specifically expressed just 
prior to compaction, at the 32-cell stage (but only on 27% of morulae) and did not 
become expressed on the majority of embryos until the day eight or nine blastocyst-
stage. During murine development, the Y-antigen is present on the trophoblast, 
visceral endoderm and primitive ectoderm of implanted egg cylinder-stage embryos 
(Fenderson et al., 1986). In the sheep, the pattern of tissue expression of the Y-
antigen is very different, as it is only present on the trophectoderm. The antigen 
appears to be lost from the 1CM at the point of blastocyst formation. It would be 
interesting to section compacted and cavitating morulae to observe if the Y-antigen has 
been lost from the inner group of cells determined to develop into the 1CM. It has 
been noted in the mouse that the expression of the Y-antigen, up to the blastocyst-
stage, appears to be regulated by the uterine environment (Fenderson et al., 1986; 
Kimber, 1990). Ovine cleavage-stage embryos could be cultured to examine when 
the expression of the Y-antigen is under embryonic control. 
The temporal and spatial patterns of immunostaining detected by the mAbs AH6, 
HOOl and H004 appear to be slightly different compared to each other (Table 6.3; 
figures 6.3 f and 6.4 a,b). Although all three antibodies have in common the 
recognition of the Y-antigen, the mAbs HOW and H004 each recognise one other 
determinant (see Tables 6.1 and 6.2). In addition to the Y-antigen, HOOl also 
recognises the difucosylated Lewisb, type I chain determinant; structurally classified as 
LND I (Kimber et al., 1988) and H004 is also known to recognise the 
monofucosylated (type II chain) H-antigen (LNnF I; Kimber and Lindenberg, 1990). 
The temporal staining pattern of the HOOl antibody is very similar to AH6 (Table 6.3) 
Although HOOl did not bind to compacted morulae, this may have been due to the 
small number of embryos examined at this stage. In contrast, the H004 antibody 
bound to determinant(s) possessing a different temporal pattern of expression 
compared to those detected by AH6 and 11001; with 11004 binding to the blastomeres 
of earlier cleavage-stage embryos. There were also subtle differences in the spatial 
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patterns of immunostaining, in particular the association of staining along the 
intercellular boundaries of trophectodermal cells, especially with the HOOl mAb (and 
to a lesser extent.with AH6). These differences in the pattern of immunostaining may 
have arisen as a consequence of the H004 and H001 antibodies each binding to 
another determinant, in addition to the Y-antigen (specifically recognised by AH6), or 
they may reflect the subtle differences between the three mAbs in the conformation of 
the epitope structure required for binding to occur. Subtle changes in the sugars 
adjacent to the Y-antigen may have influenced the binding specificity and account for 
the differences observed in the staining pattern between the AH6, HOOl and H004 
mAbs in ovine embryos and which has also been observed with these three antibodies 
in ES cells (Brown et al., 1991). 
The LNF III, X-antigen (SSEA-l) was not detected at any of the ovine 
embryonic stages examined. In the mouse this antigen appears at the eight-cell-stage 
(Solter and Knowles, 1978) and is thought to have a role in stabilising cell-cell 
interactions during the process of compaction (Bird and Kimber, 1984; Kimber, 
1988). None of the antibodies utilised in this studied identified antigens which stage-
specifically appeared at the onset of compaction in sheep embryos. Thus, a 
determinant with a potentially similar function to SSEA- 1 was not found. However, 
in the sheep, the Y-, B-, H- (type I) and the sialylated LNF II antigens all appeared in 
a stage-specific fashion, although only the H-antigen (type I) appeared immediately 
after a differentiation event. Furthermore, the above antigens (apart from the B-
antigen) eventually became restricted solely to the trophectoderm of blastocyst- stage 
embryos. Because of these stage- and tissue-specific patterns of expression, it is 
tempting to postulate that these carbohydrate determinants do have some 
developmental function. Although the pattern of carbohydrates on the murine 
embryonic cell surface has been well characterised, a clear understanding of their 
functional significance is lacking (reviewed by Kimber, 1990). 	The only 
embryological processes involving carbohydrate cell surface determinants which have 
been described in the mouse are blastomere compaction (with the X-antigen; Bird and 
Kimber, 1984) and implantation, involving heterophilic binding of determinants (the 
H-antigen) present on the cells of the uterine epithelium (Lindenberg et al., 1990). 
Although no antigens on the trophectoderm have yet been implicated in murine 
implantation, perhaps some of the trophectoderm-specific determinants identified here 
may have a role in the initial phases of implantation in the sheep. One approach in 
studying the role of these antigens in early embryonic development would be to culture 
cleavage-stage embryos in medium containing oligosaccharides, to observe whether 
such treatments perturb normal embryogenesis, with the sugar molecules perhaps 
binding to receptors on the cell surface. 
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In the mouse, the X-antigen has been widely used as a marker of the pluripotent 
cell lineage; being expressed on the 1CM, primordial germ cells and ES cells (Fox et 
al., 1981; Martin and Lock, 1983). None of the antibodies used in this study 
identified an antigen which was expressed specifically on the cells of the ovine 
1CM/primitive ectoderm and which could have been used as a potential lineage marker 
for isolated ovine ES cells. Even in the case of the X-antigen in the mouse, the 
determinant is also present on tissues unrelated to the pluripotent lineage (Fox et al., 
1981; Pennington et al., 1985). This is a disadvantage of using highly specific 
mAbs, as binding may occur on divergent cell surface molecules, on different cell 
types, as they may share the same small antigenic determinant (Kimber, 1990). 
Examination of pen-implantation stages would verify any lineage-related antigen 
expression. Nevertheless, in this study five anti-carbohydrate antibodies have 
recognised (at least three) different cell surface determinants present specifically on the 
trophectoderm of ovine blastocyst-stage embryos, from day seven to at least day 11. 
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CHAPTER 7 
EMBRYONIC STEM CELLS IN THE SHEEP 
7.1 INTRODUCTION 
Techniques for the isolation and genetic manipulation of ES cells from mouse 
embryos are now well established (Robertson, 1987; 1991). Because of the interest 
in extending the stem cell technology to other species of commercial value, some effort 
has recently been invested from a number of laboratories in attempts to isolate, into 
culture, embryonic cells possessing a similar developmental potential as murine ES 
cells from the major farm animal species (see chapter 1.6). Such stem cells would 
have a major impact on both the livestock industry, opening the way to modifying 
traits of economic importance, and allowing more fundamental studies on early 
developmental biology in farm animals. 
With specific regard to the ewe, the isolation of only one sheep cell line with a 
morphology similar to that of murine ES cells has been reported to date, utilising 
feeder cells, media and general culture techniques similar to those employed for the 
mouse (Notarianni et al., 1990a; 1991). However, it has not yet been reported 
whether these sheep cells have the potential to form chimaeras. Other laboratories 
using similar methods have not been able to maintain colonies, derived from ovine 
embryos and possessing an ES-like cell morphology (so-called since the pluripotency 
of this cell type has not been demonstrated) for more than three passages in culture, 
before the cells either die or differentiate (Handyside et al., 1987; McWhir et al., 
1991; Piedrahita etal., 1990b). 
The difficulties experienced in isolating stem cells in the sheep may be attributed 
to two characteristic differences in the pre-implantation embryology between the ovine 
and murine species. Firstly, the 1CM in the ovine embryo is less mitotically active 
than in the mouse and this is reflected in the slow rates of cell division in sheep 
embryo cultures (McWhir et al., 1991). Secondly, primitive endoderm differentiation 
from the ovine 1CM commences soon after blastocyst formation on day seven, which 
is at a relatively earlier developmental stage than the equivalent in the mouse (Gardner 
and Beddington, 1988; Handyside et al., 1987; McWhir et al., 1991). The presence 
of endoderm may induce further differentiation of 1CM cells in culture (Robertson, 
1987) and account for the morphological instability of the undifferentiated ovine cell 
phenotype in vitro (Piedrahita et al., 1990b; McWhir et al., 1991). While it may 
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appear logical initially to dissect from the embryo pure populations of undifferentiated 
cells for culture, the immunosurgical isolation of ovine ICMs, free from trophectoderm 
and endoderm, has not given rise to progressively growing cultures of stem cells 
(Notarianni et al., 1991). However, in the mouse it has been possible to derive ES 
cell lines from isolated ICMs (Martin, 1981; Axelrod and Lader, 1983) or primitive 
ectoderm cells isolated from the post-implantation egg cylinder-stage embryo (see 
chapter four). Histology has shown the greatest population of undifferentiated cells to 
be present in the gastrulating day nine to day 10 sheep embryo; a finding which 
correlated with the observation that ES-like outgrowths were derived at the highest 
frequencies from these stages (McWhir et al., 1991). So the choice of embryo stage 
from which to isolate ovine ES cells may be a compromise between the absolute 
number of 1CM/primitive ectodermal cells present and the extent of differentiation. 
The one sheep ES-like cell line which has been isolated was derived from an 
outgrowth of an intact day eight embryo (Notarianni et al., 1990a) in which the 
presence of primitive endoderm on the blastocoelic surface of the 1CM would have 
been expected (Handyside et al., 1987). 
In the studies reported in this chapter, embryos from a number of developmental 
stages, with differing levels of primitive endoderm differentiation, were cultured to 
determine which gave rise to ES-like colonies at the highest frequency. Embryos 
from these different developmental stages were cultured in media containing a range of 
serum concentrations, which may influence cellular differentiation in vitro. A serum 
substitute (Ultroser; Life Technologies) was used in two media formulations to 
examine the effects on the adhesive properties of embryonic cells. One medium 
formulation contained the growth factors insulin, which has been shown to 
preferentially increase the proportion of 1CM cells in mouse blastocysts (Harvey and 
Kaye, 1990) and platelet derived growth factor, added in an attempt to stimulate 
proliferation of the quiescent ovine 1CM/embryonic disc. Ovine embryos were also 
exposed to heat shock and puromycin treatments, which have been shown to increase 
the efficiency of ES cell isolation in the mouse (see chapter five). 
Cells referred to in this chapter as "ES-like" are defined as those having a high 
nuclear to cytoplasmic ratio, one of more prominent nucleoli, a relatively small cell 
size, rounded and possessing no overtly specialised cellular structures. That is, 
characteristics of a typically undifferentiated cell morphology, as has been described 
for murine ES cells (Evans and Kaufman, 1981; Martin, 198 1) and porcine and ovine 
ES-like cells (Notarianni et al., 1990a). Classifying colonies as ES-like, is not meant 
to imply that the cells are pluripotent. 
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7.2 EXPERIMENTAL METHODS 
Ovine embryos for ES cell culture were obtained from three breed combinations; 
Welsh X Welsh, Welsh X Scottish Blackface and Scottish Blackface X Scottish 
Blackface. Standard tissue-culture procedures were employed as described in chapter 
two. The specific treatments examined and the techniques for the culture of ovine 
embryos from different developmental stages are detailed below. 
7.2.1 Stage of Embryo Development 
Embryos were recovered from the reproductive tracts of donor ewes on 
days six, seven, eight and nine (day 0 is the day of onset of oestrus). The procedures 
for superovulation, artificial insemination and embryo collection from ewes were the 
same as those described in chapter six (sections 6.2.1 and 6.2.2). 
7.2.2 Media Formulation 
Ovine embryos were cultured in one of six different media 
formulations. Media were the same as that employed for mouse ES cell isolation (see 
chapter two, Table 2. 1), except that different serum concentrations and growth factor 
additions were used. The base media (to which sera and growth factors were added) 
consisted of Dulbecco's Modification of Eagle's Medium (without sodium pyruvate; 
Life Technologies) supplemented with 1% (v/v) L-glutamine (Flow Laboratories), 1% 
(v/v) of a 100X stock of non-essential amino acids (Flow Laboratories), 0.1mM B-
mercaptoethanol (Sigma), with 13% (v/v) Analar water (BDH) added to reduce the 
osmolarity to around 290m0s. Media did not contain murine or human recombinant 
DIA/LIF. Hereafter, this base medium shall be referred to as "ES" medium. For 
sheep ES cell cultures, the sera used were from the same batches of newborn and 
foetal calf serum as utilised for mouse ES cell cultures. Serum was heated at 56°C for 
30 minutes, prior to use, to inactivate the serum complement. In three media 
formulations, serum was added to give final (v/v) concentrations of 10% (1:1, 
NCS:FCS; ES10), 15% (1:2, NCS:FCS; ES15) or 20% (1:1, NCS:FCS; ES20) serum. 
The serum substitute "Ultroser" (Life Technologies) was used in two 
media formulations. The lyophilised powder was reconstituted in Analar water to the 
appropriate volume and was added to ES-medium to give a 4% (v/v) final 
concentration. In one formulation, the Ultroser was used to completely replace the 
bovine serum (ESus) and in the second, the medium was supplemented with 5% (v/v) 
FCS (ESus+Fcs). In the sixth medium formulation (ESI5+pDGF+I), ES15 was 
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supplemented with 20ng/ml of platelet-derived growth factor (PDGF; gift of Dr S. 
Butterwith, Department of Cellular and Molecular Biology, IAPGR, Roslin) and 
lOng/mi of bovine insulin (Sigma). 
7.2.3 Heat Shock and Puromycin Treatments 
Some day seven to day nine blastocyst- stage embryos were briefly 
exposed to either an increase in temperature, or to medium containing the antibiotic 
puromycin, just prior to culture. Ovine embryos were heat shocked for 10 minutes at 
either 41°C, 42°C, or 43°C; performed as described for the mouse (chapter 5.2.1). 
For the puromycin treatments, ovine embryos were incubated for 45 minutes in 
medium containing either 25pg/mi or 75p.g/mi of puromycin dihydrochioride (Sigma) 
(see chapter 5.2.3). Heat shocked and puromycin-treated embryos were subsequently 
cultured in ES 15  medium. 
7.2.4 Culture of Ovine Embryos for Embryonic Stem Cell Isolation 
Sheep embryos were cultured at 38.5°C in a 5% CO2 in air, humidified 
atmosphere. Embryos were explanted in groups of between two and six onto 
mitotically inactivated STO feeder cell layers, prepared in four-well tissue-culture 
plates (Nunc, Life Technologies) as described previously (chapter 2.1.3). Outgrowths 
were individually picked out of these group-cultures once they had reached an 
(empirically determined) suitable stage and gently disaggregated. All the cellular 
pieces from one embryonic outgrowth were then explanted into a freshly prepared 
feeder well. 
The methods of culture were varied for the different stages of embryo 
development. Day six morula-stage embryos were disaggregated into individual 
biastomeres before culture. Zonae pellucidae were removed with an enzymatic 
solution comprising 0.5% (w/v) pronase (grade B; Calbiochem) and 0.5% (w/v) 
polyvinylpyrrolidone (Mr 10 000; Sigma) in HEPES buffered "M2" medium (Hogan 
et al., 1986b). The zona-free morulae were then incubated at 37°C in Ca2 and Mg2 
free phosphate buffered saline containing 0.3% (w/v) EDTA (Eistetter, 1989) for three 
minutes. Dissociation of the biastomeres was completed mechanically utilising a 
finely pulled Pasteur pipette, with a flame polished tip. All of the cells from each 
embryo were explanted together into one feeder well. 
In some day seven and day eight blastocyst- stage embryos, the ICMs 
were immunosurgically isolated (Solter and Knowles, 1975). Two anti-sera were 
utilised to bind to the trophectoderm: the human anti-I polyclonal auto-antibodies 
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(known to bind to sheep embryos, see chapter six; gift of Dr. S.J. Kimber, 
Department of Cell and Structural Biology, University of Manchester) and heat-
inactivated bovine J104 anti-serum (gift of Dr. R.L. Spooner, Department of 
Immunogenetics, IAPGR, Roslin). J104 is an allogenic anti-serum raised in a cow 
by a skin graft from its calf and found to be active against sheep lymphocytes (Dr. 
R.L. Spooner, pers. comm.). After an initial 30 minute incubation in either of these 
two anti-sera (diluted to 1:10) the embryos were washed and then incubated in a 1:5 
dilution of guinea pig serum (Sigma) for 45 minutes. Embryos were then gently 
aspirated repeatedly within a finely pulled Pasteur pipette, to remove the lysed 
trophectodermal cells. However, since immunosurgery in neither anti-sera was 
reliable in isolating the 1CM, the majority of day seven and eight embryos were 
cultured intact, but after the zona had been removed with pronase digestion (in those 
embryos that had not already hatched from the zona). 
It has been noted that the majority of intact blastocyst- stage embryos 
attach to the STO feeder layer by the polar trophectoderm (here and McWhir et al., 
1991). Shortly after intact day seven and eight blastocysts had firmly attached to the 
STO feeders, it was sometimes possible to "peel" away the trophectoderm (which in 
the process of embryo outgrowth collapsed before growing outwards radially) using 
sterile watchmakers forceps. This trophectoderm peeling procedure (McWhir et al., 
1991) sometimes left the 1CM intact and attached to the culture surface, but without 
any surrounding trophectoderm. After this operation, a small volume of freshly 
inactivated STO feeders were added into the well to replace the cells removed from 
around the 1CM. 
In day nine hatched blastocysts, the embryonic disc (as by convention 
the ovine 1CM is termed from this stage onwards; McWhir et al., 199 1) was generally 
large enough to be dissected mechanically. Working within a still-air cabinet, 	in 
the dissecting microscope (magnification c.a. x50), two sterile watchmakers forceps 
were carefully used to tear away the trophectoderm from around the embryonic disc. 
With practice, very little trophectoderm remained attached to the embryonic disc after 
the operation. In the case of day nine embryos which were heat shocked, micro-
dissection was performed after the hyperthermia treatment. 
Although embryos were group-cultured, each outgrowth (derived from 
either a single blastomere, an intact blastocyst, an immunosurgically isolated or micro-
dissected 1CM/embryonic disc) was treated individually in decisions regarding when 
and how to disaggregate the ES-like component. 	Outgrowths were either 
disaggregated mechanically or enzymatically. Some outgrowths which grew initially 
as a monolayer of cells were broken-up mechanically with the aid of a blunt glass 
probe, constructed from a hand-pulled Pasteur pipette. It was possible to score the 
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probe across the outgrowth of ES-like cells a number of times to produce several 
cellular clumps, which were then transferred to a fresh feeder well. Other 
outgrowths, which instead grew in more upright, three-dimensional colonies, were 
disaggregated enzymatically in one of three trypsin-based solutions. 	Some 
outgrowths were disaggregated in "TEG" (see chapter two, Table 2.2a), however, the 
majority were disaggregated in a solution designated here as "TED" (Robertson, 
1987), or TED with 1% (v/v) chick serum (Sigma) added (Smith and Hooper, 1987). 
TED is comprised of the same basic salts solution as in TEG (chapter two, Table 2.2a) 
but contains EDTA (ethylenediamine-tetraacetic acid) instead of EGTA 
(ethyleneglycol-tetraacetic acid), an alternative source of trypsin (1:250 Difco trypsin; 
Difco Laboratories; rather than a IN stock containing 2.5% trypsin in Hank's 
Balanced Salts Solution, Flow Laboratories) and does not contain polyvinyl alcohol. 
TEG and TED contain the same concentrations of trypsin (0.25%) and chelating agent 
(0.04%). 
For enzymatic disaggregations, each outgrowth was picked off from 
the STOs and was transferred through two wash drops of TEG/TED, to remove traces 
of serum, before incubation in a fresh drop of TEG/TED. With TEG, outgrowths 
were incubated at 37°C for around five minutes before each outgrowth was finally 
broken into several cellular pieces (each around 15 cells) by repeatedly aspirating the 
outgrowth inside a fine, hand-pulled Pasteur pipette. The cells were then passaged 
into a fresh feeder well. With TED (± chick serum), outgrowths were incubated at 
room temperature for three to five minutes and disaggregation was completed with 
gentle mechanical manipulation as described above. 
The majority of colonies in the first passage cultures were often of a 
differentiated cell morphology. If these differentiated colonies threatened to overgrow 
any small, slowly growing ES-like colonies in the same tissue-culture well, the ES-
like colonies, if large enough, were generally picked off the feeders carefully and 
transferred intact into a fresh feeder well. Alternatively, the differentiated colonies 
were sometimes removed from the well by peeling them from the gelatin coated tissue-
culture surface with a pair of sterile forceps and replacing them with freshly prepared 
STO feeder cells. 
First passage ES-like colonies were generally disaggregated after seven 
to 10 days of growth, changing the medium regularly throughout this period before it 
became acidic. Typically, all ES-like colonies derived from an individual embryo 
were pooled together. The medium in the well was aspirated, the cells washed in 
PBS (chapter two, Table 2.2b) and then 0.25m1 of TEG/TED (± chick serum) was 
added. Cells were trypsinised at room temperature for three minutes and in the 
dissecting microscope, a mouth-controlled, finely pulled Pasteur pipette (backfilled 
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with a small volume of medium) was used to aspirate the ES-like colonies out of the 
well, just as they began to dissociate from the underlying STOs (leaving behind any 
differentiated colonies in the process). The aim was to disaggregate these colonies 
into small clumps of between six to 10 cells. These cellular pieces were then 
transferred to a fresh feeder well. ES-like cells which survived the trypsinisation 
procedure and maintained a stable morphology, were generally passaged onto fresh 
STO feeder wells every seven to 10 days thereafter. 
7.2.5 	Statistical Analyses 
Statistical analyses of the differences between treatments, in the 
proportions of embryos giving rise to ES-like outgrowths and colonies at each 
successive passage, was accomplished utilising the chi-squared test (see chapter 2.6 
for the mathematical formulae). 
7.3 RESULTS 
A total of 247 sheep embryos were cultured in studies aimed towards isolating 
permanent cell lines of ES-like morphology. However, no colonies of ES-like cells 
were maintained in culture for more than three passages. As there were no differences 
in the frequency of isolation of ES-like cells from sheep embryos of different 
genotypes (Welsh X Welsh, Welsh X Scottish Blackface or Scottish Blackface X 
Scottish Blackface) the data from the three breed combinations have been combined. 
The results of the effects of stage of embryo development, media formulation, heat 
shock and puromycin treatments are presented as survival profiles of the percentage of 
embryos yielding ES-like cell colonies at each passage in culture. Only embryo 
outgrowths or colonies which maintained a stable ES-like morphology throughout 
each passage were included in the data. 
7.3.1 The Effect of Stage of Embryo Development on the Isolation of 
Ovine ES-like Cells 
The survival profiles of ES-like colonies derived from individual sheep 
embryos from the four stages of development are plotted in figure 7.1. The graph 
shows the progressive decline in the proportion of embryos explanted (from all stages) 
giving rise firstly to ES-like outgrowths and then to the survival and growth of ES-like 
cells after each successive passage in culture. ES-like colonies derived from day nine 
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Figure 7.1: The survival profiles showing the effect of stage of embryo 
development on the percentage of ovine embryos giving rise to ES-like outgrowths 
and colonies after repeated passage in culture. 
(mean ± s.e.m.; e = embryos; n = replicates) 
a P<0.025 cf. day seven and P<0.001 cf day eight 
b P<0.005 cf. day seven and P<0.001 cf. day eight 
passages, before they either differentiated or senesced. The data presented in figure 
7.1 have been compiled from all embryo treatments in the studies conducted here, as 
no interactions existed between media, heat shock or puromycin treatments and 
embryo stage. Day nine embryos consistently gave rise to more ES-like outgrowths 
and early passage colonies, which tended to maintain an ES-like morphology longer in 
culture than earlier embryonic stages (figure 7.1). Of the day seven and eight 
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embryos that were cultured, the 1CM was immunosurgically isolated from only around 
15% of the blastocysts and because the potential of day seven and eight ICMs and 
intact blastocysts to give rise to ES-like colonies were not significantly different, the 
respective 1CM and intact blastocyst data have been combined for these two stages. 
Day nine embryonic discs gave rise to a significantly greater proportion 
of ES-like outgrowths (70/92=76.1 ± 2.8%) compared to day seven (44/78=56.4 ± 
5.1%; P<0.025) and day eight embryos (34f72=47.2 ± 2.2%; P<0.001) (figure 7.1). 
Some of the blastomeres from two of the five day six morulae that were disaggregated 
attached to the STO feeder layer and divided, to produce small ES-like colonies. The 
majority of single blastomeres which did attach, however, gave rise instead to 
trophoblast-like outgrowths. 
Day nine micro-dissected embryonic discs and day seven and eight 
immunosurgically isolated ICMs attached to the STO feeder layer after about 24 hours. 
Intact blastocysts (with the zona removed) were slower to attach, not beginning to 
outgrow until two to four days after explantation. A substantial proportion of intact 
blastocysts failed to attach at all and this loss contributed to the difference in the 
proportion of ES-like outgrowths between day seven and day eight embryos, 
compared to day nine embryos. 
In addition to the higher rates of attachment, day nine embryonic discs 
also tended to give rise to a higher proportion of outgrowths with an ES-like 
morphology than earlier embryonic stages. Many intact blastocysts which did attach, 
failed to produce outgrowths from the 1CM and only differentiated cell types were 
observed. 	Many blastocysts simply collapsed upon attachment, with the 
trophectoderm not growing outwards to expose the 1CM and trophectodermal peeling 
was required to reveal the 1CM component. Although immunosurgically isolated 
ICMs from day seven and eight embryos readily attached, few of these small cellular 
masses resulted in proliferating outgrowths. Most larger day nine embryonic discs 
gave rise to monolayer outgrowths of cells with a typical ES-like cell morphology, 
although the cells appeared large (figure 7.2 a). Other embryonic discs resulted in 
outgrowths comprised of tightly packed "nests" of cells which tended to grow in three-
dimensions, without any obvious signs of differentiation (figure 7.2 b). 
Cultures were monitored daily and outgrowths derived from day nine 
embryonic discs with an ES-like morphology were passaged over a four to 10 day 
interval after explantation. Outgrowths containing different numbers of cells were 
disaggregrated systematically over this period. Outgrowths containing less than 
around 50 cells were not passaged; however, outgrowths were disaggregated before 
they had begun to differentiate extensively. Within this range, there did not appear to 
be a consistent correlation between the cell number of the outgrowth and the 
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Figure 7.2: Morphology of ovine ES-like cells cultured on STO feeder layers. 
Panels (a) and (b) show outgrowths of ES-like cells (see arrows) derived from 
dissected day nine embryonic discs after four days of culture. Most embryonic discs 
gave rise to monolayer outgrowths of ES-like cell morphology (a). Although 
individual cells were relatively large and there were intercellular spaces between the 
cells of the outgrowth, each cell did possess a high nuclear to cytoplasmic ratio and 
one or more prominent nucleoli (a). Other day nine embryonic discs gave rise to 
outgrowths which grew as tight "nests" of cells, with clear clonal boundaries (b). 
After two passages in culture, discrete colonies of ES-like cells were observed in 
cultures derived from a small proportion of day nine sheep embryos (c). 











subsequent development of ES-like colonies at the first passage. Monolayer 
outgrowths were generally disaggregated mechanically, while the more three-
dimensional outgrowths were disaggregated enzymatically. Outgrowths derived from 
day seven and day eight intact blastocysts were generally disaggregated seven to 12 
days after explantation; with initial culture being extended slightly due to the delay in 
embryo attachment to the STO feeder cells. Any outgrowths from which only 
differentiated cell types had been observed throughout the culture period (which were 
not included in the data in figure 7.1), were also disaggregated after about 10 days. 
No discrete colonies of ES-like morphology resulted in the first passage cultures 
derived from these outgrowths. 
There appeared to be a direct relationship between the proportion of ES-
like outgrowths and the proportion of embryos giving rise to first passage ES-like 
colonies (figure 7.1). The disaggregation of day nine outgrowths resulted in a 
significantly higher proportion of ES-like colonies at the first passage (31/92=33.7 ± 
9.3%) compared to either day seven (9/78=11.5 ± 6.1%; Pcz0.005) or day eight 
embryonic outgrowths (7/72=9.7 ± 5.5%; Pcz0.001). No ES-like colonies resulted 
from disaggregated outgrowths derived from individual day six blastomeres (figure 
7.1). 
The losses in the proportion of ES-like cells in the transition from 
embryo outgrowth to the first passage were largely due to differentiation. Many 
disaggregated outgrowths only gave rise to differentiated cell types or alternatively, 
colonies which were initially ES-like gradually altered their cell morphology over 
several days (only colonies which maintained a stable ES-like morphology throughout 
each passage in culture were included in the data). Some additional losses of ES-like 
outgrowths were due to the failure of any of the cells from a particular outgrowth to 
survive the trypsinisation protocol, regardless of whether chick serum was present in 
the trypsin solution. (At least some cells survived to the first passage from all 
outgrowths disaggregated mechanically). TED was more effective than TEG in 
disaggregating outgrowths. The Difco trypsin in the TED solution appeared to be 
more biologically active in dissociating the embryonic cells. Furthermore, incubations 
in TED were able to be performed at room temperature and additionally, required a 
substantially shorter period than TEG to cause the desired extent of cellular 
dissociation before serum-containing medium was added and disaggregation 
completed mechanically. 
At the second passage, there were no longer any differences between 
the day seven, eight and nine blastocyst- stage embryos in the proportions giving rise 
to ES-like colonies (1.3 ± 1.0%, 2.8 ± 1.1% and 3.3 ± 2.5%, respectively; figure 
7.1). Some of the colonies present at the second passage possessed a classical ES- 
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like cell morphology (figure 7.2 c). However, only ES-like colonies derived from 
day nine embryos survived to the third passage (3.3 ± 2.5%), but could not be 
maintained any longer in culture (figure 7.1). Colonies derived from day nine 
embryos appeared to show relatively faster rates of cell division initially and for a more 
prolonged period, than earlier embryonic stages. The ES-like colonies derived from 
day nine embryos eventually behaved in a similar fashion to those of earlier embryo 
stages, however and reached a point were cell division began to slow down markedly 
(occurring around the third passage), resulting in poor cell survival after 
trypsinisation. The ES-like cells also began to senesce around this time, with any 
surviving cells having differentiated by the fourth passage. 
A common pathway of differentiation of early ES-like colonies was to a 
more epithelial-like morphology. This change in cell morphology is illustrated in 
figure 7.3 a-c; where the cells of an ES-like first passage colony (a) appeared to 
rapidly enlarge in size 12 hours later (b) and had differentiated into large, cuboidally-
shaped cells possessing large intercellular spaces after the second passage (c). These 
epithelial-like cells tended to grow directly on the gelatin-coated tissue-culture plastic 
surface, pushing the STO cells to the periphery of the colony (figure 7.3 c). A 
number of epithelial-like colonies derived from day nine embryos were expanded and 
maintained as cell lines for at least 10 passages in a variety of different media, without 
STO feeder cells; that is, with the cells growing directly on the gelatin. The one 
epithelial-like cell line that was examined, could not be induced to differentiate in vitro 
in suspension culture. 
Other cell types commonly observed in embryo cultures included 
trophoblast-, endoderm-, fibroblast- and neuronal-like cells. A number of sheep 
fibroblast-like cell lines, derived from day seven and nine embryos, have also been 
isolated and maintained without feeder cells. Some cell lines are stable, at least up to 
the tenth passage, however, other fibroblast-like cell lines gradually differentiated over 
several passages into more cuboidally-shaped cells. 
7.3.2 The Effect of Media Formulation on the Isolation of Ovine ES-
like Cells 
Some day seven, eight and nine blastocyst- stage embryos and the 
respective cell colonies derived from them, were cultured in a variety of media; to 
examine the effects of different serum concentrations, a serum substitute (Ultroser) 
and, growth factors, on the capacity of embryos to give rise to ES-like colonies and 
their subsequent maintenance in vitro. The results are presented in figure 7.4 as 
survival profiles showing the proportion of day seven, eight and nine embryos 
157 
Figure 7.3: Morphological instability of the ovine ES-like cell phenotype. The cells 
of a small first passage ES-like colony (arrow in panel a) began to enlarge markedly in 
size 12 hours later (b). When this colony was subsequently disaggregated, the cells 
differentiated into cuboidally- shaped epithelial-like cells at the second passage (c). 
These epithelial-like colonies tended to grow directly on the gelatin-coated growth 
surface, pushing the STO feeder cells to the periphery of the colony (arrow in panel c). 
Photographs were taken using phase contrast microscopy. 
Magnification: (a,b) x200 or (c) xlOO 
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yielding ES-like colonies at each passage in different media formulations. There were 
no interactions between media and embryo stage of development and approximately 
equal proportions of embryos from each of the three blastocyst- stages were explanted 
into each of the media formulations. 
The only significant difference between the six media formulations was 
in the greater proportion of embryos giving rise to ES-like outgrowths in ESus 
medium (16/24=66.7 ± 14.2%) than in ES20 medium (117=14.3 ± 11.9%; P<0.005). 
This was due largely to the observation that embryo attachment appeared to be 
increased in the ESus medium. Despite the high occurrence of ES-like outgrowths in 
ESus medium, first passage colonies were morphologically unstable and all colonies 
rapidly differentiated (figure 7.4) Although ESus medium was unable to support 
ES-like colonies, this medium was adequate for the establishment of epithelial-like cell 
lines. Apart from ES20 and ESus media, there were no significant differences 
between other media formulations in capacity to (temporarily) support the growth of 
ovine ES-like cells. However, the only media formulations which supported ES-like 
colonies to the third passage were ESUS+FCS and ES15+pDGF+I media (1/18=5.6 ± 
2.3% and 2/48=4.2 ± 3.2%, respectively; figure 7.4). All of these third passage 
colonies were derived from day nine embryonic discs (see section 7.3.1). 
7.3.3 The Effect of Heat Shock and Puromycin Treatments on the 
Isolation of Ovine ES-like Cells 
The survival profiles of ES-like colonies derived from ovine embryos 
which had been either heat shocked or incubated briefly in medium containing 
puromycin, are compared to control embryos (cultured in ES15; data from section 
7.3.2) in figure 7.5. The results have been collated from ES-like outgrowths and 
colonies derived from day seven, eight and nine blastocyst- stage embryos exposed to 
any one of the three heat shock temperatures (41, 42, or 43°C) or, either of the two 
puromycin medium concentrations (25 or 75 jig/ml). No interactions were observed 
between embryo stage of development and heat shock temperature or puromycin 
concentration. Approximately equal proportions of embryos from each of the three 
blastocyst-stages were explanted into each of the treatment groups. 
Although there appeared to be a trend for a slight increase in the 
proportion of embryos giving rise to ES-like outgrowths with both heat shock (45/69= 
65.2 ± 6.9%) and puromycin (12/16=75 ± 0%) compared to control (day seven to day 
nine) embryos (23/51=45.1 ± 5.8%; P>0.05) there were no differences in the 
proportion of embryos yielding ES-like colonies at the first passage (figure 7.5). ES-
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—0--Heat Shock (e=69; n=9) 
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cultured in ES 15  media, like colonies derived from control embryos, did not maintain a 
stable ES-like cell morphology for more than two passages in vitro, regardless of the 
stage of embryo development (figure 7.5). However, cultures derived from heat 
shocked embryos comprising epithelial-like cells have been maintained for at least 
10 passages. 
embryos outgrowths 	1 	2 	3 	4 
number of passages 
Figure 7.5: The survival profiles showing the effect of heat shock and puromycin 
treatments on the percentage of ovine embryos giving rise to ES-like outgrowths and 
colonies after repeated passage in culture. 
(mean ± s.e.m.; e = embryos; n = replicates; P>0.05) 
7.4 DISCUSSION 
Cells possessing an ES-like morphology, similar to that described by Notarianni 
and colleagues (1990a), were observed here in cultures derived from day seven to nine 
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sheep embryos, however, they could not be maintained for more than a maximum of 
three passages (approximately four weeks) in vitro. These ovine ES-like cells also 
showed characteristic slow cellular growth and the cells either eventually senesced or 
were morphologically unstable and progressively differentiated, typically into an 
enlarged cell phenotype. These findings are similar to those observed elsewhere for 
the sheep (McWhir et al., 1991; Piedrahita et al., 1990b). 
Comparing the culture techniques utilised in this study to those that have been 
employed successfully to isolate and stably maintain an ovine ES-like cell line 
(Notarianni et al., 1990a; 1991) it is not obvious which factors may be critical in the 
establishment of permanent cultures of ovine stem cells. This discussion compares 
the culture system used here to those that have been described elsewhere. Five 
particular factors are known to be different and will be discussed in turn: namely, the 
effects of incubator temperature, media, feeder cell layers, stage of embryo 
development and method of culture. 
Porcine and ovine ES-like cells have successfully been isolated and maintained 
in Vitro at 37°C (Dr E. Notarianni, pers. comm.). Here, ovine embryos were cultured 
at 38.5°C which was closer to the normal body temperature of the ewe (39°C; Altman 
and Dittmer, 1968). The incubator temperature employed in these studies was a 
compromise, as cattle embryos were being cultured over the same period (Dr. J. 
McWhir and D.N. Wells, unpublished results) and the cow has a slightly lower body 
temperature (38.5°C; Altman and Dittmer, 1968). In our laboratory at IAPGR, there 
does not appear to be any difference in the survival of ES-like colonies derived from 
ovine embryos cultured at either 37°C (McWhir etal., 199 1) or 38.5°C (here). 
The medium utilised by Notarianni and colleagues (1990a) was similar to the 
ES 15  formulation used in these studies, however, in their medium the osmolarity was 
not reduced and would have been approximately 335m0s (see chapter 2.1.2). 
Although preliminary findings suggest no difference in murine ES cell isolation with 
varying media osmolarity (Wells, results not presented) the use of 290m0s medium 
resulted in superior plating efficiency with an established murine ES cell line (McWhir, 
pers. comm.). It is appreciated that substantial differences exist between different 
batches of sera in their capacity to support the proliferation of stem cells (Robertson, 
1987). While the sera used in this study were selected for the growth of murine ES 
cells, the same sera may not necessarily be suitable for the isolation of stem cells from 
other species. However, the batches of NCS and FCS used in these studies have 
maintained the ovine ES-like line isolated by Elena Notarianni (Dr. J. McWhir, pers. 
comm.) while the serum used by Notarianni has not been successful in extending the 
culture of ovine ES-like cells beyond the third passage in our laboratory at IAPGR 
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(McWhir et al., 1991). This suggests that other factors in the culture system are 
important. 
In the studies here, only ESUS+FCS and ES15+pDGF+I were capable of 
maintaining ES-like colonies to the third passage. Embryo attachment was poor in 
ES20 medium, possibly due to the high serum content (Betteridge and Flechon, 1988). 
Interestingly, attachment was promoted in medium containing 4% Ultroser (ESus) 
which at this concentration is equivalent to 20% FCS (Product Information; Life 
Technologies). However, Ultroser may not have many large molecular weight 
proteins; thus, making the embryos more adhesive in ESUS than in high serum- 
containing medium. Despite the high rates of attachment and embryo outgrowth, 
ESus medium was not able to maintain colonies with an ES-like cell morphology 
without differentiation. It may be appropriate to promote embryo attachment in ESUS  
medium before transfer to other medium more suited to the growth of ES-like cells. 
ESus medium was, however, satisfactory for the growth of epithelial-like colonies. 
The survival profiles of ES-like colonies derived from embryos grown in serum- 
containing media were very similar, except for medium containing 20% serum where 
embryo attachment was poor and differentiation was promoted. The significant 
effects of varying media composition upon embryo attachment and outgrowth confirm 
that this is an important area for further investigation. 
While the addition of exogenous growth factors has not been necessary for the 
establishment of ovine and porcine ES-like cell lines (Notarianni et al., 1990a), such 
factors may still have some beneficial effects. ES15 medium containing PDGF and 
insulin supported the growth of ES-like colonies for longer, than just ES15 medium. 
The addition of murine recombinant DIA/LIF to medium has been observed to increase 
the frequency of ovine ES-like colonies at the first passage, however, DIA/LIF was 
not capable of preventing the subsequent differentiation of these colonies (McWhir et 
al., 1991). There may be a species specific requirement for this anti-differentiation 
factor. The ovine DIA/LIF gene has apparently been cloned and sequenced (Gough 
et al., 1989), however, it has not been reported whether the recombinant DIA/LIF 
factor has been produced in vitro. It may be useful to include ovine DIA/LIF in the 
medium. In order to be able to isolate stem cells from the sheep, it may be necessary 
to consider experiments in which embryos (or ICMs) are cultured in medium with 
different concentrations of serum, supplemented with a variety of growth factors each 
at several different concentrations. 
The choice of feeder cells in the co-culture system may have an important 
influence on the capacity to derive stem cells. The roles of the feeder layer may be in 
providing a suitable substrate for cell attachment and in producing diffusible and/or 
extra-cellular matrix-associated growth and/or anti-differentiation factors (Martin and 
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Evans, 1975; Rathjen et al., 1990b). In a comprehensive study on the effect of 
several feeder cell types, porcine ES-like cells could only be established on feeder cell 
layers prepared from the STO mouse fibroblast cell line (Piedrahita et al., 1990a). In 
the sheep, however, it was reported by the same group that colonies with an ES-like 
morphology were transiently observed only with ovine embryonic fibroblast cell 
feeders and not with STO cells (Piedrahita et al., 1990b). However, STO feeder cell 
layers (which were employed in these studies) have been utilised successfully in the 
isolation of an ovine ES-like cell line (Notarianni et al., 1990a). 
In the studies reported here, the zona pellucida was removed from early 
blastocyst-stage embryos because it had been observed initially that many embryos 
failed to hatch from the zona or, at best, embryo hatching was a prolonged process, in 
the STO co-culture system. This prolonged hatching phase, combined with the 
prolonged period before attachment to the feeder cells with intact blastocysts, often 
appeared to result in the degeneration of the 1CM. Compared to STOs, porcine 
uterine epithelial cell feeder layers have been shown to promote embryo development 
and hatching in the pig, however, unlike the STO cells, the uterine epithelial cells were 
not satisfactory for embryo attachment (Piedrahita et al., 1990a). 
It seems unlikely that any of these three factors (incubator temperature, media, or 
feeder cell layers) accounts for the failure to isolate ES-like cells from the sheep in the 
studies described here, compared to other workers (Notarianni et al., 1990a; 1991). 
Other factors which may be important are embryo stage of development and 
interactions between embryos in culture. 
The differences between the four embryo stages examined here, in the 
proportions of embryos giving rise to ES-like outgrowths and then to first passage 
colonies, were possibly due more to differences in the way the embryos were treated 
before culture, rather than actual embryo stage differences. In day nine embryos, the 
embryonic discs were dissected away from the trophectoderm before being explanted 
in vitro. In day seven and eight blastocysts, the 1CM was too small to be manually 
dissected and immunosurgery was generally unsuccessful with the J104 and anti-I 
anti-sera. So, these blastocyst- stage embryos were normally explanted intact. 
Nearly all embryonic discs (and ICMs) attached within a short time to the STOs, 
whereas relatively fewer intact blastocysts attached and they were also slower to do so. 
Similar observations have been made by Notarianni and colleagues (1991). These 
differences in attachment, combined with the observation that fewer intact blastocysts 
yielded outgrowths from the 1CM (possibly because of senescence during the 
prolonged attachment phase) lead to the significantly lower proportion of day seven 
and day eight embryos yielding ES-like outgrowths, compared to day nine embryonic 
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discs. However, the outgrowth of an eight day old ovine intact blastocyst has given 
rise to an ES-like cell line (Notarianni a al., 1990a; 1991). 
Very few of the blastomeres from disaggregated compacting sheep morulae 
attached to the STOs in these studies; a problem also experienced with disaggregated 
mouse morulae (results not presented). It is possible that the EDTA/PBS solution 
used to dissociate the blastomeres may have damaged the cell membranes. While it 
may be easier to physically dissociate pre-compacting morulae, these blastomeres may 
be at a stage where their cell surfaces are not very adhesive, as indicated in the mouse 
at the equivalent embryo stage (Kimber, Surani and Barton, 1982). 
There may have been some effects of embryo stage upon ES-like cell isolation 
from the sheep. Although isolated ICMs and embryonic discs attached at a similar 
frequency, very few ICMs gave rise to proliferating ES-like outgrowths. This may 
have been due simply to an influence of cell number, whereby a greater number of 
1CM cells may have resulted in a greater chance of propagating those cells of a stem 
cell lineage. If this was the case, then several early cleavage-stage sheep embryos 
could be aggregated together and cultured to produce "giant blastocysts", from which a 
larger 1CM component could be isolated for stem cell culture. 
The isolation of ES cells may depend upon appropriate interactions between the 
embryos in culture. While ES cells condition medium and promote their own growth 
(Martin, 1981), the presence of differentiated cells may stimulate ES cells to 
differentiate (Robertson, 1987). The culture conditions, such as density of embryos 
and frequency of cell passage, may have significant effects upon these inter-
relationships. 
In these studies, intact embryos and embryonic discs were explanted initially in 
groups, onto STO feeder layers prepared in imi tissue-culture wells, to allow any 
factors produced by the embryos or outgrowths, and in particular the 1CM/primitive 
ectodermal cells, to have co-operative effects and stimulate the overall growth of 
undifferentiated cells in the culture. It may be useful to vary the number of embryos 
in an individual culture well in order to define the optimum. By culturing murine pre-
implantation embryos in groups in microdrops, both development and cell division 
were increased (Paria and Dey, 1990). This co-operative effect of growth factors may 
be dependent upon the number of embryos cultured and in what volume of medium. 
Any embryonic growth factors would be synthesised in very small amounts and by 
culturing embryos here in lml wells, any effect may have been diluted out. To avoid 
this effect of dilution of growth factors, embryos could be group-cultured initially in 
50tl microdrops in future experiments; this would represent a 20-fold reduction in the 
volume of medium compared to what was used in these studies. The decision not to 
use microdrops in the present experiments was to avoid any possible toxic effects of 
paraffin oil on sheep embryos and cell cultures. Although there may be species 
differences in sensitivity, this fear of toxicity may have been unjustified as paraffin oil 
appears to have no detrimental effects on murine ES cell isolation (this thesis). 
Similar growth factor interactions may be important in later phases of ES cell 
isolation. It may have been beneficial to have pooled several disaggregated 1CM 
outgrowths together, into the same feeder well, rather than culturing all the cellular 
pieces from one embryo outgrowth each in a separate well. This may have helped to 
stimulate the growth of any ES-like colonies present in a paracrine manner, as murine 
ES cells do appear to condition their own medium (Martin, 1981). If this approach 
had been adopted, then it would have not been possible to follow the fate of individual 
embryos. However, with the objective of isolating permanent cultures of ES-like 
morphology, such a strategy may be useful as shown elsewhere (Dr E. Notarianni, 
pers. comm.). If successful, the stem cells would have to be single-cell cloned, as it 
could not be guaranteed that the cells were derived originally from one embryo. 
There may be important genetic effects upon the isolation of ES cells (see chapter 
three), with differences between species, strains and individual embryos. Although 
comparative data on the efficiency of isolation of ES-like cells between the pig and the 
sheep in laboratories successful in the establishment of such cells is limited, there does 
appear to be a difference between the two species, with porcine embryos yielding stem 
cell-like colonies at a higher frequency than in the ewe (Notarianni et al., 1990a; 
1990b; Piedrahita et al., 1990b). During pre-implantation embryology, the embryos 
of both pigs and sheep form the characteristic quiescent embryonic disc of the ungulate 
species. The only obvious difference between the two species, over this period of 
embryo development, is in the timing of primitive endoderm differentiation; occurring 
relatively earlier in the sheep (on day seven) than in the pig (on day 10-12) (Handyside 
et al., 1987; Notarianni et al., 1991). If this is an important difference between the 
two species, accounting for the subsequent effects on stem cell isolation, then it may 
be necessary to culture embryos at earlier stages than were used here. If problems 
with embryo and cellular attachment can be overcome, with the use of more suitable 
feeder cells or factors which promote the adhesive properties of cells, it might then 
become productive to culture individual blastomeres from morula-stage sheep 
embryos. Such cells would not have been influenced by endoderm and may even be 
more mitotically active than the cells of the quiescent 1CM or embryonic disc. 
In the mouse, the culture of implantationally delayed embryos significantly 
increases the yield of ES cell lines (see chapter three). The only ungulate species to 
have an (obligative) form of implantational delay is the roe deer (Capreolus capreolus; 
Rowlands and Weir, 1984). The culture of a small number of delayed embryos 
recovered from roe deer in the wild, during the period of seasonal embryonic 
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diapause, has not given rise to any progressively growing ES-like outgrowths or cell 
colonies (Dr. J. McWhir, unpublished work). This might suggest deficiencies in the 
culture system and the need for species specific requirements. 
As an alternative approach to minimise the effects of differentiated cells, an 
effective anti-serum specifically against trophectodermal and endodermal cells may be 
useful in both immunosurgically isolating pure populations of 1CM cells from sheep 
blastocysts and for the specific cell lysis of differentiated cell types in early stem cell 
cultures. The presence of differentiated cell types appears to promote further 
differentiation (Robertson, 1987; and author's observations). Often ES-like colonies 
are too small to be picked out of cultures without extensive damage and "cell-peeling" 
techniques are not always effective in removing all differentiated cells. It has been 
observed here that once an ES-like colony commences to differentiate, firstly around 
the periphery of the colony, it is difficult to prevent the other cells within the colony 
from also being induced to differentiate. One way to prevent this is to disaggregate 
the colony, preferably into single-cells. However, early ovine ES-like colonies 
generally do not survive trypsinisation into single-cells, especially in the case of ES-
like colonies with very low cell numbers. An alternative strategy might be to use an 
anti-serum specifically against differentiated cells, which could lyse differentiating 
cells and so prevent the "factors" that may induce the remaining cells of the colony to 
change their morphology. The use of an ovine anti- trophectoderm anti-serum 
produced by Notarianni and colleagues (1990a) (which apparently binds to primitive 
endoderm as well) may be of some use in this approach; however, it has not been 
reported that this anti-serum does not bind to epitopes on the 1CM. The B006 anti-
carbohydrate antibody specifically recognises determinants present on the cell surface 
of the trophectoderm and (to a more limited extent) the primitive endoderm (see chapter 
six) and may be of potential use for immuno-cell lysis. A difficulty would arise in 
this system if the antibodies also bound to determinants present on the feeder cells. 
The inability of heat shock and puromycin treatments to result in the maintenance 
of ovine ES-like cells for more than two passages, may reflect a fundamental species 
difference compared to the mouse and/or, unfavourable culture conditions. Heat 
shocked and puromycin-treated embryos were cultured in ES15 medium, which was 
found in contemporary experiments not capable of supporting ES-like colonies derived 
from control embryos for more than two passages either. ES15 medium 
supplemented with PDGF and insulin or, medium containing Ultroser and FCS, may 
have been (slightly) more suitable. 
With sheep embryos, it is not known what temperature increase is required to 
result in the induction of the HSPs. In species such as the mammals, the maximum 
heat shock response is typically achieved when cells are exposed to a temperature 
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approximately 5°C above the physiological norm (Lindquist, 1986). However, the 
length of time the temperature remains elevated dictates the degree of stress the cells 
experience and in turn, the level and duration of production of the HSPs (DiDomenico 
et al., 1982). As the body temperature of the sheep is 39°C (Altman and Dittmer, 
1968) it is possible that the 10 minute exposure of ovine embryos to the maximum 
temperature used in these studies of 43°C was neither sufficiently high enough nor 
long enough to stress the cells into releasing the HSPs, or at least, not for any 
extended period of time. In future experiments, the brief exposure of sheep embryos 
to temperatures in the range of 44-46°C may be more appropriate in inducing greater 
production of the HSPs and perhaps also, in producing a stimulatory effect on the 
isolation of stem cells as observed in the mouse (chapter five). When reliable 
methods for the isolation of ungulate ES cells are available, it remains to be determined 
whether or not heat shock or puromycin treatments are effective in these species. 
The heat shock effect on stem cell isolation may be related to the stage of embryo 
development. In particular, the timing of heat shock in relation to endoderm 
differentiation may be very important. Although not significant, there appeared to be 
a slight increase in the proportion of mouse embryos yielding ES cell lines following 
heat shock of expanded blastocysts compared to hatched blastocysts (see chapter five), 
If the heat shock effect operates by interrupting the expression of genes responsible for 
differentiation of the 1CM (see chapter five), one might want to impose the heat shock 
before any primitive endodermal cells have begun the process of delaminating from the 
1CM. Of the sheep blastocysts treated with heat shock or puromycin in these 
experiments, only some of the day seven embryos would have been expected to have 
had no endodermal cells present (Handyside et al., 1987; McWhir et al., 1991). 
Embryo recovery on day six would yield some early blastocysts without endoderm, 
but given that attachment of intact embryos tends to be poor, with the 1CM 
degenerating within the embryo over time and that isolated ICMs appear to be too 
small to proliferate actively in culture, such an approach may be not be very fruitful. 
Perhaps a more useful stem cell isolation strategy would involve the aggregation of 
several eight-cell embryos together, to produce giant morulae, which were then heat 
shocked just after the embryos had begun to cavitate (so as to ensure that no endoderm 
was present) followed by immunosurgery, to isolate the enlarged ICMs for further 
culture. 
In summary, with the treatments studied here, the micro-dissection of day nine 
embryonic discs gave rise to higher proportions of ES-like outgrowths and first 
passage colonies which tended to survive and maintain an ES-like morphology slightly 
longer in culture, than intact blastocysts or ICMs from earlier embryo stages. This 
increase with embryonic discs may have been due to the higher rates of attachment, 
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higher numbers of ICWprimitive ectodermal cells and to the removal of at least the 
differentiated trophectodermal tissue from the cultures. If these points are important, 
then the immunosurgical isolation of ICMs derived from "giant blastocysts" at an early 
stage, when the 1CM may be less influenced by primitive endoderm, may be 
productive. Although medium similar to one formulation tested here, has been 
successful in the stable maintenance of one ovine ES-like cell line (Notarianni et al., 
1990a), culture conditions need to be improved for ovine embryos and for the ungulate 
species in general. Medium supplemented with PDGF and insulin appeared to 
maintain ES-like colonies for slightly longer. Factors preventing differentiation such 
as ovine LW may also be beneficial in maintaining the ES-like phenotype. Mass 
explant cultures of pure 1CM tissue, in a small volume of medium, may have auto-
stimulatory effects by concentrating any growth factors and/or anti-differentiation 
factors produced by the ICMs themselves. Such culture conditions may be important 
in stimulating the growth of ES-like cells derived from tissues which are mitotically 
inactive in vivo in the ovine embryo. Despite species differences in the factors which 
may be necessary to derive pluripotent cell lines from early mammalian embryos, the 
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